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ABSTRACT 
 
Background: Glutathione-S-Transferase (GST) family of enzymes serve as a key antioxidant 
system. Clinical evidence suggests that several GST polymorphisms are associated with 
inflammatory lung diseases. The mechanisms by which these polymorphisms impact on 
cellular responses to stress remain unknown. To define the specific role of GST isoenzymes, 
we investigated the influence of GST inhibition on lung cell survival and inflammation, in in 
vitro and ex vivo models.  
 
Methodology: Pulmonary cells were exposed to GST inhibitors ethacrynic acid or caffeic 
acid alone, or in combination with oxidative stressors hydrogen peroxide, tert-butyl-
hydroperoxide or hypoxia and reoxygenation. RNA interference was employed to attenuate 
specific GST isoform activity. Cell injury was assessed by MTT assay and flow cytometry. 
Oxidative stress was investigated by: (a) DHR123 and DCF fluorescence, (b) monitoring 
intracellular redox state by HPLC, (c) measurement of protein carbonyls by 
spectrophotometry and d) evaluation of the effects of specific and broad-spectrum 
antioxidants. Mitochondrial energetics was assessed by calculation of ATP/ADP ratios by 
HPLC, while global metabolic response was evaluated by NMR spectroscopy. An ex vivo 
mouse isolated perfused lung (IPL) model was used to explore the physiological role of GST. 
 
Principal findings: Two GST inhibitors and genetic attenuation of GST significantly 
increased oxidative stress and induced cytotoxicity of lung epithelial cells and rendered 
them more susceptible to oxidative stress. While cellular energy state was not 
compromised, EA potentiated protein carbonylation and caused metabolic derangements. 
Furthermore, in the ex vivo model, EA significantly increased pulmonary permeability and 
intra-alveolar oedema, which may have been responsible for the increase in pulmonary 
elastance and resistance that were also observed. 
 
Conclusion: These observations highlight the importance of GST enzymes, specifically GST, 
in the cellular and whole lung response to stress conditions and may help to understand the 
metabolic determinants of oxidative lung injury and adaptation.  
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Chapter 1: 
GENERAL INTRODUCTION 
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SUMMARY 
Since the original description of acute lung injury (ALI) and acute respiratory distress 
syndrome (ARDS) more than 40 years ago, investigators have endeavoured to elucidate the 
mechanisms regulating the pathways leading to lung injury, with the ultimate goal of 
developing therapeutic tools to ameliorate or prevent lung injury in patients at risk.  
 
This chapter will evaluate the current understanding of the molecular and cellular 
mechanisms involved in the pathogenesis of ALI, which can develop from a great variety of 
medical and surgical situations, such as pneumonia, cardiopulmonary bypass surgery or lung 
transplantation. We will focus on the pathophysiology of ischemia/reperfusion injury (IRI) 
which remains a major cause of ALI, especially following lung transplantation where 
subsequent morbidity and mortality affects up to 25% of recipients worldwide. The 
therapeutic strategies currently employed will also be described.  
 
One important facet of IR is oxidative injury, mediated by both reactive oxygen and nitrogen 
species (ROS and RNS, respectively). Indirect injury can also be mediated by ROS through 
alteration of redox (reduction and oxidation)-sensitive signalling molecules and transcription 
factors, leading to enhanced expression of pro-inflammatory genes. Under physiological 
conditions, a balance in the generation of reactive species and their deactivation by 
antioxidant defence systems is critical in the protection of cells against free radical toxicity. 
In the event of extreme ROS generation and inadequate antioxidant defences, due to their 
reduced expression and/or activity, oxidative damage ensues and can result in severe injury 
and inflammation. The involvement of oxidative stress and the importance of intracellular 
antioxidant defence mechanisms in ALI-related pathologies will also be addressed in this 
chapter.  
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Particular attention will then be given to the Glutathione-S-Transferase (GST) family of 
enzymes which are antioxidants responsible for the detoxification of a multitude of foreign 
substrates and oxidative stress products. Allelic variations (also known as polymorphisms) of 
GST isoforms can significantly reduce enzyme activity or result in the complete loss of 
isoform expression, such that GSTs are unable to provide optimal intracellular antioxidant 
protection. More recently such polymorphisms have been observed in critically ill patients 
suffering from proliferative and inflammatory diseases. For instance, a number of studies 
have demonstrated a significant relationship between the risk of developing cancer and 
polymorphisms in xenobiotic-metabolising enzyme genes. Similarly, the potential roles of 
GST isoforms in chronic and acute inflammatory conditions of the lung, such as asthma and 
ALI respectively, are emerging. As will be discussed, these findings strongly suggest that 
allelism in specific GST genes mediates inter-individual susceptibility and outcome of 
oxidative stress-mediated diseases and highlight the potentially critical role that GST 
enzymes play in such pathologies.  
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1.1 ACUTE LUNG INJURY (ALI) AND ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) 
 
1.1.1 Background 
ALI and the more severe form ARDS are diseases of acute respiratory failure characterized 
by a constellation of clinical, radiological, and physiological abnormalities. The first 
description of ARDS appeared in 1967 in a paper by Ashbaugh et al 8 which described 12 
patients with similar respiratory distress symptoms. In the clinical setting, patients were 
seen to suffer from lung dysfunction, due to decreased pulmonary compliance and 
pathophysiological events such as diffuse alveolar-capillary damage and severe pulmonary 
oedema which in turn resulted in impaired gas exchange and hence progressive hypoxaemia 
9. In 1994, a new definition for ALI and ARDS was recommended by the American-European 
Consensus Conference Committee to improve consistency amongst diagnoses and 
treatment. These diagnostic criteria included: increased capillary permeability, arterial 
hypoxaemia (where the ratio of ‘arterial oxygen partial pressure’ vs. ‘inspired oxygen 
fraction’, PaO2/FIO2; ≤300 mmHg and ≤200 mmHg, for ALI and ARDS, respectively), diffuse 
pulmonary infiltrates on chest radiography and the need for mechanical ventilation 10. 
 
Although ALI and ARDS are now better understood and advances in supportive therapy have 
led to a significant decrease in ARDS-related death 11, they remain frequent complications in 
critically ill patients and are responsible for significant morbidity and mortality 11,12. On the 
basis of the ALI/ARDS criteria established in 1994, it was recently estimated that 75,000 
people die of ALI in the United States alone each year, which accounts for over 40% of 
patients who acquire this pulmonary disorder 13. ALI and ARDS can develop from a variety of 
insults associated with direct pulmonary injury such as pneumonia or acid aspiration, and 
indirect lung injury, where there is a systemic cause such as sepsis or severe trauma. While 
sepsis and pneumonia account for about 60% of ALI/ARDS cases, a substantial fraction of 
patients undergoing elective and non-elective surgery are at increased risk of developing 
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lung injury because of preexisting medical conditions (e.g. tissue injury, infection), 
suggesting that more than one insult could be important in the development of ALI/ARDS. 
This is often referred to as the “two-hit” or “multiple hit” theory 14. In other circumstances, 
the nature of the surgery itself may predispose to the development of lung injury because of 
ischemia and reperfusion, as in the case of cardiac surgery or organ transplantation. 
Irrespective of the precipitating insult, symptoms can develop within 1 to 3 days after the 
onset of lung injury and if the patient survives, recovery can take up to 12 months. The time 
course of ALI and ARDS sets them aside from most other lung diseases, where alveolar 
damage naturally develops over a much longer period, usually years. 
 
1.1.2 Pathophysiology 
While the above definitions enable identification of patients early in the course of ALI and 
ARDS, the syndrome is often progressive and involves a complex interplay of events that can 
develop within a few days of the initial insult and often take weeks or months to resolve. 
The pathogenesis of ARDS can be characterised by three main stages with different clinical, 
histopathological and radiographic manifestations. The initial acute phase involves the influx 
of protein-rich oedema fluid into the air spaces as a consequence of increased permeability 
of the alveolar–capillary barrier 15. This is accompanied by an infiltration of neutrophils and 
macrophages and an intense inflammatory response. The fibroproliferative phase then 
takes place in surviving patients who fail to show spontaneous resolution. The final stage of 
ARDS involves resolution and recovery, a period in which the lung reorganises and recovers.  
 
Exudative stage 
In the acute phase of ALI, cells of the alveolar-capillary membrane together with cells of the 
innate immune and haemostatic systems are targets of damage and effectors of injury 
(Figure 1.1). The vascular endothelium and alveolar epithelium are the main sites of injury in 
extrapulmonary ARDS (e.g. sepsis) or direct pulmonary insults (e.g. pneumonia) respectively. 
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As a result, intercellular junctions loosen in the endothelial capillaries and alveolar epithelial 
lining. At this stage, respiratory failure is not apparent, however further endothelial and 
epithelial injury leads to increased permeability and influx of protein-rich fluid into the 
interstitial and alveolar space from the pulmonary microcirculation 12. Two physiological 
consequences of pulmonary oedema include impairment in gas exchange and a significant 
decrease in lung compliance (which increases the work of breathing). As a result, assisted 
ventilation is required to support most ALI patients. This acute exudative stage generally 
occurs 24 to 48 h after the initial insult and is clinically characterised by the presence of 
bilateral pulmonary opacities which may be patchy or asymmetric on the chest radiograph 
16. 
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The important role of the alveolar epithelial barrier in the pathogenesis and resolution of 
ALI has more recently been appreciated 17,18. It appears that the magnitude of epithelial 
injury determines the severity of lung injury and is therefore an important predictor of ARDS 
outcome 19. Similarly, efficient alveolar epithelial repair is crucial for ALI/ARDS patients’ 
Figure 1.1 A schematic of alveolar injury in the acute phase of ALI and ARDS. The respiratory 
syndromes are characterised by an increase in the permeability of the alveolar-capillary barrier 
leading to an influx of protein-rich fluid into the interstitial and alveolar spaces. Activation of 
resident macrophages and recruitment of activated neutrophils increases the inflammatory 
response. 
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recovery.  Under normal conditions the pulmonary epithelium acts as a simple barrier across 
which rapid diffusion of oxygen and carbon dioxide occurs. In addition, the epithelial barrier 
protects underlying tissue from mechanical injury, harmful chemicals and pathogens and 
prevents cells and plasma from flooding the air spaces, thereby maintaining normal gas 
exchange. Over 90% of the alveolar epithelium is made up of flat type I cells, creating a 
short distance between the alveolar lumen and bloodstream thus optimising the exchange 
of respiratory gases. They also play a key role in alveolar fluid clearance. The remaining 
alveolar surface area is covered by multifunctional cuboidal type II cells which are 
responsible for: surfactant production, ion transport, proliferation and differentiation into 
type I cells after injury. Damage to type I cells allows both increased entry of fluid into the 
alveoli and decreased clearance of fluid from the alveolar space. Type II cells are relatively 
more resistant to injury, however diffuse loss of type II cell integrity is always observed in 
both ALI and ARDS and is associated with a number of detrimental consequences. Such cell 
injury not only contributes to alveolar flooding, but also disrupts the removal of oedema 
fluid from the alveolar space 20.  
 
This oedematous environment impairs the diffusion of gases between the alveolar space 
and the capillaries, significantly reducing gas exchange which results in severe hypoxaemia - 
another main diagnostic criterion for ARDS. Furthermore, type II cell injury leads to a decline 
in the production and turnover of surfactant – released under normal conditions to reduce 
surface tension at the fluid-air interface and thus minimise alveoli collapse and maintain 
alveolar stability. The combination of increased oedema and decreased surfactant increases 
surface tension leading to decreased lung compliance and increased risk of alveolar 
collapse. Diffuse alveolar damage can also be identified histologically, where hyaline 
membranes (composed of necrotic epithelial cell debris and exuded proteins) are a 
prominent feature lining the air spaces. This is illustrated in Figure 1.2 B and D – histology 
images of lung tissue taken from subjects who died with ARDS 6. 
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An intense intra-alveolar inflammatory response, involving inflammatory mediator 
production and often neutrophil infiltration is also characteristic of the acute phase of ARDS 
12,15. This inflammatory response is thought to be dependent upon the activation of lung 
macrophages, which can upregulate pro-inflammatory cytokines such as interleukin (IL)-1, -
6, and tumour necrosis factor-alpha (TNFα). The release of chemokines, a family of small 
chemoattractant cytokines, is often stimulated by pro-inflammatory cytokines such IL-1 and 
leads to further macrophage activation and the recruitment of monocytes, neutrophils and 
other effector cells from the blood to sites of tissue damage. In humans IL-8 is one of the 
best-characterized chemokines. While rodents lack a direct homologue of IL-8, macrophage 
inflammatory protein (MIP)-2 and keratinocyte-derived chemokine (KC) are regarded as 
functional homologues of IL-8 21 and have been found to contribute to the pathology of a 
number of neutrophil-dependent animal models of disease, including pulmonary IRI 22. The 
persistence of neutrophils and high cytokine levels in bronchoalveolar lavage fluid (BALF) 
predict a poor prognosis of ARDS patients 23, most probably due to increased chemotaxis, 
recruitment and uncontrolled leukocyte trafficking into the lung.  
Figure 1.2 Lung histology from control and ARDS patients. Representative photomicrographs of 
distal airway and alveolar tissue from control (A and C) and ARDS (B and D) patients 6. ARDS lungs 
show extensive intra-alveolar exudate (B) and small airway thickening and epithelium denudation 
(D). SA = airway; L = lumen; EP = epithelium; SM = smooth muscle; OL = outer layer; IL = inner layer. 
 24 
Increased recruitment of leukocytes to the lungs is observed following cytokine-mediated 
upregulation of surface adhesion molecules (such as E-selectin, intercellular adhesion 
molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)) on the pulmonary 
endothelium and epithelium. For many years it has been believed that vascular endothelial 
cells are the main players in inflammatory reactions following pulmonary insult, as their 
surface expression of adhesion molecules enhances the rolling and firm adhesion of 
circulating polymorphonuclear neutrophils (PMNs) and facilitates their transmigration into 
the interstitial and alveolar compartments. PMNs release leukotrienes, oxidants, platelet-
activating factor and proteases capable of damaging capillary endothelium and alveolar 
epithelium and thus disrupting the barriers between capillaries and airspaces.  
 
It is not only the vascular but also the airway epithelial expression of inflammatory 
mediators that plays an important role in the initiation and exacerbation of an inflammatory 
response within the airways. For instance, upregulation of ICAM-1 was detected on rat 
alveolar epithelial cells, in vitro and in vivo, after lipopolysaccharide (LPS) stimulation and 
adherence assays revealed a significant increase in adhesion of neutrophils, which was 
reduced by ICAM-1 blockade 24. ICAM-1-triggered tight adhesion of leukocytes, appears to 
promote epithelial cell injury through release of toxic products such as ROS (hydrogen 
peroxide, singlet oxygen) and RNS (peroxynitrite) from the recruited PMNs and activated 
lung macrophages 25. It has also been documented that enhanced ICAM-1-mediated 
adhesion of alveolar macrophages to the epithelial cells results in intensified production of 
cytokines and chemokines which leads to further inflammation and injury 26. As well as 
adhesion pathways providing a mechanism for translocation of leukocytes from blood to 
inflammatory sites and retention of leukocytes within the alveolar compartment, they also 
appear to participate in intracellular signaling. For example, the release of soluble ICAM-1 
has been found to enhance alveolar macrophage production of MIP-1 and TNFα 27. 
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Considerable experimental and clinical evidence suggests that an increase in pro-
inflammatory mediators is always accompanied by the production of powerful anti-
inflammatory mediators, which prove critical in the regulation of the inflammatory 
response.  Prime examples are IL-10 and IL-13, that exert their anti-inflammatory activity in 
part through inhibition of nuclear factor kappa B (NFB) activation by blocking hydrolysis of 
inhibitor kappa B (IB), which is generally interlocked with NFB 28. This suppresses gene 
expression and thus further production of pro-inflammatory mediators. Cytokine inhibitors 
such as IL-1-receptor antagonist and soluble TNF receptors are also frequently found in the 
alveolar space 29. It is the balance between pro- and anti-inflammatory mediators that 
determines the outcome of the inflammatory response – i.e. progression or containment. 
However, inflammation is not solely localised to the lungs, as pro- and anti-inflammatory 
mediators are also elevated in the circulation of ARDS patients 30. Moreover, the majority of 
ARDS-related mortality is not from primary respiratory failure, but from multiple organ 
failure 31. This is perhaps mediated by leakage of inflammatory cytokines from the alveolar 
space into the circulation leading to systemic expansion of the pulmonary inflammation, 
however the precise source of inflammatory mediators remains unknown. 
 
Fibroproliferative stage 
Some patients display complete recovery after the acute phase, others exhibit pulmonary 
fibrosis generally at 4 to 7 days after the initial insult. During this stage, type II cells multiply 
to reconstitute the alveolar lining yet if injury is very severe, chronic inflammation ensues 
along with leukocytosis, interstitial inflammatory infiltrates, fibroblast proliferation and 
increased deposition of connective tissue 16. Patchy areas of evolving fibrosis can be 
visualised on chest radiographs and is clinically presented by persistent hypoxaemia, 
increased alveolar dead space and a further decrease in pulmonary compliance 12. It is not 
surprising therefore, that the presence of pulmonary fibrosis correlates with ARDS-related 
mortality and represents a major cause of death in ALI patients 32. 
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Resolution and Recovery 
The recovery phase is generally characterised by the gradual resolution of hypoxaemia, 
improved lung compliance and the complete resolution of radiographic abnormalities. 
Despite severe injury to the lung, the pulmonary function of the majority of survivors 
returns to nearly normal levels within 6 to 12 months. However, severe disease and 
prolonged mechanical ventilation identify patients at highest risk for persistent 
abnormalities of pulmonary function 33. Those who survive the illness generally have a 
reduced health-related quality of life 34. 
 
1.1.3  Supportive therapy and treatment 
Over the past two decades, significant advances have emerged in our understanding of the 
clinical conditions and pathophysiological changes associated with ARDS which have in turn 
led to the assessment of several novel treatment strategies. Although many specific 
therapies have not proved beneficial, which may be due to the heterogeneous nature of the 
respiratory syndrome, improvement in the supportive care and altering the approach to 
mechanical ventilation of patients is believed to have contributed to the recent decline in 
the mortality rate 35. Supportive care for patients includes the identification and treatment 
of the precipitating insult (e.g. infections such as sepsis or pneumonia) to attenuate 
pulmonary and systemic injury while simultaneously maintaining adequate oxygenation, 
fluid balance and nutritional support.  
 
Ventilation strategies 
Since one of the major physiological abnormalities in ARDS is hypoxaemia, current 
therapeutic strategies are designed to increase tissue oxygen delivery by increasing both 
arterial oxygen tension (by mechanical ventilation) and cardiac output. Mechanical 
ventilation is often employed to maintain adequate gas exchange until resolution however it 
must be carefully monitored to prevent the development of ventilator-induced lung injury 
 27 
(VILI) – a condition associated with alveolar over-distension and damage. It is also believed 
that the phasic opening, overstretching  and closing of lung units causes release of cytokines 
and amplification of the local and systemic inflammatory response 36. Therefore limiting the 
extent of volume expansion by using lower tidal volumes and preventing repeated collapse 
by the application of positive-end expiratory pressure (PEEP) is currently used to reduce 
these iatrogenic components of injury and inflammation. Moreover the use of PEEP can help 
to reverse alveolar collapse and allow a lower oxygen concentration to be administered, 
thus reducing the risk of oxygen-induced lung injury 37. These changes in the method of 
mechanical ventilation in addition to the improved supportive care of critically ill patients, 
have reduced mortality rate significantly 38.  
 
Attenuation of pulmonary oedema  
Many studies have explored additional treatments which target specific aspects of ARDS 
such as the development of pulmonary oedema. Restrictive fluid management is one 
method used to decrease hydrostatic pressure in the pulmonary circulation and thus 
attenuate oedema formation. Such treatment was found to reduce intravascular pressures 
and lung injury scores and improve oxygenation, resulting in more ventilator-free and ICU-
free days. However this did not translate into significant differences in mortality between 
patients receiving liberal and restrictive fluid management 39. Another approach has 
involved the use of beta-adrenergic agonists (such as salbutamol) to induce clearance of 
oedema fluid and thus aid resolution of ARDS. A recent UK clinical study found that patients 
treated with salbutamol had significantly lower lung water and plateau pressures, 
suggesting enhanced fluid reabsorption, and displayed reduced lung injury 40. Manocha et 
al. also showed that patients receiving a higher dose had significantly more days free of 
severe hypoxaemia and ALI 41. However, all other variables, including mortality, were not 
significantly different between salbutamol and placebo treated groups. Subsequent studies 
using β2 agonists have been terminated as the effectiveness of such treatment in ARDS 
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patients is not clear. Other groups have attempted to replenish the key players of fluid 
clearance – alveolar epithelial cells, which frequently undergo cell death during ARDS. 
However, the beneficial effects of epithelial mitogens, used to promote epithelial 
proliferation, have only been shown experimentally 42.  
 
Surfactant therapy 
Since epithelial cells are also responsible for the production of surfactant, which plays an 
important role in normal lung function and exhibits anti-inflammatory and antibacterial 
properties, their loss often leads to surfactant dysfunction in the lungs of ARDS patients. 
Surfactant-replacement therapy has proved successful in neonatal and child respiratory 
distress syndrome however no significant benefits have been observed in adults 43,44. In fact, 
a recent study, carried out in 2009, revealed that instillation of exogenous natural porcine 
surfactant into patients with ALI/ARDS had adverse effects and showed a trend towards 
increased mortality 45. The variability in the results of clinical trials may be, in part, due to 
the various surfactant preparations used, the different delivery and dosing methods 
employed, and the types of patients targeted for this therapy 12. 
 
Anti-inflammatory therapy 
The enhanced inflammatory response in ALI and ARDS prompted several groups to explore 
the use of anti-inflammatory treatments in the attenuation of ARDS severity. General anti-
inflammatory agents such as ibuprofen and prostaglandin E1 have proved unsuccessful as 
treatments 42. While some studies have suggested that systemic corticosteroids may be 
beneficial in the inflammatory regulation of late-stage ALI/ARDS, others have reported that 
they have no influence on mortality and may in fact be deleterious when given too early 46. 
Inhibition of specific factors involved in the inflammatory cascade of ARDS, such as IL-1, 
TNFα and adhesion molecule expression has also been investigated, but these have 
generally been unable to improve survival 47. This may reflect the complexity of the 
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inflammation or the inability to deliver these agents early enough in the course of the 
illness. Another key mediator of the inflammatory response is the enhanced β2 integrin-
mediated migration of circulating neutrophils from the blood to the alveolar space. Blocking 
β2 integrins has protected against lung injury in many experimental studies 48 yet the clinical 
relevance of these animal models remains unclear. While ARDS is clearly an inflammatory 
syndrome it appears that modulation of the inflammatory response, using both general and 
specific treatments, is a controversial approach. 
 
Vasodilators 
In 1992, inhaled nitric oxide (iNO), a selective pulmonary vasodilator, emerged as a potential 
therapy for ARDS as it decreased pulmonary vascular resistance without affecting systemic 
blood pressure and improved oxygenation by redistributing pulmonary blood flow towards 
ventilated lung units 49. Despite such promise, the potential therapeutic role of iNO in adults 
remains uncertain, for recent studies have shown that iNO resulted in only a transient 
increase in PaO2/FIO2 of ARDS patients 
50 and failed to reduce mortality or the duration of 
mechanical ventilation 51. Treatment with several less selective vasodilators, including 
hydralazine and prostaglandin E1  have also been proposed as possible therapeutic agents in 
reducing pulmonary arterial hypertension, but these too have been largely unsuccessful 12. 
 
In summary, although some therapies have resulted in improved oxygenation and reduced 
lung injury scores, these have not translated into reductions in the duration of mechanical 
ventilation or mortality. Until new data emerge, the focus will remain on supportive care, 
including identification and treatment of any underlying disease. Further understanding of 
disease heterogeneity and the underlying causes, through use of biological and genetic 
approaches is required in providing major new insights into the pathogenesis of ALI.  
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1.2 ISCHEMIA/REPERFUSION  
 
1.2.1 Background  
ALI and ARDS can develop from ischemia followed by reperfusion, either in the lungs or in 
distant vascular beds. Ischemia describes an inadequate perfusion of tissues resulting in 
reduced oxygen delivery and the deprivation of crucial metabolic substrates together with 
reduced elimination and hence accumulation of metabolic end-products. Among the 
substrates, oxygen (O2) and glucose are particularly important for oxidative and anaerobic 
metabolism. Timely re-establishment of blood flow is essential to salvage the ischemic 
tissue. However reperfusion after a prolonged period of ischemia induces a wide array of 
inflammatory responses and oxidative damage as a result of increased oxidative stress, 
rather than restoration of normal function. This coordinated series of events involving 
components of the innate and adaptive immune systems can result in widespread necrosis 
and apoptosis and subsequently exacerbate local damage to the ischemic tissue. The 
resulting injury is commonly termed ‘Ischemia/Reperfusion Injury’ (IRI) 52.  
 
Pulmonary IRI is a complex pathological condition, characterised by non-specific alveolar 
damage, lung oedema and hypoxaemia. It can occur in several pulmonary disorders such as 
pulmonary artery thromboendarterectomy 53 and thrombolysis after pulmonary embolism.  
54 IRI can also develop shortly after major surgery, including cardiac surgery using 
cardiopulmonary bypass and lung transplantation due to transient or prolonged periods of 
cessation of pulmonary blood flow. For patients with progressive end stage lung disease and 
a poor prognosis, lung transplantation is a therapeutic option which offers an opportunity 
for improved survival and quality of life. These diseases include cystic fibrosis, chronic 
obstructive pulmonary disease (COPD), pulmonary fibrosis and pulmonary hypertension 55 
and collectively are amongst the most common causes of morbidity and mortality 
worldwide. In spite of significant medical advances in the diagnosis and treatment of this 
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heterogeneous group of diseases, many patients experience continued impairment in 
pulmonary functional capacity and fail to respond to conventional medical therapy, thus 
lung transplantation remains the treatment of choice. 
 
Lung transplantation 
Donor lungs are assessed thoroughly against several criteria such as: donor history, 
minimum pulmonary secretions, clear chest radiographs and blood type, in an attempt to 
determine function, viability and compatibility. This enables identification of lungs which are 
most likely to handle several hours of ischemia, without significant impairment in their 
function after reperfusion. Only those judged as suitable (approximately 10 - 30%) are 
selected for transplantation 56 allowing approximately 1,500 lung transplantations to be 
performed annually 57. It is acknowledged that a degree of early lung allograft dysfunction 
(due to widespread epithelial and endothelial cell death) is an inevitable problem that 
occurs in nearly all lung transplantation recipients 5. Furthermore, in up to 20-25% of 
transplants, IRI presents in its most severe form Primary Graft Dysfunction (PGD). PGD has a 
mortality rate of up to 40% 58 and represents the primary cause of morbidity and mortality 
in the early postoperative period 59. In addition severe IRI can also be associated with an 
increased risk of acute rejection that may lead to PGD in the long term 60. Similarly to ALI 
and ARDS, a grading system, established by The International Society for Heart and Lung 
Transplantation, is now used to define PGD based on PaO2/FIO2 and the presence of 
infiltrates on chest x-rays 61. IRI-mediated Grade 2 and Grade 3 PGD is equivocal to ALI and 
ARDS, respectively 58. 
 
The techniques employed for lung preservation and transportation may contribute to such 
severe injury. Initially the lungs are retrieved and flushed with a preservation solution (such 
as modified Euro-Collins solution, or more recently extracellular-type solutions like 
Perfadex: a low potassium dextran solution supplemented with glucose) at 4°C, following 
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which they are immersed in crystalloid solution and transported on ice. While hypothermia 
is essential in decreasing metabolic rate and energy requirement of the lungs until 
implantation into the recipient, it is in part responsible for the injury sustained during 
recovery, preservation and transplantation. In addition, static inflation of the lung with O2, 
(where the lung is maintained in its inflated or inspiratory state), is employed for 
transportation, yet there are controversies as to whether the state of lung inflation or type 
of gas mixture in the alveoli leads to a better outcome 62,63. While several parts of the lung 
remain susceptible to ischemic injury, the current techniques can maintain satisfactory graft 
function for up to 8 h of ischemia. 
 
1.2.2 Pathophysiology of pulmonary IRI  
Experimental and clinical evidence suggest that IRI occurs in a biphasic pattern. Alveolar 
macrophages are activated during ischemia and mediate the early phase of reperfusion 
injury, as their specific inhibition prior to ischemia results in better lung function 
immediately after reperfusion 64. In contrast, recipient lymphocytes and neutrophils appear 
to be primarily involved in the delayed phase of reperfusion injury, which often occurs 
within 24 h of initial reperfusion 65. Interestingly, short periods of cold ischemia alone, or in 
combination with lung reperfusion do not appear to cause severe injury, however lung 
reperfusion after prolonged periods of ischemia leads to significant apoptosis and necrosis 
66. Thus, it appears that the degree of apoptotic and necrotic cell death is significantly 
influenced by the ischemic duration, and exacerbated by reperfusion 67. 
 
Cold ischemia-induced injury 
Although hypothermia is essential in organ transplantation, it disturbs many intracellular 
mechanisms. For instance membrane stability, which depends on the lipid-bilayer integrity 
and on tight control of temperature, pH, and osmolarity, is disrupted by cold ischemia 
during the lung preservation period. One of the major roles of membranes is to accurately 
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control movement between cells or intracellular compartments. Hypothermic storage 
increases membrane permeability to calcium in particular, resulting in the release of calcium 
from intracellular depots and rapid influx through the plasma membrane 68. The alteration 
of pH and calcium concentration alters the intracellular buffering capacity and subsequently 
disrupts many processes which may ultimately cause cellular damage 68. For example 
calcium increases calmodulin activity which stimulates the production of prostaglandins. 
These inflammatory mediators (along with oxidative stress products) can promote leukocyte 
recruitment and degranulation with resulting proteolytic damage to the organ. Elevated 
cytosolic calcium induces the conversion of xanthine dehydrogenase (XD) to xanthine 
oxidase (XO), which significantly enhances free radical production upon re-oxygenation 69 
(as illustrated in Figure 1.3). The role of ‘calcium overload’ in the pathogenesis of IRI has 
been supported by several groups who have demonstrated the protective effect of calcium 
channel blockers such as verapamil and diltiazem 70,71. 
 
Hypothermia also slows the degradation rate of waste molecules and decreases the activity 
of key intracellular and membrane-bound enzymes, most of which show a 1.5- to 2.0-fold 
decrease in activity for every 10°C decrease in temperature 68. For instance, a fall in the 
activity of mitochondrial translocases, key in transporting adenosine diphosphate (ADP) into 
the mitochondrion for conversion to high-energy adenosine triphosphate (ATP), disrupts the 
cellular balance of ATP, ADP and adenosine monophosphate (AMP). Adenylate kinase 
converts excess ADP accumulating in the cytoplasm, to ATP and AMP. This effect not only 
results in the loss of ATP precursors from the cell, but also increases cytosolic ATP which is 
subsequently degraded into hypoxanthine, given the anoxic conditions. Upon reoxygenation 
(following reperfusion and/or ventilation), hypoxanthine is broken down into superoxide 
(•O2
-) and hydrogen peroxide (H2O2) (as illustrated in Figure 1.3 
5), and thus enhances the 
level of oxidative stress.  
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Oxidative stress, resulting from increased ROS generation is a major aspect of both ischemia 
and reperfusion. While the endothelium is the main source of oxidants in lung ischemia, 
macrophages, neutrophils and epithelial cells also contribute. Two important mechanisms 
lead to the production of ROS; the first, as described above, results from the XO-mediated 
degradation of hypoxanthine into •O2
- upon reoxygenation. The other mechanism depends 
on the NADPH oxidase system, which is present on the membrane of neutrophils and 
monocytes/macrophages and catalyses the reduction of O2 into H2O2
 and •O2
- 72 In the 
absence of mechanical flow, endothelial cell membranes depolarize which also induces 
activation of NADPH oxidase 73. Moreover, Hx has been found to inhibit the mitochondrial 
superoxide dismutase (SOD), resulting in the accumulation of •O2
- at the onset of Rx 74.  
 
Powerful oxidants are also generated by iron, which can be released from ferritin and 
cytochrome P-450 during ischemia. In its free form, iron can cycle between the oxidised 
(Fe3+) and reduced state (Fe2+), and catalyse the transformation of H2O2 and •O2‾ into the 
highly reactive hydroxyl radical (•OH¯) via the Fenton reaction. In addition, free iron 
Figure 1.3 Reactive oxygen species (ROS) formation during pulmonary ischemia/reperfusion and 
anoxia/reoygenation 5. 
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facilitates the breakdown of lipid hydroperoxides into further oxidative products and 
accelerates the oxidation of glutathione (GSH). Such findings have been supported by iron-
supplementation or iron chelation studies which have exacerbated or protected against 
tissue injury, respectively 75,76.  
 
While IR normally corresponds to anoxia/reoxygenation in organ transplantation, the lung 
alveoli contain O2 during
 ischemic preservation, which helps maintain aerobic metabolism. 
However alveolar O2 tension
 can drop significantly after prolonged ischemia, resulting in a 
shunt from aerobic to anaerobic glycolytic respiration, generating more lactate and less ATP. 
Thus, despite slower metabolism (due to hypothermic conditions), ATP is gradually depleted 
which affects key homeostatic processes. For instance, the sodium-potassium ATPase pump, 
essential in maintaining the ionic composition of the cell, becomes paralysed in the absence 
of ATP. Potassium moves out of the cell whereas sodium, which is normally kept at a low 
concentration in the cell, is taken up. This ionic shift can cause cell swelling and death. In the 
setting of ALI, these factors impair epithelial alveolar fluid uptake which can accelerate 
oedema formation 24,77.  
 
Reperfusion injury 
It is well documented that much of the injury to transplanted organs occurs not during 
ischemia, but during reperfusion/reoxygenation. For instance, one study reports that 
cardiomyocytes exposed to 1 h of simulated ischemia followed by 3 h reperfusion 
demonstrate accelerated death following reperfusion compared with cells maintained in 
ischemic conditions over 4 h (where cell death was 73% and 17% of total population, 
respectively) 78. Therefore, despite cold ischemic conditions reducing the metabolic rate of 
many processes, a number of events can still occur and be deleterious to the preserved 
organ upon reperfusion, including accumulation of ROS and activation of inflammatory 
mediators. 
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ROS are recognised as the primary mediators of reperfusion injury and several experimental 
studies have found that ROS-induced injury is attenuated by XO inhibitors specifically, 
suggesting XO is a major initiator of ROS generation and subsequent injury 79. Upon re-
oxygenation, XO uses O2 to convert accumulated metabolites hypoxanthine and xanthine to 
uric acid, and forms the highly reactive •O2
- (Figure 1.3) and •OH¯ radicals as by-products. In 
addition, excess NO can react with •O2
- to produce peroxynitrite. The •O2
- radical is also 
produced by NADPH oxidase and components of the mitochondrial electron transport chain 
(ETC) following incomplete oxygen reduction. These processes are fully described in ‘1.3: 
Reactive Oxygen Species’. Such ROS and RNS attack DNA, lipids and proteins and initiate a 
production cascade of tissue damaging oxygen species 80. Oxidative stress, arising from 
excessive ROS production and their inadequate removal by antioxidants, can directly or 
indirectly result in apoptosis following cell/organelle damage or activation of redox-sensitive 
cell death signalling pathways, respectively. These processes will be discussed in more detail 
in ‘1.4: Oxidative Stress’.  
 
An increase in ROS can also induce an inflammatory response following activation of donor 
and recipient leukocytes, epithelial and endothelial cells, which will in turn release a wide 
range of soluble “pro-inflammatory” molecules, including prostaglandins, leukotrienes and 
cytokines. As such, ischemia and reperfusion are associated with a marked increase in TNFα, 
interferon-γ, IL-1, and IL-8 specifically 5. Such mediators act as signalling molecules, 
activating resident leukocytes and stimulating an upregulation in cell surface adhesion 
molecules on the microvascular endothelium 5. While adhesion molecules are unlikely to 
directly induce cell death, their enhanced expression propagates existing inflammation and 
injury via recruitment of circulating leukocytes, for blockade of specific adhesion molecules 
at the time of reperfusion significantly reduces reperfusion injury 81.  
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Nature of cell injury 
A direct correlation between the degree of apoptosis and pulmonary dysfunction remains 
controversial. Some studies have found a reduction in kidney and heart IRI when anti-
apoptotic agents are injected before reperfusion in mouse models of warm ischemia 82. In 
addition, experimental and clinical studies have reported that the two major apoptotic 
pathways are activated at the early and later stages of reperfusion: the intrinsic pathway, 
mediated by the mitochondria, is activated by ROS; whereas the extrinsic pathway is 
activated by the ligation of death receptors with their ligands, such as Fas with Fas-ligand. In 
addition, numerous regulatory mediators and supplementary pathways such as mitogen-
activated protein kinase (MAPK)-mediated tyrosine phosphorylation and activation of Bcl-2 
pro/anti-apoptotic family members have been implicated in the fine-tuning of the apoptotic 
response following pulmonary IR. At present the relative importance of these apoptotic 
factors in lung IRI remains unknown 83. 
 
It is also possible that blocking the apoptotic pathway after ischemia may promote necrosis 
and increase release of pro-inflammatory agents which may lead to prolonged 
inflammation. Tissue necrosis, an uncontrolled form of cell death, has also been associated 
with significantly worsened lung function (assessed by PaO2, wet:dry weight ratio and peak 
airway pressure) and severe inflammation 84, which peaks rapidly after reperfusion. Such 
inflammation is absent following apoptosis, most probably due to the controlled nature of 
cell death and the rapid phagocytosis of dead cells by macrophages 67.  
 
Despite controversies regarding the nature of cell death in IRI, there is substantial evidence 
to suggest that apoptosis is a prominent feature in several pulmonary disease pathologies 
such as lung cancer and ALI 83,85. In addition, one study examining tissue biopsies following 
human lung transplantations found that over a third of cells exhibited evidence of apoptosis 
after 2 h reperfusion, even in successful lung transplants with good clinical outcome 86. 
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1.2.3 Potential therapeutic strategies in prevention and treatment of pulmonary IRI 
Over the past decade, a better understanding of the key molecular and cellular mechanisms 
of pulmonary IR has led to the development of several potential therapeutic strategies, 
some of which have been briefly described in ‘1.1.3: Supportive therapy and treatment’ and 
are discussed in further detail below. In addition, an improved assessment and preservation 
of donor lungs and careful management of transplanted lungs after reperfusion have 
collectively been associated with a reduced severity of IRI and incidence of PGD following 
transplantation. Despite these advancements, the incidence of PGD remains high and is the 
most common cause of death in the early post-transplant period 87. 
 
Treatment of underlying donor lung injury prior to transplantation 
Insults to the donor lung prior to retrieval, may activate the release of inflammatory 
parameters which can contribute towards and amplify the impact of IRI following 
transplantation, as illustrated in Figure 1.4.  
 
Activation of 
inflammatory 
parameters
 
 
 
Figure 1.4 Insults that potentially aggravate pulmonary ischemia/reperfusion injury (IRI). These 
events can occur in the donor (before lung retrieval) or during cold ischemic preservation of the 
lung 5. 
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Strategies have thus been taken to identify and treat such factors independently. For  
instance, a significantly higher level of inflammatory cytokines have been found in lung 
tissue and BALF taken from cadaveric donors compared with those taken from donors with 
no previous injury. Furthermore, such donors have been strongly associated with 
development of PGD 88. Brain death has also been found to disrupt homeostatic regulation 
and affect endocrine function, which may reduce the tolerance of the organs towards 
ischemia 89,90. Such donors have been treated with steroids after brain death declaration 
which was found to improve PaO2 and increase lung donor recovery 
91. Therefore, it has 
been proposed that immediate assessment of lung inflammation prior to lung 
transplantation could be useful in determining the suitability of lungs for transplantation 
and the tolerance to prolonged ischemia 5. 
 
Preconditioning 
Tissues exposed to one small insult can develop tolerance to a subsequent major insult, a 
concept termed preconditioning. Hyperthermic, ischemic and chemical preconditioning 
have been explored in animal lung models in an attempt to attenuate pulmonary IRI. All 
types were shown to upregulate the synthesis of heat shock proteins which maintained ion 
transport and alveolar fluid clearance and thereby preserved gas exchange function and 
attenuated increased vascular permeability 92,93. Experimental models of ischemic 
preconditioning (IP) specifically, have shown a reduction in markers of lung IRI (such as 
malondialdehyde) and pulmonary arterial pressure compared with the non-preconditioned 
group 94. Preconditioning with various chemicals has also been beneficial. For example NO 
induces pulmonary neutrophil apoptosis, reducing their ROS production (primarily •O2
-) and 
decreasing the release of inflammatory cytokines from alveolar macrophages 95. An inhibitor 
of mitochondrial complex II, 3-nitropropionate, has also been able to precondition the lungs 
and attenuate subsequent IRI by preventing oxidative phosphorylation and oxidative stress 
to the cell after reperfusion 96. 
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Interestingly, experimental studies have shown that a critical threshold of ischemia 
(duration and cycles) was required to trigger the adaptive mechanisms involved in IP-
mediated protection against IRI in myocardium 97. Above this threshold, the protection 
conferred by IP was a graded phenomenon dependant on the intensity of the 
preconditioning stimulus. Similarly, the duration of reperfusion also determines the 
protection achieved by IP 98. While IP has been effective clinically in hepatic resection 99 and 
in coronary artery bypass graft surgery 100, it has not yet been attempted in the human lung 
due to the complexity of its dual blood supply and ventilation. 
 
Surfactant therapy 
Surfactant dysfunction increases progressively during pulmonary IRI 101 which correlates 
with decreased pulmonary compliance and lung oxygenation 102. In the setting of lung 
transplantation, experimental and clinical studies have found that exogenous surfactant 
therapy can improve pulmonary function and enhance immediate recovery from IRI 103. 
Moreover, nebulized synthetic surfactant has been successfully used in several lung 
transplant patients with severe IRI and leads to rapid recovery and removal of mechanical 
ventilation shortly after the application 103. Despite these promising findings, it is important 
to note that surfactant treatment in ALI patients has not shown significant benefits 43,44. 
 
Modulation of inflammatory processes 
Several inflammatory pathways have been associated with the development of IRI and thus 
inhibited in an attempt to attenuate injury. For instance, the potent chemokine IL-8, found 
in BALF and lung tissue has been strongly associated with the risk of death following lung 
transplantation 104. Moreover, administration of anti-IL-8 antibody at the start of 
reperfusion significantly reduces neutrophil infiltration after 3 h reperfusion in a rabbit 
model of IRI, improving lung survival and outcome 105. Another key mediator of IRI is the 
complement system, a circulating group of small inactive proteins which initiate an 
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amplified cascade of cleavages upon stress-induced activation, resulting in increased 
vascular permeability, degranulation of white blood cells and severe cell injury. The toxic 
effects of C5a specifically have been highlighted by its ability to induce granule secretion 
from phagocytes and release of toxic oxygen metabolites from neutrophils and 
monocytes/macrophages 106. In order to attenuate C5a-mediated damage, complement 
receptor-1 has been used as a soluble complement antagonist prior to reperfusion. This 
reduced swine lung oedema, decreased neutrophil infiltration and improved oxygenation of 
transplanted lungs 107.  
 
Alternatively, anti-inflammatory pathways can be enhanced to reduce IRI. For instance, the 
continuous administration of prostaglandin PGE1 into animal models has been found to 
reduce endothelial permeability, neutrophil adhesion and platelet aggregation upon 
reperfusion primarily due to its anti-inflammatory nature 108. Prospective randomised trials 
are yet to determine whether routine PGE1 has an overall beneficial effect in the 
postoperative period after clinical lung transplantation. Gene therapy has also been 
employed to enhance the expression of anti-inflammatory players. Two independent studies 
have successfully transfected donor lungs of rats and humans with an adenoviral vector 
encoding the human IL-10 gene (AdhIL-10) via the transtracheal route prior to retrieval and 
during preservation of the lung, respectively. This anti-inflammatory cytokine inactivates 
antigen-presenting cells and consequently inhibits pro-inflammatory cytokine secretion. The 
AdhIL-10–treated rat lungs exhibited attenuated inflammation and improved function after 
transplantation 109. Similarly, AdhIL-10–treated human lungs (from cadaveric donors) which 
were determined as clinically unsuitable for transplantation, showed significant 
improvement in function (higher PaO2 and reduced pulmonary vascular resistance) when 
compared to controls, following 12 h ex vivo lung perfusion. A shift from pro-inflammatory 
to anti-inflammatory cytokine expression was also observed in addition to recovery of the 
alveolar–blood barrier integrity. These data highlight that gene therapy can improve the 
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function of human donor lungs, potentially rendering injured lungs suitable for 
transplantation into patients 109,110.  
 
Nitric oxide 
Intracellular NO is significantly reduced following pulmonary IR in human and animal studies 
111,112 which may be associated with rapid destruction of NO by oxygen-free radicals after 
reperfusion and/or release of NO synthase (NOS) inhibitors 111,113. As NO is a potent 
vasodilator it can reduce pulmonary vascular resistance and facilitate the distribution of 
blood flow in the lung, resulting in improved pulmonary hemodynamics and oxygenation. 
Interestingly, the benefits of NO are not shared by other vasodilators, highlighting a unique 
biological action of NO. This could be related to its anti-inflammatory nature, which has 
been reported in several independent studies 114,115. Multiple strategies have therefore 
been developed to compensate for the fall in endogenous NO during lung transplantation, 
which include: (a) administration of exogenous NO either directly by inhalation 116 or 
indirectly by infusion of an NO donor (such as nitroglycerin) 117; and (b) increasing the 
activity of the enzyme NOS by transfection of an adenovirus containing endothelial NOS into 
the donor before lung retrieval 118.  
 
As described earlier, iNO improves the ventilation–perfusion mismatch, enabling more 
efficient gas exchange and better oxygenation 119. However, the role of iNO in preventing IRI 
during clinical lung transplantation remains controversial as recent multicentre trials have 
failed to show survival benefits of iNO 120. In addition, a major concern with increased NO 
delivery, is that NO can react with •O2
- and form the highly reactive peroxynitrite, causing 
widespread structural and functional damage to lung tissue 116. Thus, NO may be ineffective 
or even harmful in the setting of IRI.  
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Antioxidant/Redox gene therapy 
Based on the involvement of oxidative stress in IRI, several strategies in animal models have 
been undertaken to attenuate production or reduce the harmful effects of free radicals and 
oxidants. However the results remain contradictory. 
 
General antioxidant therapy has shown promising results in reducing pulmonary IRI in 
animal models. For instance, administration of 2-mercaptopropionylglycine (a potent free 
radical scavenger) to rats prior to lung isolation was found to reduce protein oxidation by 
65% and lipid peroxidation by 40% 121. In addition, exogenous administration of broad 
spectrum N-acetyl cysteine (NAC) effectively protected the lungs from reperfusion injury 
after prolonged ischemia 122. The results indicate that relatively low and non-toxic 
concentrations of free radical scavengers can markedly inhibit the oxidation of tissue 
sulfhydryls, soluble protein, and lipids associated with lung IRI. 
 
Similarly, many studies have reported that enhancement of specific antioxidant pathways 
also attenuates IRI. For instance, it has been shown that removal of •O2‾ specifically, with 
native SOD enzymes or SOD mimetics (which mimic the catalytic activity of the human SOD 
enzymes), protects against IRI in animal models 123. It is believed that protection is achieved 
through: inhibition of peroxynitrite formation (by the breakdown of •O2‾ before it can react 
with NO), attenuation of neutrophil infiltration, inhibition of pro-inflammatory cytokine 
release and prevention of the cellular energetic failure. This rapid fall in intracellular ATP can 
occur when •O2‾ and peroxynitrite induce DNA damage which activates poly (ADP-ribose) 
synthetase (PARS), resulting in the depletion of nicotinamide adenine dinucleotide (NAD+), 
an essential cofactor in respiration 124. Thus, the use of SOD mimetics such as M-40403 can 
remove •O2‾ without interfering with other ROS and may offer a novel therapeutic 
approach for the treatment of IRI 123. Catalase delivery and iron chelators are also used to 
detoxify specific ROS or prevent formation of locally produced oxygen radicals, respectively. 
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Genetic manipulation is another strategy used to augment intracellular antioxidant capacity. 
For example, adenoviral expression of mitochondrial SOD in a mouse liver significantly 
reduced IR-induced acute liver damage and associated redox activation of both NFB and 
Activator Protein (AP)-1 125. This study built the foundation for redox-mediated gene 
therapies directed at ameliorating IRI. 
  
Enzymatic sources of ROS have also been potential therapeutic targets, including NADPH 
oxidase, XO and the mitochondrial respiratory chain. For instance, Yang et al. found that IRI 
was significantly attenuated in mice deficient in the p47phox subunit of NADPH oxidase or 
following administration of apocynin, a specific NADPH oxidase inhibitor 126. These data 
suggest that NADPH oxidase plays a predominant role in mediating oxidative damage during 
lung IR 127 and therefore may represent a novel therapeutic target for the treatment of IRI. 
 
Attention has also been given to direct downstream targets of ROS/RNS. For instance •O2
-, 
peroxynitrite (ONOO‾), •OH¯ and H2O2 are all capable of initiating DNA single-strand 
breakage, with subsequent activation of the nuclear enzyme PARS (as described above), 
which is inhibited by antioxidant treatment. Overactivation of PARS results in depletion of 
intracellular stores of NAD⁺ and ATP, which are key factors in mitochondrial respiration and 
glycolysis, and thus results in cellular energy depletion and necrotic-type cell death. 
Furthermore, PARS has also been recently implicated in enhancing NFB-dependent 
transcriptional activation of multiple pro-inflammatory mediators, including TNFα. The 
ability of PARS to modulate cell death and inflammatory mechanisms has made it a target in 
the attenuation of experimental lung IRI. Fariver et al, found that intra-tracheal PARS 
inhibition significantly protected against increases in vascular permeability and alveolar 
leukocyte accumulation, and improved arterial pO2 in early reperfusion. Furthermore, the 
nuclear translocation of NFB and AP-1 and the secretion of pro-inflammatory cytokines 
into the alveolus were all attenuated by 4 h of reperfusion 128 
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Despite these recent advances, IRI still remains a major obstacle in many ALI-related 
disorders and in successful transplantation and cardiopulmonary surgery. The development 
of new strategies to repair and improve the quality of the lungs could have a tremendous 
impact on the success rate of lung transplantation. In addition, novel genetic-based 
technologies such as microarray analysis may help to determine which genes play a 
protective role in the transplantation process and thus reveal potential new strategies to 
improve lung selection and preservation. A greater understanding of the oxidative stress 
element of lung IRI in particular is likely relevant to many types of ALI-related disorders and 
thus may benefit not only lung transplant recipients but also a large number of other 
patients presenting symptoms of severe lung injury. 
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1.3 REACTIVE OXYGEN SPECIES 
 
1.3.1 Origins of oxygenation 
For the first two billion years of Earth’s existence, there were only negligible levels of oxygen 
in the atmosphere, and virtually every living organism made energy by anaerobic 
fermentation. It is believed that the evolution of oxygen-producing cyanobacteria, the first 
photosynthetic organisms that combined CO2 and H2O with energy derived from sunlight to 
form glucose (C6H12O6), led to an accumulation of O2 approximately 2.3 billion years ago 
129. 
The transition from an anoxic atmosphere to an oxygen-rich one took several hundred 
million years and led to the evolution of many O2-metabolising organisms, which coupled 
the oxidation of organic matter with the reduction of O2 in a new respiratory pathway. This 
yielded approximately four times as much energy per molecule of glucose oxidised than any 
of the previously used anaerobic pathways 130. Oxygen levels have since continued to 
generally rise which may explain the evolutionary explosion of novel O2-dependent 
pathways which has ultimately helped to drive and shape the evolutionary development of 
species with increased physiological complexity 130. As such, plants and most animals 
developed specialised gas exchange organs to allow efficient diffusion of O2 and CO2, 
required to meet metabolic demand 130. 
 
Oxygen has thus proved to be a useful energy fuel, as an electron acceptor, allowing 
increased size and complexity of organisms and we are now so dependent on this high-
efficiency system that humans and most mammals cannot survive without a continuous O2 
supply. However several O2 derivatives (referred to as reactive oxygen species, ROS) can 
potentially damage many metabolic networks. Thus, evolution has driven organisms to 
develop an intricate network of pro- and anti-oxidant mechanisms, at the expense of 
utilising O2 to generate the major intracellular energy source.  
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1.3.2 Free radicals and reactive oxygen and nitrogen species 
A free radical is any species capable of independent existence with at least one unpaired 
electron in its outermost shell 131. Normally, electrons are arranged in shells as paired 
electrons which spin in opposite directions and keep the molecule relatively stable and 
thereby less reactive. However, the presence of an unpaired electron makes the molecule 
relatively unstable and more reactive.  
 
The life cycle of a free radical can be divided into three distinct processes: initiation, 
propagation, and termination. Initial generation of free radicals can occur in two ways. The 
first is by homolytic cleavage, whereby a neutral molecule is covalently cleaved into two 
free radicals, and the electrons making up the bond are distributed to the two species. An 
example is the splitting of water by high energy radiation to form the hydrogen radical (H⁺) 
and •OH- (A). Radicals may also be formed by single electron oxidation and reduction of an 
atom or molecule. The production of •O2
- in the ETC is the most common intracellular 
example of this. Once formed a free radical can propagate by reacting with a stable atom or 
molecule to form another free radical, such as when a lipid peroxyl radical (LOO•) combines 
with an unsaturated lipid (L-H) to form a lipid radical (L•) and a lipid hydroperoxide (LOOH) 
(B). This is also illustrated in Figure 1.5 (page 59). Alternatively, free radicals can be 
eradicated when two free radicals combine to form a more stable species (C). 
 
(A) Initiation: H2O   H⁺  +  •OH
- 
 
(B)  Propagation:  LOO•  +  L-H     L•  +  LOOH      
 
(C)  Termination:  •Cl-   +   •Cl-      Cl2 
 
Chemically-reactive species with an unpaired electron and an oxygen/nitrogen centre are 
referred to as reactive oxygen/nitrogen species (ROS/RNS). They tend to readily react with 
adjacent molecules by donating, abstracting, or even sharing their outer-shell electron(s).  
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At low levels these species are essential in cellular signalling and homeostatic processes 
however uncontrolled reactions with important cellular components such as DNA, proteins 
or the cell membrane can cause severe cell injury. In addition, such reactions often involve 
the transfer of unpaired electrons to the target, generating a second free radical/ROS, which 
can react with a new target. Much of the high reactivity of ROS is due to such molecular 
chain reactions, which significantly amplify their toxic effects 131. 
 
1.3.3 Pro-oxidant mechanisms 
Production and release of ROS and RNS can be stimulated by a series of extracellular 
signalling molecules such as hormones, growth factors, pro-inflammatory cytokines (e.g. 
TNFα) and physical-environmental factors (e.g. UV irradiation). Intracellular factors or 
processes that trigger ROS generation include nutrient metabolism, endoplasmic reticulum 
(ER) stress and xenobiotic detoxification. These are discussed in more detail below. 
 
Mitochondrial Electron Transport Chain (ETC) 
Mitochondria are organelles found in virtually all eukaryotic cells and are responsible for the 
conversion of energy stored in nutrients into ATP, the main usable energy intermediate in all 
living organisms. In summary, broken down nutrients donate electrons to electron carriers 
such as NAD+ and flavin adenine dinucleotide (FAD) which in turn become reduced to NADH 
and FADH2. These electrons are then passed through a series of proteins within the ETC 
found in the inner mitochondrial membrane via redox reactions. Thus, each acceptor 
protein along the chain has a greater reduction potential than the last. The energy released 
as electrons flow down the ETC is used to pump protons (H⁺) from the mitochondrial matrix 
into the inter-membrane space, creating an electrochemical H⁺ gradient across the 
mitochondrial inner membrane. This electrochemical gradient allows ATP synthase to use 
the flow of H+ through the enzyme back into the matrix to generate ATP from ADP and 
inorganic phosphate 132. 
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Molecular oxygen is the final electron acceptor at the end of the ETC. Normally, the 
complete transfer of four electrons and four protons reduces O2 to 2H2O, however leakage 
of electrons can result in premature/incomplete reduction of O2 to generate •O2
-. Of the 
five complexes involved in the ETC, complexes I and III are the main sources of ROS 
formation.  At physiological oxygen levels, it has been suggested that about 1-4 % of the O2 
reduced by mitochondria may form •O2
- 133. However under conditions of metabolic 
perturbation, such as hypoxia / reoxygenation, the percentage of O2 incompletely reduced 
can rise and thus increase ROS production by the mitochondria 134. Importantly, the 
mechanism is compartmentalized within the mitochondria, thus free electrons cannot 
escape into the cytoplasm to react nonspecifically with other molecules. Similarly, •O2
- is a 
charged molecule so it tends to stay within the inner mitochondrial compartment, however 
it can be converted (by SOD) to H2O2, which readily diffuses across the mitochondrial 
membrane and can propagate ROS generation and ultimately cellular damage. 
 
Endoplasmic reticulum (ER) ROS generation 
The ER is the site of post-translational protein modifications and assembly required for their 
normal biological functions. Glycosylation (the forming of disulfide bonds) is essential in the 
folding and stabilization of proteins and is carried out by oxidoreductases in a relatively 
oxidizing environment, compared with the cytoplasm. Oxidative protein folding in the ER is 
also driven by an ETC that ultimately leads to the reduction of O2 but can generate •O2
-. 
While the sequence of events in the ER ETC is less characterized than that mediating 
mitochondrial respiration, when metabolic load and demand for protein modification is 
increased, the ER is also a likely source of ROS generation particularly. In such circumstances 
it is estimated that oxidative protein folding may account for up to 25% of total cellular ROS 
generation 135. 
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NADPH oxidase 
The NADPH oxidases are another major source of ROS production in normal physiology and 
pathophysiological settings. These membrane-bound enzymatic complexes also contain an 
ETC that transfers electrons from cytosolic NADPH to O2 and thus also generate •O2
–. Unlike 
the mitochondrial ETC, ROS generation is the principal purpose of this highly specialised 
system rather than it being simply a by-product. For many years NADPH oxidases were 
thought to be uniquely utilized by phagocytic cells for oxidative burst-mediated pathogen 
killing. Yet the discovery of NADPH oxidase homologues, now referred to as NOXs, and their 
widespread expression in non-phagocytic cells suggests that most cells have the capacity to 
generate ROS through NADPH oxidase systems. While members of the NOX family are 
analogous in structure, a key difference is that oxidases in non-phagocytic cells are 
continuously active at a low level even in the absence of stimulation, while the phagocyte 
oxidases are only activated upon stimulation. Such ROS generation is required for diverse 
physiological functions, including the response to various hormones and growth factors. For 
instance, insulin-stimulated ROS production relies on NOX4 in adipocytes 136 and NOX2 
expressed in skeletal and cardiac muscle 137,138. 
 
Xanthine Oxidase (XO) 
Xanthine oxidoreductase (XOR) is a ubiquitous metalloflavoprotein found as one of two 
interconvertible yet functionally distinct forms; xanthine dehydrogenase (XD) and XO. These 
two enzymes are involved in the final steps of purine nucleotide degradation. While XD is 
constitutively expressed, XO is generated by the post-translational modification of XD, yet 
both XD and XO are involved in catalysing oxidation of hypoxanthine to xanthine and 
xanthine to uric acid 139. In order to drive these reactions, XD requires NAD+ while XO 
requires the reduction of O2, thereby generating •O2
-. Under normal physiological 
conditions, production of •O2
- is generally low, however, a large body of evidence supports 
an important role for XO-mediated ROS generation in tissue injury during reperfusion and a 
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number of experimental studies have reported the protective effects of XO inhibitor 
allopurinol in hypoxia and ischemia-induced endothelial injury 140. This data suggests that 
increased XO activity is a major source of increased ROS in such circumstances, which could 
be in part a result of elevated Ca2⁺-induced irreversible conversion of XD to XO during an 
ischemic period. 
  
Nitric oxide synthase (NOS) 
NOSs are homodimeric oxidoreductases that catalyse the oxidation of L-arginine via 
reduction of O2 in the presence of NADPH, to generate NO. There are three isoforms: 
neuronal (nNOS), endothelial (eNOS) and inducible (iNOS). Both nNOS and eNOS are 
constitutively expressed in a wide variety of cells and their activity is regulated by 
intracellular Ca2+ levels via bound calmodulin. By contrast, iNOS is inducibly expressed 
mainly in macrophages upon stimulation by cytokines and other agents, and can rapidly 
produce NO to micromolar concentrations 141. All three NOSs rely on the cofactor 
tetrahydrobiopterin (BH4) to couple the reduction of O2 to the oxidation of L-arginine and 
maintain the stability of the NOS dimers 142. Should the availability or the efficiency of BH4 
decrease (which may be due to ROS damage), or if there is a deficiency in the substrate L-
arginine, NOS can become uncoupled resulting in the production of •O2
- instead of NO 143. 
These two species rapidly react to form the highly reactive ONOO‾ which can result in major 
cellular damage 144, as will be discussed. 
 
The listed sources of ROS appear to be important both individually and collectively, with 
complex interactions occurring between different pro-oxidant mechanisms, particularly in 
pathological settings. For instance intracellular ROS can decrease the activity of 
mitochondrial respiratory enzymes which can lead to further electron leakage and greater 
ROS generation 133. Stress-induced perturbation of the ER, a major Ca2+ storage site, can 
result in increased cytosolic and mitochondrial Ca2+ levels 145. This can significantly interfere 
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with the mitochondrial ETC through Ca2+-induced release of cytochrome C (an initiator of 
apoptosis) and inhibition of complex IV, secondary to Ca2+-mediated activation of eNOS and 
nNOS and increased generation of NO 146. While the ER ETC may be a significant source of 
ROS, oxidative stress can also be a cause, rather than a consequence of ER stress. As ER is 
the site of protein modification, oxidative stress can increase levels of protein misfolding 
which could affect the structure and function of proteins involved in potentially pro-oxidant 
mechanisms. Furthermore, oxidative stress may cause direct degradation of important 
molecules such as BH4, the essential cofactor of NOS, resulting in the ‘uncoupling’ of NOS, 
•O2
- generation and thus amplification of oxidative stress 147. Similarly, mitochondrial ROS 
generation can lead to NADPH oxidase activation in endothelial cells, representing another 
‘ROS-induced ROS release’ phenomenon 148. 
 
1.3.4 Physiological role of ROS and RNS 
The complex and ambivalent nature of ROS and RNS is now well recognised, with many 
playing a dual role as both beneficial and deleterious species. A number of beneficial roles 
are undertaken by ROS and RNS in normal physiological conditions, where low or moderate 
concentrations are maintained through tight regulation of their generation and degradation. 
Mounting evidence suggests their crucial involvement in: (a) the immune system, 
particularly in the defence against microorganisms; (b) numerous signalling pathways; and 
(c) regulation of gene expression. 
 
Host defence and inflammation 
A host’s defence mechanisms are mediated by the innate and adaptive immune systems. 
The former is non-specific in nature and includes various physical, chemical and cellular 
barriers which collectively represent the first line of defence against microorganisms and 
trigger an inflammatory response upon pathogen detection. Phagocytes that are drawn to 
the site of infection, via chemotaxis, engulf and destroy the microorganisms by 
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phagocytosis. In such an inflammatory environment these activated neutrophils and 
macrophages produce large quantities of ROS including •O2
- (via the phagocytic isoform of 
NADPH oxidase 149), H2O2, NO and hypochlorous acid. This ‘oxidative burst’ plays a key role 
in the defence against environmental pathogens which suggests that natural selection has 
driven organisms to opportunistically use the toxic properties of ROS to our advantage as a 
defence against microbial invasion.  
 
In addition to the specific function of ROS in pathogen destruction, the immune response as 
a whole is a redox-regulated process. For instance, the activation of T lymphocytes is 
significantly enhanced by •O2
– and H2O2 
150. Another study reported that intracellular redox 
state also modulates the immunological functions of macrophages 151. Collectively, it 
appears that the presence of ROS and a tightly controlled redox state is an essential 
component of our immune system. 
 
Cellular signalling 
Traditionally it was thought that cytokines and other large complex signalling molecules 
were the primary and exclusive mediators of cell signalling. It is now widely documented 
that very low fluxes of ROS are essential for inter- and intra-cellular signalling. ROS and RNS, 
like other secondary messengers, can be generated at the time of receptor activation and 
are relatively short-lived. However controversies still remain regarding the specificity of 
their action. Conventionally, signalling specificity is achieved through non-covalent binding 
of a ligand to its cognate receptor of complementary shape and charge. By contrast, ROS are 
small, relatively simple molecules that readily react with specific amino acid building blocks 
of numerous proteins. As a result some believe that the reactive nature of ROS render them 
indiscriminate and potentially lethal oxidants 152. Yet, low concentrations of H2O2 or NO-
derived species tend to react more readily with proteins containing cysteine residues 
thereby limiting the number of potential targets. The term ‘oxidative regulation’ has thus 
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been proposed to indicate the active role of oxidative-reductive modifications of proteins in 
regulating their functions. It has also been hypothesized that further specificity of ROS-
mediated signalling is controlled by sub-cellular compartmentalization of both ROS and their 
potential targets. This could provide spatial proximity between the source of ROS 
generation and its target, although this has not been studied extensively 153. 
 
The major signalling molecule NO, perhaps best reflects the multifaceted role of reactive 
species in physiology and pathophysiology. While NO is an important player in 
inflammation, nitrosative protein modifications and oxidative stress, it is also a major 
controller of blood pressure and flow throughout the body and can function as a 
neurotransmitter. The principal physiological role of NO is to promote vasodilatation via 
activation of soluble guanylate cyclase, a heterodimeric heme protein 154, which produces 
intracellular cyclic guanosine monophosphate (cGMP). This inhibits calcium entry into the 
cell, activates K+ channels, leading to hyperpolarization and stimulates cGMP-dependent 
protein kinases, which activate myosin phosphatases. Collectively, these events lead to 
smooth muscle relaxation. Recent evidence suggests that •O2
– can also influence vascular 
tone, through chemical reaction with NO as opposed to activation of signalling pathways. 
Given the high reactivity of NO with •O2
– (to form ONOO‾), it is thought that increased •O2
– 
can limit bioavailability of NO and indirectly stimulate vasoconstriction. Similarly, NO is 
considered to exert "antioxidant effect" and anti-inflammatory effects by reducing levels of 
•O2
– and thus limiting •O2
– -induced NFB activation and resultant inflammation 155. 
 
Many cells produce intracellular ROS as a downstream response and regulator of various 
different signalling cascades 156. For instance, angiotensin-II and IL-1 stimulate NADPH 
oxidase-mediated •O2
- production in vascular smooth muscle cells and fibroblasts, 
respectively 157. ROS production in endothelial cells specifically is associated with induction 
of cytosolic tyrosine kinase phosphorylation and downstream regulation of junctional 
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permeability. In this way junctions between adjacent endothelial cells are dynamically 
modulated to induce alterations in vascular permeability and to support the trans-
endothelial migration of leukocytes during inflammation 158. ROS are also involved in 
intercellular signalling. For example platelets involved in wound repair and blood 
homeostasis, are known to release ROS in order to recruit additional platelets to sites of 
injury 159. 
 
Regulation of gene expression: protection against hypoxia 
In complex organisms, oxygen homeostasis is tightly regulated by the red blood cell mass 
and respiratory ventilation, with changes in arterial blood O2 being constantly monitored by 
sensory organs such as the carotid body. Several studies have reported that ROS-mediated 
signalling may also play an important role in chemotransduction: the process by which 
changes in PaO2 are detected and activate specific cellular effectors. Cytochrome C oxidase 
in particular (of the mitochondrial ETC) has been implicated in oxygen-sensing in the carotid 
body, generating increased ROS during episodes of hypoxia which are thought to induce 
hypoxic nuclear genes. This is suggested to occur via stabilisation of hypoxia-inducible factor 
(HIF-1), the principal transcription factor mediating cellular and systemic responses to 
hypoxia, although the mechanisms underlying this regulation are not completely 
understood 160. It has also been reported that mitochondria possess a novel pathway for NO 
synthesis which is induced when cells experience hypoxia and is cytochrome C oxidase-
dependent but independent of NOSs. It appears that NO reacts with •O2¯ to form ONOO¯, 
which may directly or indirectly modify specific proteins such as HIF-1 via tyrosine nitration, 
as observed in cells exposed to hypoxia. Such modifications could stabilise HIF-1 and lead to 
the induction of nuclear hypoxic genes 161. 
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1.4 OXIDATIVE STRESS 
In healthy aerobic organisms ROS and RNS are produced as a normal product of cellular 
metabolism primarily by the mitochondrial ETC but also by numerous other intracellular 
mechanisms. Under physiological conditions, the formation of oxidants is kept in balance 
with their efficient removal by a series of endogenous antioxidant defence systems (which 
are described in 1.5). However when ROS generation exceeds the capacity of these defence 
systems, the cells experience oxidative stress. Thus, oxidative damage defines the 
consequences of a mismatch between the production of the ROS/RNS and the ability to 
defend against them. The harmful effects are dependent on the severity and duration of this 
imbalance. For instance mild oxidative stress may be overcome by upregulating the 
synthesis or activity of antioxidant defence mechanisms. By contrast, increased levels or 
prolonged periods of oxidative stress can overwhelm antioxidant defences and may result in 
accumulation of oxidation products which can damage important intracellular 
macromolecules including DNA, membrane lipids and proteins and give rise to cytotoxic and 
mutagenic degradation products. In this instance, the outcome generally includes 
dysregulation of homeostatic mechanisms and severe injury/cell death 162. 
 
1.4.1 Role in pathological diseases 
The ageing process is probably the most inevitable consequence of sustained oxidative 
stress and to a large extent is mediated by direct free radical action on DNA, lipid and 
protein molecules 163. Oxidative stress has also been implicated in a number of serious 
pathological conditions including cardiovascular disease, cancer, diabetes, neurological 
disorders and IRI 164-166. These appear to fall into two main categories. In the first group, 
diseases such as cancer and diabetes are characterised by oxidative species disrupting the 
thiol/disulfide redox state through increased oxidation of thiol groups and accumulation of 
oxidatively modified proteins. This can deleteriously affect activity and/or function of 
proteins, such as those controlling the cell cycle, in the case of cancer. Impairment of 
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glucose tolerance, which is termed ‘mitochondrial oxidative stress’, is implicated in diabetes 
as several independent strategies have reported that a reduction in mitochondrial ROS 
production prevents some of the typical secondary complications of diabetes 167. 
Neurodegenerative diseases such as Alzheimer’s disease and Down’s syndrome are also 
accompanied by an accumulation of oxidative damage and some studies have revealed that 
it is the oxidation of cellular proteins specifically that may be a critical determinant of brain 
function 168.  
 
The second group comprises of diseases characterised by severe inflammation and 
enhanced activity of one or more ROS generators. For example, in atherosclerosis and 
chronic inflammation, an upregulation in NADPH oxidase is observed. It is currently 
hypothesised that elevated intracellular oxidative signals can modulate the expression of a 
selective set of vascular inflammatory genes 169. Also encompassed in this group of diseases 
is IRI, for example that arising following lung transplantation, where oxidative stress is 
accompanied by cell injury and a pronounced inflammatory response as a result of altered 
gene regulation.  
 
1.4.2 Cellular Injury 
Oxidative stress is characterized by the excessive formation of ROS and RNS including •O2¯ 
and NO, which can be converted into other reactive species. For instance, at elevated 
concentrations, •O2¯ and NO can both act as precursors in the generation of ONOO‾, a 
strong and highly reactive general oxidant and nitrating agent. As the •O2
– radical is 
unstable in aqueous solution and is rapidly dismutated to H2O2, a number of its biological
 
effects are likely to be secondary to H2O2 production, which is relatively more stable, 
diffusible and cell membrane permeable. Furthermore, iron-mediated reduction of H2O2 by 
•O2¯ gives rise to singlet oxygen (¹O2*) and •OH¯ radical. This radical is an exceedingly 
strong and indiscriminate oxidant that can abstract hydrogens, add hydroxylate, or accept 
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electrons, depending on the target molecule. •OH¯ reactions are extremely rapid and at 
high concentrations are the primary mediators of oxidative stress-associated tissue injury 
170, being responsible for over half of all free radical damage in the body, involving: DNA 
damage, lipid peroxidation and protein oxidation. 
 
Oxidative damage to DNA, lipids and proteins 
The •OH¯ radical reacts with all components of the DNA molecule, damaging both the 
purine and pyrimidine bases and also the deoxyribose backbone 131. The most extensively 
studied DNA lesion is termed 8-hydroxyguanine (8-OH-G). Permanent modification of 
genetic material, resulting from “oxidative damage”, can often represent the first step in 
mutagenesis, carcinogenesis, and ageing. It has also been reported that oxidative damage of 
genes encoding key transcription factors (such as Nrf2), which regulate the expression of 
antioxidant genes and hence indirectly the intracellular redox state, can enhance 
susceptibility to oxidant-mediated inflammatory diseases in mouse models 171. This is most 
likely due to the reduced Nrf2-dependent expression of several critical antioxidant enzymes. 
 
Free radical species (such as •OH¯) as well as non-radical oxygen species (such as H2O2, ¹O2* 
and ONOO¯) can trigger peroxidative modification of unsaturated phospholipids, glycolipids, 
and cholesterol. Polyunsaturated fatty acid (PUFA) residues of phospholipids are particularly 
sensitive to oxidation by •OH¯, as first demonstrated in 1980 172. Free radical-initiated 
peroxidation has since been reported as a major problem in oxidative stress conditions, as it 
results in self-propagating chain reactions that amplify damage to lipid membranes and 
other important macromolecules. The key event in ‘initiation’ is the formation of a lipid 
radical (L•). This can occur by hydrogen atom abstraction from an unsaturated lipid 
substrate (L-H) by an initiator free radical such as •OH¯. Peroxynitrous acid (ONOOH) can 
also induce lipid peroxidation, subsequent to homolytic decomposition which produces 
•OH‾ and •O2N, either of which could act as a H⁺-abstracting initiator 
173.  
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The propagation step normally begins with the rapid addition of molecular oxygen to L• to 
form a highly reactive peroxyl radical (LOO•) 174 followed by the abstraction H⁺ from L-H by 
LOO• to generate lipid hydroperoxide (LOOH) and another radical L•, as illustrated in Figure 
1.5. The cycle continues as the new lipid radical is oxidised in the same way. Thus, when a 
radical reacts with a non-radical, another radical is always produced resulting in a ‘chain 
reaction mechanism’. This propagation phase is generally more complicated than these 
simple transfer and additions steps, often involving radical coupling with oxygen, atom or 
group transfer, fragmentation, and rearrangement of the peroxyl radical. These radical 
reactions stop when two radicals react and produce a non-radical species, which only occurs 
when the concentration of radical species is high enough for two radicals to collide. 
Figure 1.5 Mechanisms of free-radical induced lipid peroxidation. A lipid radical is formed after the 
initiation step and following oxidation into a lipid peroxyl radical, is involved in the propogation of 
lipid radicals or the formation of lipid hydroperoxides, which in turn have a number of different fates. 
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The major products generated during this process are lipid hydroperoxides (LOOHs), which 
can also arise from direct reaction of singlet oxygen (1O2*) with PUFA groups or cholesterol. 
These LOOHs are prominent non-radical intermediates of lipid peroxidation that migrate 
readily intracellularly, due to their increased polarity and long half-life. In doing so, LOOHs 
can participate in redox reactions, the nature and magnitude of which often determines 
whether peroxidative injury is exacerbated (by free radical-mediated chain peroxidation) or 
prevented (by antioxidant-catalysed two-electron reduction to form relatively non-toxic 
alcohols) 175. If neither antioxidants nor detoxifying enzymes are encountered, LOOHs alone 
can significantly modify membrane structure and function. In addition to damaging 
membranes directly, LOOHs can undergo iron-mediated one-electron reduction to oxyl 
radical (LO•) intermediates. At least three possibilities are open to LO• radicals: i) direct H-
abstraction and initiation of chain peroxidation; ii) β-scission with formation of aldehydes 
and alkyl radicals; and iii) rearrangement and oxygenation to give epoxyallylic peroxyl 
radicals (OLOO•), that can trigger further rounds of free radical-mediated lipid peroxidation. 
During this period new hydroperoxide substrates are generated and the damaging effects of 
primary peroxidation are exacerbated 175. In addition, a number of aldehydic by-products 
including epoxyaldehydes, 2-alkenals, malondialdehyde (MDA) and α,β-unsaturated 
aldehydes such as 4-hydroxynonenal (HNE) and acrolein have genotoxic, chemotactic and 
cytotoxic properties 176,177. For example MDA has been reported as mutagenic in bacterial 
and mammalian cells, while others such as 4-HNE are extremely toxic and highly reactive 
secondary electrophiles, capable of eliciting stress signalling. Thus, free-radical induced lipid 
peroxidation not only damages the structural and functional organization of lipid 
membranes but also generates numerous lipid-derived aldehydes (LDAs) which have been 
implicated in further DNA, lipid and protein modification via adduct formation. This can 
result in alteration of key intracellular homeostatic processes leading to either tumour 
initiation or cell injury and death. 
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ROS can also mediate protein oxidation, inactivating membrane enzymes, receptors, 
signalling molecules and transport proteins, causing huge disruption to many intracellular 
homeostatic processes, which is also detrimental to the cell’s survival. A study by Stadtman 
et al., found that the side chains of all amino acid residues (in particular cysteine and 
methionine), are susceptible to oxidation by •OH¯ and •O2¯ 
178. Another group found that 
ONOO‾ modifies thiol groups or side chains of several amino acids and interacts with 
transition metal centres. The consequential alteration in proteins' function renders ONOO‾ a 
central mediator of NO-derived oxidative stress and damage. Although all cells have the 
capacity to repair oxidative damage to DNA, lipids and proteins, excessive damage can be 
overwhelming and ultimately result in cell death. 
 
Apoptosis vs. necrosis 
In normal physiological conditions, apoptosis (programmed cell death) is essential in both 
cell development and in the destruction of cells that pose a threat to an organism. It is 
characterised by cell shrinkage, loss of plasma membrane asymmetry, protease and 
endonuclease activation, and fragmentation of nuclear DNA. Apoptotic cells are non-
inflammatory as they are generally removed by phagocytosis. By contrast, necrosis (non-
programmed death) is characterised by cell swelling, lysis, and random DNA fragmentation 
and often elicits inflammation in vivo. The decision of a cell to commit to apoptotic cell 
suicide is controlled by the overall balance of survival and death signals. Those required for 
continued survival include extracellular growth factors or hormones which trigger 
intracellular pathways that block activation of caspase cascades, while those promoting cell 
death may be triggered by oxidant-mediated damage to intracellular macromolecules or 
extrinsic signalling pathways which activate intracellular caspases 179. Importantly, the 
extent of oxidative injury will determine whether a stressed cell will survive or succumb via 
apoptosis or necrosis. A scheme created by Girotti et al, illustrates a pattern of graded 
responses to oxidative stress: i) no net damage when the antioxidant capacity is sufficient to 
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either prevent or repair peroxide lesions; ii) mild oxidative injury, which may trigger 
cytoprotective responses, such as induction of GSH and/or antioxidant enzymes; iii) more 
extensive damage, which triggers apoptosis because some undefined threshold is crossed, 
beyond which both constitutive and inducible repair capacity is exceeded; and iv) gross 
damage which results in rapid necrosis 175. 
 
In severe oxidative stress conditions, peroxidation and damage of the mitochondrial 
membrane may stimulate the intrinsic apoptotic pathway, whereby Bcl-2 activates Bax 
which punches holes in the outer mitochondrial membrane. The released cytochrome C 
associates with the apoptotic protease activating factor 1 in an ATP-dependent manner to 
form an apoptosome which binds to and cleaves caspase-9. Subsequent activation of other 
“executive” caspases (3 and 7) ultimately lead to apoptosis and controlled phagocytosis of 
the cell 84. Cytochrome C may also be released following oxidative or nitrosative damage to 
cardiolipin (CL) which anchors cytochrome C to the inner mitochondrial membrane. The 
highly unsaturated phospholipid CL, located exclusively in the inner mitochondrial 
membrane, is thought to be extremely susceptible to peroxidation, especially as it is 
adjoined to the mitochondrial respiratory chain, a major source of ROS. It is also important 
to note that the release of cytochrome C not only induces apoptosis but also disrupts the 
mitochondrial ETC and thus affects ATP generation. Similarly, CL also plays an important role 
in stabilizing numerous enzymes of the mitochondrial ETC. Hence, alterations to the CL 
profile such as a decrease in its content or peroxidation may result in widespread 
mitochondrial dysfunction 180.  
 
In addition, there is a growing body of evidence to suggest that oxidant derivatives such as 
LOOHs are early intermediates and second messengers in the activation of certain protein 
kinases (such as MAPKs) and phospholipases. This is believed to play an important role in 
oxidant-induced signalling, stimulating gene expression associated with cytoprotection, 
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apoptosis, or other responses 181. For example, Geiger et al showed that exogenous or 
endogenous peroxides can trigger an apoptotic cascade in leukaemia cells which is 
accompanied by accumulation of LOOHs and loss of viability. Such effects were inhibited by 
antioxidant BHT (butylated hydroxytoluene), implying that lipid peroxidation products could 
be key players in stress-induced cell signalling 182. Thus an accumulation of such compounds 
are likely to overwhelm detoxification mechanisms and may also induce apoptosis via 
stimulation of signal transducation mechanisms 181. 
 
1.4.3 Redox signalling and inflammatory gene expression 
For over a decade, ROS have been implicated in initiating inflammatory responses in the 
lungs through the activation of signal transduction pathways, such as MAPKs and 
phosphoinositide 3-kinase (PI3K) and transcription factors NFB and AP1, leading to 
enhanced gene expression of pro-inflammatory mediators 183. Many of these pathways and 
transcription factors are dormant in resting pulmonary cells or exhibit only background 
activity. However in oxidative stress conditions, primary and secondary oxidants alike serve 
as signalling messengers in the initiation and perpetuation of the inflammatory process.  
 
For instance, in normal physiological conditions NFB is involved in regulating a vast array of 
processes, including cellular growth and programmed cell death (apoptosis), but it also 
appears to be crucial in determining cellular responses to oxidative conditions. In its inactive 
state, the heterodimeric NFB, which is generally composed of subunits p50 (NFB1) and 
p65 (RelA), is associated with IB (an NFB inhibitor) and resides in the cytoplasm. Several 
experimental studies have reported that excessive oxygen radicals can cause degradation of 
IB, allowing NFB phosphorylation, translocation to the nucleus, attachment to specific B 
moieties and up-regulation of genes encoding pro-inflammatory mediators 184. This ROS-
mediated mechanism of NFB activation is supported by several studies who have found 
that antioxidants such as NAC and SOD can suppress the NFB activation in episodes of 
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stress 184. In addition, TNFα-induced increase in VCAM-1 and MCP-1 (monocyte chemotactic 
protein-1) expression, mediated by a redox-sensitive mechanism involving NFB, is inhibited 
by the NADPH oxidase inhibitor apocynin 185. One particular study found that H2O2 extended 
NFB nuclear localization period in cells co-stimulated with TNFα or IL-1β by suppressing its 
export from the nucleus. This is thought to be due to prolonged polyubiquitination of 
signalling intermediaries, which promote phosphorylation and destabilization of newly 
synthesized IB proteins and thus release of NFB 186. In the clinical setting, overproduction 
of •O2
- in sepsis-related ARDS was implicated in the oxidative enhancement of NFB 
activation and cytokine expression in the patients lungs 187. Moreover, activation of the 
NFB pathway in airway epithelial cells in particular is implicated in lung inflammation and 
injury in response to local and systemic stimuli 188. While these results suggest ROS plays a 
key role in NFB activation during oxidative stress, it is important to note that this response 
is dependent on the level of ROS, as a severe increase in ROS can also inactivate NFB via 
redox modifications 189. 
 
Recently, it has been shown that oxidative stress and LDAs in particular can also regulate 
nuclear histone modifications, such as acetylation, methylation and phosphorylation. Such 
changes can lead to chromatin remodelling, and subsequent recruitment of basal 
transcription factors and RNA polymerase II, inducing the expression of pro-inflammatory 
mediators 190. There is evidence that oxidative stress also inhibits histone deacetylase 
activity and in doing so further enhances inflammatory gene expression. Thus, oxidative 
stress is known to regulate both key signal transduction pathways and histone modifications 
involved in inflammatory gene expression in lung inflammation. 
 
Examples of pro-inflammatory proteins expressed in lung cells exposed to oxidative stress 
include cytokines TNFα and IL-8. These chemoattractant proteins are secreted into the 
circulation to generate a chemotactic gradient and enhance neutrophil transmigration into 
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the alveolar compartment and lung interstitium 74,176,191 The expression of various adhesion 
molecules including ICAM-1 and VCAM-1 (which increase adhesiveness of neutrophils and 
macrophages, respectively) is also upregulated on both the endothelial and epithelial cells in 
response to a number of stimuli including oxidative stress. For instance, Beck-Schimmer’s 
group studied the effect of 1 h hypoxia on ICAM-1 and VCAM-1 expression in alveolar 
epithelial cells and found a two-fold increase in mRNA levels followed by a modest increase 
in protein expression between 2 and 4 h 192. This resulted in an increase in neutrophil and 
macrophage adherence to epithelial cells, an effect suppressed by TNFα antibody and 
blocked by anti-ICAM-1 and anti-VCAM-1 antibodies. These results support a role of 
adhesion molecules in oxidative stress conditions of hypoxia, which promote adherence of 
neutrophils and macrophages to alveolar epithelial cells in a TNFα-dependent manner. 
Collectively these pro-inflammatory molecules play a crucial role in orchestrating the cell-to-
cell, and humoral communication in the microenvironment of oxidant-activated cells and 
are thus important in inflammatory responses of ALI-related diseases. 
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1.5 INTRACELLULAR ANTIOXIDANT MECHANISMS 
All organisms have acquired a highly effective array of protective agents and antioxidant 
mechanisms to defend themselves from the cytotoxic actions of ROS and RNS, including free 
radicals. This defence system comprises of two major components. The first includes 
mechanisms that identify damaged molecules and instigate their destruction or enzyme-
mediated repair. For instance the chemical integrity of DNA is essential in normal cell 
function and survival, thus cells are equipped with several mechanisms to counteract 
oxidative damage to DNA. In the first instance, modified nucleotides in the nucleotide pools 
are detected and hydrolyzed, thus avoiding their incorporation into DNA or RNA. In 
addition, damaged bases in DNA with relatively small chemical alterations (the most 
common lesion being 8-OH-G) are mainly repaired by the base excision repair systems which 
locate and excise damaged bases by specific DNA glycosylases. The second component of an 
organism’s defence system comprises of numerous antioxidants which limit oxidative 
reactions and detoxify potentially damaging ROS and RNS. These antioxidants not only 
suppress harmful oxidative pathways, but they also help to maintain a steady intracellular 
redox environment, which is required for the normal function and survival of cells and 
whole organisms. 
 
1.5.1 Non-enzymatic antioxidants 
Several low molecular weight antioxidants are in place to forestall initiation of oxidative 
damage and/or limit its propagation. These non-enzymatic molecules intercept various ROS, 
generally non-specifically. These include: ascorbic acid (water-soluble Vitamin C), an 
electron donor that scavenges ROS, protects vitamin E and GSH against oxidation in cell 
membranes and acts as a coenzyme for ascorbate peroxidises; α-tocopherol (lipid-soluble 
Vitamin E) and BHT are chain-breaking antioxidants capable of efficiently scavenging peroxyl 
radicals (LOO•) formed in phospholipid bilayers of cell membranes; bilirubin produced by 
heme-oxygenase (itself an antioxidant enzyme); carotenoids, physical quenchers of singlet 
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oxygen; and the strong reducing agent uric acid. Controversially, recent studies have 
revealed that NO can also function as a chain-breaking antioxidant by reacting with peroxyl 
radicals. In the process, lipid nitrites and nitrates appear to be generated via rearrangement 
of unstable nitrosoperoxyl intermediates 193. Thus, NO by itself can act as a lipid antioxidant, 
but in the presence of •O2¯ these intermediates can become ONOO‾/ ONOOH, a powerful 
lipid pro-oxidant. The expression of NO and regulation of its dual activity is therefore key in 
both physiological and stressed conditions. 
 
GSH is a ubiquitous thiol (sulfhydryl)-containing tripeptide and synthesised by γ-
glutamylcysteine and GSH synthetases in an ATP-dependent manner. GSH is another vital 
antioxidant which protects against oxidative/nitrosative stresses and forms glutathione 
disulphide (GSSG) upon oxidation. It is the major redox buffer of the cell, thus controls many 
intracellular pathways including pro-inflammatory processes in the lungs 194. GSH is a very 
soluble and highly abundant intracellular molecule that exhibits several protective roles 
against oxidative stress, it: (a) scavenges •OH¯ and singlet oxygen directly; (b) regenerates 
the antioxidants Vitamins C and E, back to their active forms; (c) maintains the redox state 
of critical protein sulfhydryls; and (d) is a cofactor of several detoxifying enzymes such as 
glutathione peroxidase (GPx) and glutathione-S-transferase (GST)194. The capacity of GSH to 
undertake these roles correlates with the GSH:GSSG redox state, and decreases upon 
depletion of GSH and accumulation of GSSG (i.e. a decrease in GSH:GSSG ratio) which can 
occur in oxidative stress conditions and following a decrease in the activity of glutathione 
reductase (GR), the enzyme that regenerates GSH. Alterations in lung GSH metabolism are 
widely recognized as a central feature of many inflammatory lung diseases such as ARDS 195, 
thus it appears that GSH is critical to the lungs' antioxidant defences, particularly in 
protecting the epithelium from oxidative/free radical-mediated injury and inflammation 196. 
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Melatonin, a mammalian hormone synthesized from serotonin, is also reported to display 
powerful antioxidant properties via a wide variety of mechanisms 197. Unlike Vitamin C and 
Vitamin E, melatonin is effective in both aqueous and lipid phases, which accounts for its 
increased level of inter and intra-cellular diffusion. Melatonin can directly scavenge ROS 
including H2O2 and ONOO
- and is five times more effective than GSH in neutralizing •OH¯. 
Importantly, as this involves donation of two electrons (not just one), melatonin does not 
become a free radical following neutralisation 198. While its ability to scavenge •O2
- remains 
controversial 199,200, it appears to decrease •O2
- production from the mitochondrial ETC by 
increasing the activity of complexes I and IV and stabilising mitochondrial membrane 201 and 
as a result also enhances production of ATP 202. Melatonin has also been reported to 
decrease NOS and XO activity, although the underlying mechanisms are unclear 203,204. In 
addition to targeting free radicals directly and their major intracellular producers, melatonin 
has been found to increase gene expression and activity of several antioxidant enzymes 
SOD, catalase and GPx in both animal models and patients 205. 
 
1.5.2 Antioxidant Enzymes 
The low molecular weight antioxidants are essential in cellular defence against oxidative 
stress but are unable to fully protect against the broad spectrum of radicals which are 
continuously produced in aerobic cells. Antioxidant enzymes such as SOD and catalase, along 
with non-enzymatic antioxidants described above, constitute the first line of defence against 
intracellular ROS.   
 
SOD exists in several forms which differ in terms of: structure, location, active metal centre, 
and number of subunits 206. For instance, the cytosolic SOD1 and extracellular SOD3 contain 
copper and zinc, while the mitochondrial SOD2 contains manganese. Nonetheless SOD 
enzymes all catalyse the dismutation of •O2
- to form H2O2. However, in the presence of 
transition metals •O2
- and H2O2 can form the highly reactive •OH
-, therefore SOD enzymes 
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act in conjunction with H2O2-removing enzymes such as catalase and glutathione peroxidise 
to ensure complete breakdown of ROS 207. Catalase is a tetrameric enzyme consisting of four 
identical heme-containing subunits, each bound to an NADPH molecule 208. One molecule of 
catalase can convert millions of molecules of H2O2 to H2O and O2 per second. As such, it 
plays an invaluable cellular defence against oxidative stress. 
 
While SOD and catalase are essential in the direct destruction of and protection against •O2
- 
and H2O2, they are ineffective against the cumulative toxicity of lipid peroxidation which can 
be initiated by the primary ROS escaping decomposition by these enzymes. Unlike 
excision/repair of bases in DNA, excision/repair of LOOH lesions in cell membranes has not 
been well characterized in mechanistic terms. Aldehyde dehydrogenase, alcohol 
dehydrogenase and aldo-keto reductase enzymes all play a role in the breakdown of 
secondary oxidation products, however it is the Glutathione System, comprising of GPx, GST, 
GSH and GR which has sparked considerable interest over the past decade as prime 
mediators of peroxyl and LOOH detoxification (Figure 1.6). This system has evolved to 
detoxify not only endogenous products of oxidative stress but also exogenous xenobiotics 
which are deleterious to the cell and can exacerbate existing injury and inflammation 209. 
 
Four major selenium-containing GPx have been characterised in mammals. The most 
common is GPx-1, a homotetramer that is generally expressed in the cytosol and 
extracellular matrix of virtually all cell types 210. All GPx enzymes catalyse the conversion of 
H2O2 to H2O at the expense of GSH, which is converted to GSSG. Conversely GR replenishes 
GSH (from GSSG) through oxidation of NADPH to form NADP⁺. Among these isoenzymes 
only GPx-4, found in the nucleus, cytoplasm and membranes, uses phospholipid 
hydroperoxides as substrates, generating corresponding alcohols and GSSG. Therefore, their 
collective ability to detoxify lipid hydroperoxides via oxidation of GSH is limited 211. 
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In addition to the selenium-dependent GPx activities, mammalian cells also have selenium-
independent GPx activity displayed by GSTs. These belong to a supergene family of 
ubiquitous multifunctional enzymes, comprising of at least eight classes of isoenzymes, all of 
which have been reported in human tissues 212. They play a major role in the detoxification 
of electrophilic xenobiotics (foreign chemical compounds such as carcinogens and 
mutagens) and also mediate the degradation of lipid peroxidation products through 
conjugation to endogenous nucleophilic GSH. The GSH-conjugates are generally less reactive 
and more soluble compounds that can be readily removed from the cell via membrane-
based GSH-conjugate pumps 4. The broad substrate specificity of GSTs and their widespread 
distribution enables them to protect all cells against a huge range of toxic chemicals and 
secondary oxidation products. As a result a huge number of recent studies have highlighted 
the key role played by GSTs in oxidative stress and inflammatory disorders. 
Figure 1.6 The major intracellular reactive species, their principal sources (in blue boxes) and 
their specific antioxidants (in red font). Primary reactive species produced either directly by 
producers or as a result of reaction with other species are scavenged by principal antioxidant 
enzymes such as SOD and catalase. GPx and GST antioxidants are generally responsible for 
detoxifying secondary oxidative stress products. 
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1.6 GLUTATHIONE-S-TRANSFERASE (GST) FAMILY 
 
1.6.1 Roles of Glutathione-S-Transferases 
The GSTs are a family of multifunctional proteins which play important roles in the 
intracellular detoxification of foreign compounds and oxidative stress products and are 
involved in the modulation of key signalling pathways, as illustrated in Figure 1.7. 
 
Detoxification of xenobiotics and oxidative stress products 
All organisms are exposed to foreign compounds in the environment that enter the body 
mostly through ingestion and inhalation. Failure to properly eliminate these compounds can 
lead to serious cellular injury. Similarly, all organisms can experience periods of severe 
oxidative stress resulting in the accumulation of lipid peroxidation products which can also 
be detrimental to the survival of cells/tissues. GSTs are major drug-metabolizing and 
antioxidant enzymes that detoxify a large number of such potentially damaging compounds. 
To do this, they catalyse nucleophilic attack by GSH on foreign and endogenous non-polar 
compounds that contain an electrophilic carbon, nitrogen, or sulphur atom. Such 
conjugation of GSH accelerates the neutralisation of the substrate’s electrophilic centre 
resulting in the formation of a less reactive, water-soluble substance. Two binding domains 
are critical for this catalytic activity: a GSH binding site (G-site) and an adjacent substrate 
binding site (H-site). In general the resulting metabolic derivative is less cytotoxic than the 
parent compound and can be readily excreted from the cell by trans-membrane MRP 
(multidrug resistance-associated protein) 213.  
 
The substrates of GST fall into two main categories. Foreign compounds include: (i) drugs 
such as antibiotics and cancer chemotherapeutic agents and (ii) environmental chemicals 
and their metabolites (acrolein, inorganic arsenic), some of which are chemical carcinogens 
such as the polycyclic aromatic hydrocarbons (PAHs) found in cigarette smoke, and exhaust 
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fumes. Collectively this group of substrates are commonly referred to as xenobiotics. Of 
interest to us however, is the second category of substrates, a broad spectrum of 
endogenous electrophilic products of oxidative stress. This includes organic hydroperoxides 
such as lipid hydroperoxides and some of their breakdown products, including lipid-derived 
aldehydes (LDAs). Such secondary electrophiles may include MDA and α,β-unsaturated 
aldehydes such as 4-HNE and acrolein which is highly reactive due to its instability and 
toxicity. If left to accumulate, these are likely to propagate oxidative stress and are 
responsible for alterations in cell signalling, cellular damage and cytotoxicity 212.  
 
GSTs can not only catalyse the conjugation of their substrates with GSH, but can also exhibit 
modest Se-independent GPx activity, directly reducing lipid, cholesteryl and fatty acid 
hydroperoxides via oxidation of GSH to GSSG, in a GPx-independent manner 214. Nucleotide 
oxidation products such as base propenals and hydroperoxides are also detoxified by GST in 
a peroxidase manner 4. Evidently, GST along with other antioxidant enzymes such as GPx1, 
protect cells against a range of harmful electrophiles generated as a result of oxidative 
damage.  
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Figure 1.7 The involvement of GST in detoxification and modulation of key signalling pathways. 
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Modulation of signalling pathways 
As well as xenobiotic and secondary oxidant detoxification, GSTs are also thought to directly 
regulate stress-induced signalling pathways such as apoptosis 215. For instance, one group 
found that mouse GST (mGSTM1-1) physically interacts with apoptosis signal-regulating 
kinase 1 (ASK1) and acts as a negative regulator both in vitro and in vivo. ASK1 is a MAP 
kinase kinase kinase that can activate the c-Jun N-terminal kinase (JNK) and the p38 
signalling pathways and therefore plays a critical role in cytokine- and stress-induced 
apoptosis. It was reported that mGSTM1-1 results in the suppression of ASK1 activity as well 
as ASK1-dependent apoptotic cell death. These findings suggest that mGSTM1-1 may 
participate in the regulation of stress-activated signals by suppressing ASK1 activity 216. 
 
A number of studies also suggest that GST regulates JNK activity. Under non-stressed 
conditions GST monomer has been found to associate with JNK and inhibit its activity. 
However, increasing ROS levels cause GST–JNK dissociation, allowing activation of JNK and 
subsequent phosphorylation of downstream transcription factors, including c-Jun and p53, 
leading to stress-induced changes in the cell cycle, DNA repair or apoptosis 217. In such 
circumstances, administration of ROS scavenger NAC prevents GST dissociation from Jun–
JNK complex. Therefore, GST appears to switch between a ‘monomer’ and a 
‘dimer/multimer’ form in response to changes in intracellular redox state and thus acts as a 
redox-sensitive regulator of JNK signalling. Furthermore, GSTP1/P2(-/-)-derived mouse 
embryo fibroblast cells have a noticeably higher basal level of JNK activity, yet transfection 
of GST reduces JNK phosphorylation, kinase activity and Jun-mediated transactivation 218.  
 
GSTs are also involved in the synthesis and modification of eicosanoids (eg. prostaglandins, 
and isoprostanes). These are signalling molecules formed from arachidonic acid that exert 
complex control over many bodily systems, including inflammation. A few transferases 
exhibit remarkable specificity in catalysing the isomerization of prostaglandin PGH2 to a 
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mixture of PGD2 (and its downstream product 15d-PGJ2) and PGE2, or reduce it to PGF2α. 
Prostaglandin 15d-PGJ2 specifically possesses distinct biological activities. For instance it can 
modify cysteine residues in the cytoskeleton-associated protein Keap1, reducing its ability to 
target transcription factor Nrf2 for proteasomal degradation and therefore enabling Nrf2 to 
induce gene expression via the antioxidant response element (ARE) 219. By contrast, 15d-
PGJ2 has been reported to inhibit NFB-dependent gene expression 
220, as illustrated in 
Figure 1.8 4. Transferases also have the ability to aid the elimination of a number of 
eicosanoids (such as 15d-PGJ2) via MRP transporters following conjugation with GSH 
221. 
Consequently the expression of genes trans-activated by the Nrf2 may be antagonized while 
NFB-driven gene expression may enhance. Thus, the involvement of different transferases 
in the synthesis and elimination of these compounds places GSTs as central regulators in a 
diverse number of signalling pathways. 
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Figure 1.8 Role of GST in the synthesis, isomerisation and attenuation of prostaglandins 4 
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Another of GSTs’ common substrates, 4-HNE, is also an intracellular signalling molecule and 
stimulates Nrf2-mediated gene expression through the ARE 222. In addition 4-HNE can 
induce phosphorylation of IB, resulting in the activation of the redox-sensitive NFB 223. 
This common LDA can also activate other signalling molecules such as JNK, p38 and protein 
kinase C which can in turn modulate apoptosis 224. Thus, it has been suggested that GST-
mediated conjugation of 4-HNE with GSH will influence many signal transduction pathways 
and modulate the activity of major transcription factors. 
 
1.6.2 GST families and classes (isoforms) 
Early workers assumed that separate enzymes were responsible for the metabolism of 
different substrates, however Jakoby and his co-workers demonstrated that GSTs were a 
superfamily of enzymes with unique but overlapping substrate specificities 225. 
Characterisation of GSTs was thus difficult as they appeared to catalyse similar reactions 
between GSH and several distinct electrophiles yet differed in amino acid sequence. As a 
result they are often collectively termed isozymes/isoenzymes. In 1985 the complete amino 
acid sequences from the cDNAs of a number of isoenzymes became available and coupled 
with the similarities/differences in substrate specificities, affinity for non-substrate ligands, 
intracellular location and tertiary/quaternary structural properties, a system of classification 
for mammalian GSTs was developed 226 227.  
 
There are three distinct families of GSTs in mammals: cytosolic (which forms the largest) and 
mitochondrial families comprising of soluble enzymes that are structurally similar and 
catalytically active as homodimers or heterodimers, and membrane-bound (MAPEG) 
monomers which are mostly involved in the production of eicosanoids. Eight distinct classes 
of soluble GST isoenzymes, encoded by genes on several different chromosomes, are 
recognised in humans. These include: alpha (), mu (), pi (), sigma (), theta (), omega 
(), zeta () and kappa (), as illustrated in Figure 1.9 215. 
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Cytosolic GST enzymes within each class typically share over 40% identity, while those 
between classes share no more than 25% and display distinct catalytic as well as non-
catalytic binding properties. The majority of cytosolic GST isoenzymes are found in the 
cytoplasm, however some can associate with mitochondria and membranes (e.g. mouse 
GST-A4, M1 and P1) 228. It was recently reported that GSTP1 is also expressed in the nucleus 
and can prevent apoptosis by attenuating the oxidative stress-induced DNA damage 229. In 
contrast, the MAPEGs are all membrane-bound enzymes encoded by single genes and have 
arisen separately from the soluble GST. They fall into subgroups I, II and IV and include: 
microsomal GSTs (MGST 1, 2 and 3) which play a role in detoxification of electrophiles; 
leukotriene C4 synthase (LTC4S) that synthesizes leukotriene A4; FLAP, an arachidonic acid-
binding protein required for 5-lipoxygenase-mediated leukotriene synthesis; and 
prostaglandin E2 synthase 1 (PGES1), that catalyses isomerization of PGH2 to PGE2 
230. 
Figure 1.9 Classification of GST enzymes into distinct families and classes/isoforms. This is based 
on intracellular location, substrate specificity, affinity for non-substrate ligands and 
tertiary/quaternary protein structure. 
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1.6.3 GST gene expression and activity 
A number of human GST isoforms are constitutively expressed in certain tissues. For 
instance, GST α1, α2 and 1 are the major GST subunits expressed in the adult liver 226, 
while GST 1 is highly expressed in the lung 231. Collectively, these isoenzymes (as well as 1 
and 2) are the most abundant in mammalian tissues, which highlights the importance of 
these specific GSTs, particularly in organs such as the liver and lung, which are heavily 
involved with the detoxification of xenobiotics and secondary oxidative stress products.  
 
Similarly, a study carried out by Knight et al, examining the expression of various GST 
enzymes in a variety of mouse tissues, reported constitutively high expression of cytosolic 
GSTs in the liver (primarily GST), the kidney and part of the gastro-intestinal tract, 
highlighting the importance of these tissues in the detoxification of ingested xenobiotics 232. 
However, the majority of tissues expressed multiple GST isoforms and little relationship was 
found between the class designation and tissue-specific expression therefore the specific 
roles of individual enzymes within murine tissues remain a matter of speculation.  
 
Regulation of GST expression  
The regulation of the most abundant mammalian GST isoforms (α,  and ) has been 
studied in detail. These families appear to exhibit varying degrees of sex-, age-, tissue-, and 
species- patterns of expression, resulting in marked inter-individual differences in the 
constitutive expression of GST isoforms. Several groups have also reported that cells derived 
from human tumours often constitutively express higher levels of GST isoenzymes 
(specifically GST), which may explain how tumour cells display a multidrug-resistant 
phenotype to anticancer therapies 215. While biological mechanisms for such variation are 
poorly understood, it appears that GST over-expression can be induced by transcriptional 
activation, stabilization of either mRNA or protein, and gene amplification. 
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Induction of GST expression 
Endogenous factors, such as hormones, growth factors, and cytokines, as well as a 
structurally diverse range of exogenous compounds may play a critical role in mediating 
alterations in GST expression in physiological and pathophysiological conditions. A number 
of signalling molecules and transcription factors (such as Jun, Fos and NFB) are reported to 
be involved in GST upregulation through the transcriptional activation of GST genes via the 
ARE, the xenobiotic-responsive element (XRE), the GSTP enhancer 1 (GPE) or the 
glucocorticoid-responsive element (GRE) found in the promoter region of GST genes. 215. 
 
Many of the compounds that induce GST expression are themselves substrates for these 
enzymes, suggesting that GST upregulation represents an adaptive response to chemical or 
oxidative stress caused by various electrophiles. For instance, exposure of hepatocytes to 
carcinogens leads to an increase in GST expression (particularly GST) and resistance to that 
particular carcinogen. This phenomenon is commonly observed in the malignant 
transformation of cells 233,234. Similarly, the increased resistance of human tumours 
following exposure to a single chemotherapeutic agent is thought to be due to an 
upregulation of GST protein 235 as well as specific multi-drug resistant proteins that 
facilitate transport of drugs out of cell 236. While the precise underlying mechanism is 
unknown, this could be due to increased transcription and/or stability of the GST mRNA. 
 
Several studies suggest that GST expression can also be regulated by ROS. For instance, H2O2 
dose-dependently upregulates GSTP1 in human blood cells 237, while the •O2¯ generator, 
paraquat, has been shown to induce GST expression in mouse keratinocytes 238. Similarly in 
in vivo mouse models, paraquat induced an upregulation of most GSTs (bar GST θ) even in 
the lungs and kidneys, despite their ubiquitously high basal GST expression 239. One 
potential underlying mechanism for this phenomenon may involve GST dissociation from 
JNK under stressed conditions, via dimerisation of monomer units (as described previously). 
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This would enable phosphorylation of downstream kinases, which can directly upregulate 
transcription of many genes including radical scavenging enzymes such as GST. By contrast, 
if these GSTs accumulate, they can potentially re-form a complex with JNK to limit the 
degree and duration of JNK kinase activity and downstream effects. This suggests the 
presence of an autoregulatory loop for GST regulation of JNK and a direct mechanism for 
GST upregulation in stressed conditions 218. 
 
It is also postulated that secondary oxidative stress products such as 4-HNE and other 
hydroperoxides specifically can modify protein thiol groups on Keap1, thus preventing the 
targeted degradation of Nrf2. Accumulating Nrf2 translocates to the nucleus, where it is 
recruited to the ARE enhancers in the promoters of inducible genes. A large number of GST 
and other antioxidant genes (SOD1) have been found to contain an ARE or related 
sequences. The notion that Nrf2 is involved in mediating basal expression of GST (both 
cytosolic and MAPEG) is supported by the fact that in Nrf2 null mice, the normal 
homeostatic levels of many class α,  and  transferases are reduced by over 80% 240,241.  
 
A degree of functional redundancy has also been observed in the expression of GSTs. For 
instance, certain cytosolic GSTs are upregulated in GSTA4 and GSTZ null mice 222. Similarly, 
loss of GPx1 in rats and mice, leads to a marked increase in hepatic GST α,  and θ 
expression 242. In both animal models, it is thought that the increase in the intracellular 
levels of reactive aldehydes, hydroperoxides and H2O2, due to loss of GSTs or GPx, 
respectively, induces GST expression (possibly through modification of Keap1) as a 
compensatory response. This supports the thinking that GST expression can be dictated in 
part, by accumulation of endogenous substrates. However, deficiency in particular GST 
isoenzymes can have deleterious effects on cell survival as is sometimes observed in cells 
and tissues of individuals exhibiting polymorphisms in these major detoxifying enzymes. 
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Attenuation of GST expression or activity 
Both the catalytic activity and intracellular expression of GST appear to be influenced by 
GSH availability. This was highlighted in children with inherited GSH synthetase deficiency, 
who showed barely-detectable levels of GSH, deficiency of GST and a 75% reduction in GST 
activity as compared to control individuals 243, while the levels of other GSH-dependent 
enzymes (GR and GPx) were normal. Thus, it was suggested that the deficiency of GST in 
such patients is due to the enzyme’s instability in the absence of adequate GSH levels.  
 
GSTs expression and activity may also be affected by naturally occurring variations in the 
gene sequence, referred to as genetic polymorphisms. Human GST polymorphisms have 
been well characterized and their occurrence appears to be ethnic-dependent. At least five 
of the human GST classes/isoforms display polymorphisms, where inherited substitutions or 
deletions result in the complete loss or the expression of a less active form of GST 
isoenzyme. For instance, 20 to 50% of individuals, (a percentage which is higher in 
Caucasians and Asians than in Africans), do not express the GSTM1 enzyme due to a 
homozygous gene deletion 244,245. This is referred to as a null mutation and is illustrated in 
Figure 1.10A. Cells from these individuals appear to be more susceptible to DNA damage 
induced by GSTM1 substrates such as PAHs 246 and such individuals are more at risk of 
developing adenocarcinoma of colon and lung 231. GSTT1 null mutations are also common, 
occurring in approximately 60% of Asians, 40% of Africans and 20% of Caucasians 246. 
 
Single base pair substitutions within the coding region of GSTs can also give rise to cDNA 
and protein variants, as opposed to the complete loss of an enzyme. For example, GSTP1 
gene polymorphisms commonly occur following base pair substitutions in exon 5 (where the 
amino acid isoleucine is substituted by valine at position 105) and exon 6 (where an alanine 
is replaced by valine at position 114), as illustrated in Figure 1.10B. These amino acid 
substitutions are within (or in close proximity to) the active site of the GSTP1 protein and 
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thus influence the tertiary conformation and reduce enzyme activity and affinity towards 
common substrates such as 1-chloro-2,4-dinitrobenzene (CDNB) 247,248. In addition, 
individuals with the Val105 allele have a higher risk of developing lung cancer than those with 
the Ile105 allele. However a number of studies have reported that the GSTP1 enzyme 
containing Val105 has higher rather than lower affinity towards certain substrates, suggesting 
that the differences in activity reflect differences in binding of the electrophilic substrates to 
the hydrophobic binding site of GSTP1.  
 
A
B
 
 Figure 1.10 Overview of the mu-class GST gene cluster and GSTP1 gene, mRNA and protein 2. 
(A) The GST gene cluster has been mapped to chromosome 1. The GSTM1 gene consists of 8 exons 
and is flanked by two almost identical 4.2kb regions. The GSTM1 null allele arises from homologous 
recombination of the left and right repeats resulting in a 16kb deletion containing the entire GSTM1 
gene (bottom of the diagram). (B) The GSTP1 gene on chromosome 11 contains 7 exons. The arrows 
indicate polymorphic sites. Two of the polymorphisms result in amino acid substitutions in codons 
104 (IleVal) and 113 (AlaVal) in exons 5 and 6, respectively. 
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In summary, GST isoenzymes are central to the detoxification of foreign chemicals and 
oxidative stress products and play an important role in modulating several intracellular 
signalling pathways, which can ultimately influence cell survival/death pathways and 
inflammatory gene expression. Some GST isoforms (namely α, , and ) are constitutively 
expressed in a number of organs, however their expression does not appear to be strictly 
tissue-specific. Several factors have been reported to induce the upregulation of GST 
isoenzymes, generally in response to stress. By contrast, it appears that attenuation of GST 
expression/activity, generally as a result of GST polymorphisms, can significantly reduce an 
individual’s antioxidant capacity and can severely hinder an individual’s response to chemical 
agents (such as carcinogens) and elevated levels of oxidative stress.   
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1.7 GST POLYMORPHISM IN INFLAMMATORY LUNG PATHOLOGIES 
GST ,  and θ classes specifically have been studied in the human lung and are considered 
key players in the cellular protection against environmental and oxidative stress, as shall be 
discussed in this section. Such genes are known to be polymorphic in up to 50% of the 
healthy human and mouse population. Several groups have reported that genetic 
polymorphisms of these cytoprotective enzymes are likely to contribute to inter-individual 
differences in the clearance of xenobiotics and oxidative stress products, due to attenuated 
activity or a lack of one or more GST isoenzymes. This not only highlights the key role of 
these specific GSTs in the protection against oxidative stress, inflammation and injury but 
also suggests that GST genotypes may determine susceptibility to various chronic and acute 
inflammatory lung pathologies (including cancer and respiratory diseases) and their 
outcome 4.  
 
1.7.1 Chronic inflammatory lung disorders 
 
Lung cancer 
Since GSTs are important in the detoxification of xenobiotics (such as carcinogens) and thus 
can protect susceptible tissues from somatic DNA mutations, their polymorphisms have 
sparked considerable interest in the field of cancer. It was thought that GST polymorphisms 
may impair cellular ability to metabolically eliminate carcinogenic compounds and thus 
increase the risk of cancer development. Over 500 studies have examined the association of 
GST polymorphisms with various malignancies. While several suggested that GST variants 
are potential risk factors in the development of cancers (including lung, breast, bladder and 
prostrate 249,250,251,252), results have been generally inconsistent. In the field of lung cancer 
specifically, the distribution of GSTM1 and GSTT1 null polymorphisms has not been found to 
be significantly different between lung cancer and control patients, suggesting that these 
polymorphisms are not independent risk factors for lung cancer 249,253. However another 
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study found that the combination of GSTM1 and GSTP1 polymorphisms was significantly 
associated with an elevated lung adenocarcinoma risk 254.  
 
More than 75% of lung cancer is attributed to environmental carcinogen exposure, such as 
polycyclic aromatic hydrocarbons (PAHs) found in tobacco (a major GSTM1 substrate) 255, as 
such compounds can cause DNA damage (by adduct formation or base damage) and result 
in genomic instability in the lung cells 256,257. However, not all individuals who are exposed to 
such compounds develop lung cancer, suggesting that genetic variation influences risk of 
developing this malignancy. While an individual’s DNA repair capacity could attenuate the 
degree of DNA damage, GSTM1, P1 and T1 are known to play a central role in detoxification 
of major classes of tobacco carcinogens. Not surprisingly, higher levels of PAH-adducts are 
readily found in individuals with GSTM1 null genotype. Furthermore, several studies have 
found that null genotype of either GSTM1 or GSTT1 are associated with an increased risk of 
smoking-related lung cancer, especially when polymorphisms are found in combination 258. 
Similarly, another study revealed that non-smokers carrying the GSTM1 null genotype alone 
or in combination with the GSTP1 Val105 allele displayed up to 4-fold increased risk of 
developing lung cancer after 20 years of ‘passive smoking’ 259. These studies support the fact 
that inter-individual variation of GST genotypes affects the ability with which carcinogens 
can be detoxified and thus may play a significant role in modifying lung cancer risk 246. 
 
GSTs not only detoxify environmental chemicals found in tobacco, but also catalyse the 
conjugation of GSH with a number of electrophilic cancer drugs 215. Since chemotherapy 
represents the major treatment for cancers, resistance of tumour cells to the cytotoxicities 
of cancer drugs is a major obstacle in effective therapy. For instance, up-regulation of GSTT1 
and GSTP1 has been observed in several human tumours and is thought to play an important 
role in the detoxification of cancer drugs and inhibition of apoptotic pathways 251,260. Several 
studies have also suggested that chemotherapeutic drugs may be more effective when 
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detoxifying enzymes show a reduced activity. For example, one study showed that among 
cancer patients receiving chemotherapy, those possessing GST polymorphisms (such as 
GSTP1-Val105 variant allele) responded better to treatment and were significantly less at risk 
of dying 261. Yet the relationship between GST polymorphisms and the resistance to 
chemotherapeutic agents has been inconsistent 262. 
 
It is important to recognise that polymorphisms in GST ,  and θ have a relatively weak 
effect on tumourigenesis in the absence of deleterious environmental conditions (such as 
smoking). However, several studies indicate that loss of these genes or a modification in 
their catalytic activity, alone, can increase susceptibility to many inflammatory diseases. 
These include allergies, atherosclerosis and rheumatoid arthritis and those specifically 
affecting the lung including asthma 263, COPD 264 and ALI 7. 
 
Asthma 
Asthma is a prevalent chronic disease characterized by reversible airflow obstruction and 
airway inflammation which can be induced by inhalation of toxic environmental substances. 
In 2000, Fryer et al. first reported the positive association between GSTP1 Val105 
polymorphism and bronchial hyper-responsiveness and asthma, and suggested that genetic 
variation in this gene may predispose individuals to airway inflammation 265. Since then, 
independent studies have reported that GSTM1 and T1 null genotypes and GSTP1-Val105 
polymorphism alone significantly increase the risk of asthma development in adults 266,267,268. 
In addition, GSTM1 and T1 expressed by adults with a smoking history appear to be less 
efficient in the protection against asthma development. This indicates that high doses of 
tobacco toxins may permanently modify the capacity of GSTM1 and/or T1 detoxification 
system. In addition it appears that genetic variations in the GSTP1 promoter and coding 
regions may also contribute to the occurrence of childhood asthma 269.  
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Evidently, GST polymorphisms (specifically GSTP1, the major cytosolic GST enzyme 
expressed in the human lung) are frequently associated with asthma and/or asthma-related 
phenotypes. It is likely that a reduced antioxidant capacity results in the inefficient 
detoxification of ROS which results in continued inflammation in the lung, activation of 
broncho-constrictor mechanisms and precipitation of asthmatic symptoms 270. However, it is 
important to note that these positive associations are controversial. For instance, Kamada et 
al. found no association between the GSTM1 null genotype and asthma, however they did 
report that the presence of GSTM1 null genotype appears to modify GSTP1 gene expression 
270. Such gene-gene interaction may highlight the complexity of GST gene regulation in the 
pathogenesis of asthma. It has also been suggested that the apparent effects of these GST 
polymorphisms may vary depending on the study design, sample selection (e.g. ethnicity), 
definition of disease and/or environmental factors.  
 
Chronic obstructive pulmonary disease (COPD) 
The association between the GSTP1 gene and COPD has been investigated in numerous 
studies however the data remain inconsistent. In 1997 Harries et al. 271 reported a non-
significant increase in the proportion of homozygous Val105 status among British patients 
with COPD as compared to healthy control subjects. This finding was also reported by 
Rodríguez et al. in the Spanish population 272. By contrast, Ishii et al. found that the wild-
type variant Ile/Ile is related to the development of COPD in the Japanese population 273. 
These inconsistent data could be explained by the small sample size of healthy subjects and 
patients and/or the ethnic differences between studies. For instance, some authors believe 
that GSTP1 Val105 polymorphism is protective against COPD only in Asian populations 274. 
 
One of the more recent studies investigated GSTP1 polymorphisms (in exon 5 (Ile105Val) 
and exon 6 (Ala114Val)) in 234 unrelated COPD cases and 182 healthy controls from a 
Tunisian population 264. While ‘exon 6’ polymorphism was absent in the two groups studied, 
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they found that frequencies of ‘exon 5’ GSTP1 polymorphism in COPD patients differed 
significantly from the control group and revealed that homozygous mutant genotype Val/Val 
was 2-fold higher in COPD patients. Therefore it seems that the Val/Val genotype at amino 
acid position 105 plays an important role in predisposition to COPD while the contribution 
of Ala114Val polymorphism may not be relevant, at least in the Tunisian population. 
 
1.7.2 Acute inflammatory lung disorders 
Several factors can contribute to the risk of developing ALI/ARDS. Since the initial 
description of ARDS in 1967, many studies have focussed on the role of oxidative stress and 
inflammation in the pathogenesis and course of the disorder, however, conflicting results 
remain. More recently, efforts have turned towards investigating the role of genetic 
variability, specifically of genes encoding cytokines and other inflammatory mediators, in 
the initiation and progression of ALI. An imbalance between ROS and antioxidant capacity is 
also characteristic of ALI and thus several investigators hypothesized that genetic 
differences in oxidative stress genes (such as GSTs), may determine susceptibility to and 
outcome of several acute lung pathologies. Therefore a number of recent clinical studies 
have investigated the effects of GST polymorphisms in ALI and ARDS. 
 
Moradi et al. investigated the role of GST M1, P1, and T1 polymorphisms in the clinical 
response of ARDS patients treated with broad spectrum antioxidant NAC 275. Increased 
mortality in the control group of ALI/ARDS patients (i.e. in the absence of NAC treatment) 
was associated with GSTM1 null polymorphism alone and the double deletion of GSTM1 and 
T1. Moreover, in these groups of patients NAC treatment significantly lowered mortality 
rate. These results not only suggest that ALI patients lacking GSTM1 protein or both GSTM1 
and T1, are more vulnerable to oxidative stress and have increased rates of mortality, but 
also highlight the role of such genetic background in the responses to antioxidant therapy 
treatment in such patients. 
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The potentially unique role of GST isoenzymes has also been highlighted in preliminary 
studies related to lung transplantation. Here, the investigators found a strong association 
between donor GST genotypes and the development of severe ALI (PGD) in the recipient 
following lung transplantation 7. Investigators found that the incidence of PGD was 12% in 
control patients receiving lungs with both GSTM1 and P1 functional proteins developed PGD. 
This incidence increased 2-fold when the donor was GSTM1 null or exhibited the GST Ile105 
genotype. Moreover, when patients received lungs with both GSTM1 null and P1 genotypes, 
the incidence of PGD rose significantly to 70% (more than 5 times that observed in control 
patients receiving both functional enzymes) (Figure 1.11). 
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Figure 1.11 Influence of donor GST genotypes on the incidence of PGD post-transplantation. 63 
donors of 92 patients enrolled in the Lung Transplant Outcomes Group Cohort Study. The primary 
outcome was Grade 3 PGD beyond 48 h post-transplantation. A significant association was found 
between donor GSTM1 null and GSTP1 +313 AA (Ile105) genotypes with PGD. While 12% of patients 
receiving donor lungs with wild type GST genes developed PGD, this figure increased to 36% and 
42% in the case of donor GSTM1 null and GSTP1 Ile105 genotypes, respectively. Of the 14 subjects 
with GSTM1 null and GSTP1 Ile105 genotypes, 10 developed PGD (71.4%) 7 
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Therefore, GST  and  polymorphisms, independently and combined, appear to increase a 
patient’s susceptibility to IRI and PGD. Further investigation validated the clinical significance 
of these findings by showing that donor GSTM1 genotype was independently associated 
with PGD and significantly improved the ability of existing risk scores to predict PGD 276. 
Furthermore, it has been suggested that such polymorphisms are likely to contribute to 
inter-individual differences in response to clearance of oxidative stress products and thus 
may determine susceptibility to various inflammatory and proliferative pathologies 4. 
Despite these findings, the precise role of these GST isoenzymes in lung homeostasis is 
unknown. In particular, the impact of attenuated GST activity on cell survival and adaptation 
to acute pulmonary stresses such as IRI, and the mechanisms involved are yet to be 
elucidated. This PhD is set out to explore these novel aspects involved in oxidative stress and 
inflammation. 
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2.1 HYPOTHESES & AIMS 
As discussed in the Introduction GSTs constitute a superfamily of multifunctional enzymes 
which play a key role in protecting macromolecules from attack by reactive electrophiles. 
These include carcinogens and secondary oxidative products that would otherwise trigger 
cellular dysfunction and/or contribute towards an inflammatory response. Several clinical 
studies have suggested that polymorphisms in GST M1, P1 and T1 genes in particular, are 
risk factors in the development of numerous cancers and pulmonary inflammatory 
conditions such as asthma and ARDS. In addition to their important role in detoxification of 
xenobiotic and oxidative compounds, it has also been reported that GSTs can regulate cell 
proliferation and apoptosis via modulation of JNK and p38 signalling pathways 277. These 
findings collectively highlight the importance of endogenous GST in modulating cell survival 
and inflammation. Therefore, our principal hypothesis was that GST is a key determinant in 
the adaptation and survival of lung cells exposed to stress. In light of this, the objective of 
this PhD was to investigate for the first time, the specific role of endogenous GST in lung cell 
survival and inflammation, in both in vitro and ex vivo models.  
 
Our principal aim was to explore the biological role of GST in in vitro cell culture models. In 
order to investigate the importance of GST enzymes in oxidative and metabolic stress 
conditions, cells with normal or reduced GST activity were exposed to various stresses – 
relevant to ALI-related disorders. Initially we explored the influence of GST activity 
attenuation on cell viability and intracellular redox state.  Additionally, we wished to 
investigate whether reduced GST activity affected the intracellular metabolic profile and the 
activation of redox-sensitive signalling pathways, which may in turn modulate both cell 
injury and inflammatory gene expression. We hypothesised that attenuation of GST activity 
may increase oxidative stress which could modulate redox-sensitive signalling and 
potentially enhance stress-induced cellular injury and pro-inflammatory gene expression. 
 
 92 
To expand on in vitro findings, we then investigated the role of GST in a physiological setting. 
This was explored using an ex vivo isolated perfused lung (IPL) model (in collaboration with 
Dr Kenji Wakabayashi). We hypothesised that administration of GST inhibitors would also 
increase oxidative stress in the mouse lung, causing cellular injury/death, increased 
pulmonary permeability and consequently alterations in respiratory mechanics. Furthermore 
we hypothesised that the stress induced by prolonged perfusion in the presence of GST 
inhibitors may directly modulate inflammatory gene expression, which could potentially 
enhance pro-inflammatory cytokine release. 
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2.2 EXPERIMENTAL DESIGN 
 
2.2.1 Aim 1: Influence of GST inhibition on pulmonary cells in physiological conditions 
The alveolar epithelium and capillary endothelium are both affected by IRI, however it is 
unclear whether they are injured simultaneously or whether the injury occurs primarily in 
one cell type. This PhD largely focussed on the role of GST in epithelial cells, which are 
essential in pulmonary function under both physiological and pathological conditions. 
 
Pulmonary cell culture 
The pulmonary epithelial cell lining, composed of alveolar type I and II cells (AEI and AEII), 
forms a continuous barrier to the environment and is the first line of defence against 
infectious agents and toxins. While both epithelial types contribute to sodium and water 
reabsorption across the alveolar epithelium and in a pathological setting can both stimulate 
leukocyte influx, through the production of pro-inflammatory cytokines, AEII in particular 
are believed to be key players in the pathogenesis and resolution of ALI/ARDS. Type II cells 
are wholly responsible for surfactant synthesis and secretion 278 and for the regeneration 
and repair of the damaged alveolar epithelium through proliferation and differentiation into 
AEI 279. For these reasons, AEII in particular are thought to be important maintaining the 
integrity, function and host responses to oxidative stress following direct and indirect insults 
to the lung.  
 
The epithelial barrier is also the primary structure injured following direct pulmonary insults 
and is a major target of inflammation. Diffuse loss of both types of epithelial cell, via 
apoptosis and necrosis, can result in the impairment of physiological functions, increased 
permeability of the alveolar–capillary barrier and leakage of plasma into the alveolar space 
which is associated with the typical ALI-related clinical scenario of interstitial as well as 
alveolar oedema, decreased compliance and impaired gas exchange. 
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The central role of epithelial cells in both the defence against and as targets of injury, led us 
to investigate the effect of GST inhibition in type II cells. The majority of experiments were 
carried out with murine lung epithelial (MLE-12) cells from an AEII cell line. These cells have 
previously been used as a model of alveolar epithelial cells in ALI-related studies, where cells 
were exposed to hypoxia/reoxygenation and hyperoxia 280,281. To investigate if the results 
obtained were applicable to human lung epithelial cells, some principal experiments were 
also carried out using the human A549 cell line. Damage to the pulmonary endothelium is 
also a major feature in the development of ALI, thus in a series of experiments, I also used 
primary mouse lung endothelial cells, which had previously been isolated and characterised 
in our laboratory.  
 
Antioxidant depletion 
Oxidant-mediated tissue injury is a major player in the pathogenesis of ALI and ARDS. In 
recent years, the crucial role of GST enzymes specifically, has been highlighted in the 
protection against oxidative stress in both chronic and acute inflammatory conditions. The 
majority of studies investigating the importance of these enzymes have over-expressed 
intracellular GST resulting in non-physiological levels of GST activity 282. In contrast, there is 
limited information regarding the influence of attenuated endogenous GST activity in the 
setting of oxidative stress, as observed in patients with GST polymorphisms. Thus, to gain 
further insight into the role of GST in normal lung cells, we studied the influence of GST 
inhibition on lung cell survival under control conditions. We used two different approaches 
to attenuate GST activity namely pharmacological agents and RNA interference. We also 
explored the effect of attenuated GST activity on intracellular redox state, metabolic profile, 
redox signalling and inflammatory gene expression. Some of these readouts were then 
assessed in models relevant to ALI with attenuated GST activity, as discussed in Aim 2.  
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Pharmacological inhibitors 
Two chemically different and well characterised GST inhibitors, ethacrynic acid (EA) and 
caffeic acid (CA) were employed. Their molecular structure is illustrated in Figure 2.1. Some 
studies have shown EA to specifically inhibit GSTπ isoform 283 while others have found EA to 
be a broad non-selective GST inhibitor 284. In addition, EA also acts as a substrate, forming a 
conjugate with GSH via Michael addition, both spontaneously and by GST driven catalysis. 
The EA-GSH conjugate generated is itself a potent GST inhibitor. Similarly, CA, a naturally 
occurring plant polyphenol, has long been reported as a strong inhibitor of GST 285,286, 
achieving reversible or irreversible inhibition. For instance, CA’s major glutathione 
conjugate, 2-S-glutathionylcaffeic acid (2-GSCA), is a strong but reversible inhibitor of GST, 
while CA alone is a more efficient irreversible inhibitor of GST 285.  
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Small interfering RNA (siRNA) 
Strong associations between lung injury and GST null polymorphisms in  and  isoforms in 
particular 7,275 have highlighted the importance of specific GST isoforms in the protection 
against acute and chronic lung inflammation. In order to explore the roles of specific GST 
isoforms and to complement our study using pharmacological GST inhibitors, we attempted 
to modulate endogenous GST  and/or  activity by RNA interference (RNAi).  
Figure 2.1 The molecular structure of GST inhibitors: (A) ethacrynic acid and (B) caffeic acid. 
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RNAi is an invaluable tool for gene function analysis in both in vitro and in vivo settings. It 
inhibits gene expression through sequence-specific degradation of the target messenger 
RNA (mRNA) (the immediate precursor to protein) in a long-acting manner. The process 
involves delivery of double-stranded siRNA molecules, typically 21-23 nucleotides in length, 
into the cell using various transfection methods. As illustrated in Figure 2.2, siRNA molecules 
become integrated into a multi-subunit protein complex commonly known as the RNA-
induced silencing complex (RISC). The siRNA duplex unwinds and only the antisense strand 
remains bound to RISC, which then locates the target RNA sequence. On pairing with the 
complementary mRNA sequence, the target mRNA is cleaved by endonuclease argonaute (a 
catalytic component of RISC) into smaller portions that can no longer be translated into 
protein. As a result, protein synthesis of the target gene stops - an effect identical to that 
seen if the gene itself had been silenced. 
 
 
 
 
 
Figure 2.2 An overview of RNA interference-induced gene silencing (taken from Applied Biosystems) 
RISC loading with exogenous double-stranded siRNA 
 
RISC-induced unwinding of siRNA and passenger strand cleavage 
 
RISC activation and recognition of complementary mRNA 
 
Argonaute-mediated degradation of complementary mRNA 
 
Product release and gene silencing 
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2.2.2 Aim 2: Influence of GST activity attenuation on cellular response to stress  
Despite extensive research into IRI, the precise mechanisms underlying such tissue injury 
and the roles of specific antioxidants, such as GST, in these conditions remain incompletely 
understood. It is accepted that ischemia, classically defined as a restriction of blood supply 
to a tissue, has two main consequences. Firstly, tissues are deprived of substrates that are 
essential for normal metabolism (primarily O2 and glucose) and secondly, metabolic waste 
products (which can be toxic) gradually accumulate. Furthermore, reintroduction of O2 into 
ischemic tissues, upon tissue reperfusion, contributes to the augmented production of 
reactive species.  
 
The motivation to study IRI and the importance of GST activity more accurately at a 
molecular level, led to the development of a number of oxidative and metabolic stress 
models which were used to reproduce critical stress components of this condition in vitro. 
These included cellular exposure to: (i) chemical oxidative stress, (ii) hypoxia followed by 
reoxygenation (Hx/Rx) and (iii) metabolic stress (substrate depletion). Such models formed 
the foundation of our cellular experiments and are described in more detail below. 
 
A Chemical oxidative stress 
We employed the chemical stressor H2O2 as this is a widely used prototype of stimulated 
oxidative stress and is associated with tissue injury following ischemia reperfusion. Lipid 
peroxidation derivatives can also induce or enhance oxidative stress. While 
malondialdehyde (MDA) is a common lipid-derived aldehyde, it is generated from 
hydroperoxides such as tert-butyl hydroperoxide (tBH). The latter is a membrane-permeant 
oxidant that has been extensively used as a model of oxidative stress in different biological 
systems 287. Thus we also utilised this chemical as an oxidative stressor in a select number of 
our experiments.  
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B Hypoxia reoxygenation (Hx/Rx) 
While reperfusion of an ischemic tissue is necessary for long term cell survival, it is often 
accompanied by a complex inflammatory response and significant cell injury and death. 
Subjection of cell cultures to prolonged periods of hypoxia and eventual reoxygenation was 
anticipated to reproduce the effects experienced by tissues subjected to ischemia-
reperfusion in vivo. Thus, we incubated cells in an atmosphere consisting of 95% N2 and 5% 
CO2 using a purpose-built hypoxic incubator for up to 24 h, following which cells were 
incubated with normoxic media in a normoxic chamber for increasing periods of time. 
 
C Metabolic stress (substrate deprivation) 
Deprivation of metabolic substrates is acknowledged as an important component of clinical 
IRI. This insult was reproduced in vitro by incubation of cells with a media depleted of a 
number of essential substrates. Graded substrate depletion was achieved by incubating cells 
in either full media (lacking fetal calf serum) or a depleted medium consisting of a basic 
balanced salt solution with or without glucose, as previously documented 288.  
 
It is important to acknowledge that there are important limitations to each of these models 
with respect to the simulation of ischemia reperfusion. Specifically, each model represents 
only certain aspects of the IRI. Nevertheless, these models have helped us to: (a) evaluate 
the cellular survival and metabolic responses to these forms of insult; and (b) study the role 
of GST in oxidative and metabolic stress conditions, following attenuation of GST activity. 
 
2.2.3 Aim 3: Exploring the physiological role of GST using an ex vivo IPL model 
The use of in vitro platforms in research presents obvious ethical and cost advantages and 
also important scientific advantages, over in vivo models. For instance, it is easier to 
measure the impact of an experimental variable (such as a drug) on a simple, well-controlled 
system. However, entire organisms (as well as the tissues and organs that collectively form 
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an organism), are significantly more complex in terms of both arrangement and interactions 
of cells, thus in vivo models are considered more clinically-relevant than in vitro models. 
Nevertheless, whole animal studies can also have their limitations. For instance it is difficult 
to study the role of a specific protein in one particular organ, as administration of 
pharmacological agents (such as inhibitors) into an in vivo model could cause significant 
systemic disturbances which may alter the physiology and complicate the evaluation of the 
organ of interest. 
 
To overcome these difficulties isolated perfused organs - commonly referred to as ‘natural 
tissue models’ can be employed 289. These offer the closest in vitro models of the in vivo 
state, preserving the in vivo cellular heterogeneity and structural complexity and ensuring 
that the important cell-cell and cell-matrix contact is maintained. Thus in this PhD project, 
the physiological, in vivo role of GST, was explored using an IPL system. This involves the 
lung as a complete organ with its many cellular and humoral interactions among resident 
cells. Employment of this model allowed us to focus on the effects of GST inhibition in the 
lung itself, maintaining the physiological relevance while excluding for instance the diuretic 
effect of the GST inhibitor EA. Therefore addition of EA to the perfusate of the IPL model 
allowed us to identify EA-mediated changes in: respiratory mechanics; pulmonary 
permeability; and expression of inflammatory players in the lung. We hoped that these 
results would complement the knowledge gained from in vitro studies and enhance our 
understanding of the roles of endogenous GST in the lung.  
 100 
 
 
 
 
 
 
 
Chapter 3: 
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SUMMARY 
This chapter lists the materials and describes the methodologies employed during this 
project including techniques used for cell culture, in vitro siRNA transfection and ex vivo 
isolated perfused lung model, as well as those employed to quantify RNA, intracellular or 
surface protein expression, enzyme activity and cell viability. 
 
A large part of this project focussed on in vitro studies, whereby different cell lines were 
exposed to various stresses in combination with reduced GST activity. This was achieved by 
pharmacological inhibition or post-transcriptional knockdown of specific GST isoforms. The 
influence of such treatments on a number of physiological conditions and intracellular 
pathways was investigated, including cell viability, intracellular redox stress, metabolic 
profile, activation of signalling molecules and modulation of inflammatory gene expression. 
A general synopsis of the approaches used to investigate these endpoints is described 
within this chapter, while a more detailed description of the procedures are provided in 
subsequent chapters. Investigations into the in vivo role of GST were carried out with an ex 
vivo IPL model, which has previously been developed in our laboratory. The methodology 
employed will be described fully at the end of this chapter.  
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3.1 MATERIALS 
 
General reagents  
The principal components of cell media including Dulbecco's Modified Eagle's Medium 
(DMEM), DMEM and Ham's F-12 Nutrient Mixture (DMEM:F12), RPMI-1640, Foetal Calf 
Serum (FCS) and 1% penicillin/streptomycin/gentamycin (PSG), as well as Phosphate 
Buffered Saline (PBS), Dulbecco’s PBS (DPBS) and Hank’s Balanced Salt Solution (HBSS) were 
supplied by Invitrogen Ltd (Paisley, UK). Trypsin/ethylenediamene tetracetic acid (EDTA) 
(T/E), Bovine Serum Albumin (BSA), Tween 20, Dimethylsulfoxide (DMSO) and sodium azide 
were purchased from Sigma Chemical Company (Dorset, UK). Hydrogen peroxide (H2O2) and 
tert-butyl hydroperoxide (tBH) were also obtained from Sigma, while the TNFα was bought 
from R&D systems (Abingdon, UK). BOC (London) supplied 95% N2, 5% CO2 gas mixture 
which was connected to the Galaxy CO2 Hypoxic Incubator, (Wolf Laboratories, York). 
 
Pharmacological agents 
The majority of pharmacological agents which included GST inhibitors ethacrynic acid (EA) 
and caffeic acid (CA); the NADPH oxidase inhibitor, diphenyleneiodonium chloride (DPI); the 
cell-permeable SOD inhibitor, diethyldithio-carbamate (DETC); the broad-spectrum ROS 
scavenger, N-acetyl cysteine (NAC); the p38 MAPK inhibitors, SB202190 and SB203580; the 
ERK pathway inhibitor, U0126; the NFB inhibitor MG132 and the PI3K inhibitor, LY294002 
were supplied by Sigma. Finally, the NOS inhibitor, N-nitro-L-arginine Methyl Ester 
hydrochloride (L-NAME) was purchased from Merck (Darmstadt, Germany), while the 
caspase inhibitor zVAD was purchased from Invitrogen. 
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3.2 CELL CULTURE 
All cell culture procedures were carried out in clean, sterile conditions using a Class II 
Biosafety laminar flow cabinet. The majority of in vitro experiments were performed using 
MLE-12 cells (purchased from American Type Culture Collection: ATCC), an SV40-
transformed mouse lung epithelial cell line of alveolar type II (AEII) cell lineage. These cells 
were grown in DMEM:F12 media supplemented with 5% FCS and 1% PSG. Human alveolar 
epithelial A549 cells (ATCC), which were cultivated in RPMI-1640 supplemented with 5% FCS 
and 1% PSG, and primary mouse lung endothelial cells (kindly provided by Dr J Dokpesi), 
were also used in a select number of experiments. In brief, the latter were isolated from 
C57BL/6 mice and purified by CD45⁺ cells (leukocyte) depletion and CD31+ cell enrichment 
using a Miltenyi MACS separation unit - involving the separation of magnetically-labelled 
endothelial cells from other cells. The flow-through was depleted of CD45+ cells and 93% of 
the cells eluted from the column expressed CD31 (PECAM-1), typical of endothelial cells, of 
which 84% were viable (assessed by 7-aminoactinomycin-D, a plasma membrane 
impermeable fluorescent dye used to determine the viability of cells by flow cytometry). 
They also expressed other characteristic endothelial markers including VE-Cadherin, ICAM-1, 
ICAM-2 and endoglin and while E-selectin and VCAM-1 were not basally expressed, they 
were markedly up-regulated in response to LPS and TNFα stimulation. Furthermore, in 
culture they exhibited the typical ‘cobblestone’ morphology of the vascular endothelium. 
These were grown in gelatine-coated flasks/wells, containing complete medium made of 
DMEM supplemented with 1% sodium pyruvate, 1% non essential amino acids, 50g/ml 
endothelial cell growth stimulant (ECGS), 10% FCS, 12U/ml heparin, 25mM HEPES, 1% PSG 
and 2mM L-glutamine (all of which were purchased from Invitrogen or Sigma).  
 
All cells were cultured at 37°C in humid conditions with 5% CO2 and 95% air and were 
monitored daily using a phase contrast microscope (Olympus CK30-F200; Olympus Co. 
GmbH, Hamburg, Germany). Culture media was replaced every 2-3 days with fresh media 
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and once confluency was reached (where cell coverage of the flask > 90%), cells were 
harvested. MLE and A549 cells were maintained in culture up to passage 15, while mouse 
primary endothelial cells were used for experimentation only up to passage 10. Since all of 
these cells are adherent, trypsinisation was required for cell collection. Briefly, growth 
media was removed by aspiration and cells washed in PBS (to remove traces of trypsin 
inhibitors present in FCS). An appropriate volume of T/E (x1) was added to cells and 
incubated for 2-5 min at 37°C, until cells appeared ‘rounded’. Cell culture vessels were then 
tapped to aid detachment from the growth surface. Growth media containing FCS was 
added to prevent further trypsinisation (and subsequent cell damage) and cells were 
pelleted from suspension by centrifugation at 1800rpm for 7 min.  
 
The pellet was resuspended in 1ml growth media and cells were counted using a 
haemocytometer. Cells were either subcultured into 150cm² flasks (at 5x106cells/flask) or 
seeded into 12-, 24- or 96-well plates (at optimised densities, specific to the cell type) for 
experimentation. Alternatively, for long-term storage of epithelial cells, the cell pellet was 
resuspended in an appropriate volume of cryogenic solution (FCS containing 10% DMSO) 
and transferred as 1ml aliquots to cryogenic vials. These were initially frozen in a -80°C 
freezer at a rate of -1°C/min in a Thermo Scientific Nalgene Cryogenic Freezing Container 
and later transferred to a liquid nitrogen chamber. For recovery of cells, cryovials were 
heated rapidly at 37°C and the cell suspension was added to a T150cm2 flask containing 
20ml of growth media to dilute the DMSO contained within the cryogenic solution.  
 
 
3.3 GLUTATHIONE-S-TRANSFERASE ACTIVITY ASSAY 
The GST activity of pure bovine liver GST (Sigma) and that found in cell lysates was 
determined using the GST Fluorometric Activity Assay Kit (Biovision, Cedarlane Laboratory 
Ltd, CA). This is a simple, fluorescence-based in vitro assay which utilizes monochlorobimane 
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(MCB), a dye which reacts with reduced glutathione in the presence of GST. MCB itself is 
almost non-fluorescent, however following GST-catalysed MCB-GSH conjugation, the dye 
fluoresces blue. Thus, level of fluorescence is proportional to the GST activity. The assay was 
carried out following the manufacturer’s instructions. In brief; 100l samples were 
transferred in triplicate to wells of a 96-well black fluorescent plate, to which 100l MCB 
substrate and 10l GSH (200mM) (provided in the assay kit) were added. Fluorescence was 
measured in a fluorescent plate reader (Flx-800, Bio-tek Instruments Inc., UK) at 
excitation/emission wavelengths: 380/461 nm. Raw data were exported to Microsoft Excel 
and used to create fluorescence-time graphs. The gradient (slope) over the initial 10 minute 
period was calculated as fluorescence units per minute (FU/min) and converted to GST 
activity in ‘mUnits’ (mU) or ‘mU/mg of protein’, using the standard curve.  
 
 
3.4 SiRNA TRANSFECTION & REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION 
 
3.4.1 siRNA transfection protocol (RNA interference) 
RNAi is an invaluable tool for gene function analysis, revolutionizing these studies in both in 
vitro and in vivo settings. The sequence of events is described fully in 2.2.1, but ultimately 
RNAi inhibits gene expression through sequence-specific degradation of the target mRNA. 
MLE cells were transfected with scrambled, non-specific siRNA (as a control) or siRNA 
specifically targeting GSTM1 or GSTP1 isoforms (Dharmacon siRNA Technologies, Thermo 
Fisher Scientific, UK) using Lipofectamine 2000 vector system (Invitrogen) in accordance 
with the manufacturer’s protocol. A detailed protocol of siRNA transfection is included in 
Chapter 8.3. After transfection cells were incubated in complete media at 37°C for 48 or 72 
h and either collected for cDNA or protein knockdown analysis, or used for experiments. 
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3.4.2 Reverse transcriptase-Polymerase Chain Reaction (PCR) 
RT-PCR consists of a number of steps, including: (i) RNA extraction from cells, (ii) reverse 
transcription, where RNA is used as a template from which complementary DNA (cDNA) is 
synthesised, and (iii) amplification of target cDNA and its quantification by quantitative PCR. 
These steps will be described briefly in this chapter, while a more detailed protocol can be 
found in Chapter 8.3. 
 
Total RNA was isolated from transfected cells using an RNeasy Mini kit (Qiagen, California, 
USA) according to the manufacturer's guidelines. This involved cell lysis using reducing 
agents, homogenisation and RNA extraction. RNA extracts were either stored at -80°C until 
further use (to avoid degradation) or used immediately in cDNA synthesis. For the latter, 
RNA was quantified spectrophotometrically at 260nm (Biophotometer plus, Eppendorf, UK) 
and calculated in ‘µg/µl’. Single-stranded cDNA was synthesized from 2g RNA, in 
MicroAmp Optical tubes (Applied Biosystems), using a master mix created with reagents 
from the TaqMan RT-PCR kit (Applied Biosystems, Warrington, UK) according to the 
manufacturer’s instructions. All cDNA samples were vortexed and stored at -20°C. 
 
Prior to real-time/quantitative PCR, reagents are in excess while cDNA template and product 
are at very low concentrations. Amplification of the target cDNA sequences by PCR was 
carried out using the TaqMan Gene Expression Master Mix (2X) (Applied Biosystems) and 
FAM-linked TaqMan probes Mm00833915_g1 and Mm00496606_m1, targeted against 
mouse GSTM1 and P1, respectively (Applied Biosystems). It is important to note that 
separate tubes were used for the amplification of these two target cDNA sequences. 
Eukaryotic 18S rRNA probe was also employed as an internal control. The PCR master mix 
was aliquoted into MicroAmp Optical tubes, following which cDNA samples, DNA plasmid 
(as positive control) or water (as negative control) were added appropriately and tubes 
were inserted into the PCR machine.  
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Following PCR, data was collected using the ABI PRISM 7700 and Sequence Detection 
System (SDS) 1.9.1 (Applied Biosystems, UK). Real-time PCR data are displayed as sigmoidal-
shaped amplification plots and converted to a logarithmic scale in which fluorescence 
change (y axis) is plotted against the number of cycles (x axis), as illustrated in Figure 3.11. 
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To analyse the results, the ‘threshold’ (indicated as a red line on the amplification plot) was 
set above the background (i.e. the baseline, representing the noise level in early cycles and 
typically between cycles 3 and 20) but within the exponential growth phase, for all samples 
except the positive and negative controls. Relative quantification of target cDNA was 
performed using the comparative cycle threshold (CT) method. The CT of a given sample is 
the specific cycle at which the amplification plot crosses the threshold (i.e., at which there is 
the first clearly detectable increase in fluorescence). The CT value of the target cDNA was 
normalised against that of the 18S rRNA (the internal standard) of the equivalent sample, as 
described previously 290. Data are presented as mean + sd. 
Figure 3.1 A typical real-time PCR amplification plot 1. The graph displays the relative cDNA levels of 
gene X in several different samples. The x axis represents the cycles of PCR while the y axis 
represents the change in fluorescence. The red horizontal line is the threshold and is set above the 
background fluorescence but within the exponential phase. The point at which the fluorescent 
signals cross the threshold is the cycle threshold (CT). The following stages are highlighted: a. Plateau 
phase; b. Linear phase; c. Exponential phase; and d. Background. 
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3.5 ANALYSIS & QUANTIFICATION OF PROTEIN EXPRESSION 
 
3.5.1 Protein assay 
Total protein levels of samples were quantified using the Pierce BCA Protein assay (Fisher 
Scientific, Leicestershire, UK). Advantages of this assay include better linearity than 
Coomasie-based Bradford assays and compatibility with higher concentrations of 
detergents. It involves the reduction of Cu+2 to Cu+1 which then selectively reacts with 
bicinchoninic acid (BCA) reagent. The purple-coloured reaction product exhibits a strong 
absorbance at 562 nm and is detected by a colorimeter. The protein assay was carried out in 
accordance with the manufacturer’s instructions. In brief, BSA standards were prepared by a 
series of dilutions and ranged from 0 – 1500µg/ml. Samples were diluted (1 in 5). Both 
samples and standards were plated in triplicate. Following addition of working reagent to 
each well, the plate was gently tapped to ensure thorough mixing and incubated for 30min 
at 37°C. The absorbance of samples at 560nm was measured using a colorimetric plate 
reader (MRX II absorbance reader, Dynex Technologies, Magellan Biosciences) and protein 
concentrations of such samples were determined with reference to BSA standard curve. 
 
3.5.2 Western blotting procedure 
 
Sample preparation 
Western blotting is an analytical technique used to detect specific proteins in a given sample 
of cell/tissue extract. For sample preparation, cells were harvested by trypsinisation and 
centrifuged at 1800rpm for 5 min at 4°C. Cell pellets were resuspended in cell lysis buffer: 
50mM HEPES, 100mM, 1% TritonX-100, 1mM EDTA, 1mM EGTA, 20mM NaF, 1mM Na3VO4. 
Protease inhibitors pefabloc, aprotinin, pepstatin and leupeptin (all purchased from Sigma) 
were added to the lysis buffer immediately before use at 10g/ml. Samples were incubated 
on ice for 20 min and briefly sonicated every 5 min, following which lysates were 
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centrifuged at 12,000g for 15 min at 4°C to remove nuclei and debris. Whole mouse lung 
homogenates were prepared as described in 3.10. Cell and tissue supernatants were 
retained for immediate use or stored at - 20°C. 
 
Electrophoresis, protein transfer and visualisation 
Equal protein levels (determined by the protein assay) of each sample were loaded/well (20 
- 60µg) and resolved on 10% or 4-12% sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) gels, depending on the molecular weight (MW) of the protein of 
interest. Proteins were then transferred by ‘dry blotting’ onto a nitrocellulose membrane 
using the iBlot Gel Transfer Device (all materials were purchased from Invitrogen, UK). 
Membranes were blocked for 2 h at room temperature with 5% non-fat milk in tris-buffered 
saline (TBS) with 0.05% Tween 20 (TBS-T) and incubated overnight at 4°C with a primary 
antibody (Table 3.3) diluted in TBS-T containing 5% BSA/1% azide. The following day, 
membranes were washed in TBS-T for 5 min (x3) and incubated for a further 1 h with a 
horseradish peroxidise (HRP)-conjugated secondary antibody (Table 3.1) diluted in TBS-T 
with 5% non-fat milk. Membranes were then washed with TBS-T, as above and once with 
TBS. Enhanced chemiluminescence detection system (ECL, Amersham, UK) was used to 
visualise target proteins in the G:BOX iChemi XR image analyzer (Syngene, Cambridge, UK).  
 
Images were developed using GeneSnap software and exposure times ranged from 30 
seconds to 5 min, depending on band intensity. GeneTools software was used to measure 
‘band densities’, allowing semi-quantitative analysis of target protein. Inevitably, there are 
small differences in the amount of protein loaded into each well of the gel therefore the 
expression of α-tubulin or β-actin, two ubiquitously expressed housekeeping proteins was 
also quantified as an internal control. These were selected appropriately according to their 
MW, so as not to overlap with bands from primary target protein. The relative expression of 
target protein was calculated by normalisation to level of internal control. 
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Antigen 
 
Estimated MW 
(kDa) 
Type Dilution Company 
GST  26 Polyclonal 1:500 Abcam, Cambridge, UK 
GST  23 Polyclonal 1:500 Abcam, Cambridge, UK 
p-p38 43 Polyclonal 1:1000 New England Biolabs, UK 
p-p65 65 Polyclonal 1:500 New England Biolabs, UK 
α-tubulin 50 Monoclonal 1:2000 Sigma-Aldrich, UK 
β-actin 45 Polyclonal 1:2000 New England Biolabs, UK 
Goat HRP - HRP-conjugated 1:2000 New England Biolabs, UK 
Mouse HRP - HRP-conjugated 1:5000 New England Biolabs, UK 
Rabbit HRP - HRP-conjugated 1:2000 New England Biolabs, UK 
Anti-biotin 
HRP 
- HRP-conjugated 1:5000 New England Biolabs, UK 
 
 
 
 
 
3.5.3 Enzyme-linked immunosorbent assay (ELISA) 
This biochemical technique is used to detect the presence and quantity of an unknown 
antigen in a sample. We used an ‘in-house’ colorimetric sandwich ELISA to quantify soluble 
keratinocyte-derived chemokine (KC) and macrophage inflammatory protein-2 (MIP-2) 
released into cell media, and the perfusate and BALF of IPL experiments. In brief, 96 
Immuno MicroWell plates (NUNC, Denmark) were coated with 100µl monoclonal anti-
mouse CXCL1/KC or MIP-2 capture antibody (R&D systems, UK) diluted to 1g/ml or 8g/ml 
in DPBS, respectively. Following overnight incubation, wells were washed (x4) with wash 
buffer (0.05% Tween 20 in DPBS) and loaded with 300l blocking buffer (1%BSA, 5% 
sucrose, 0.05% azide in DPBS) for 1 h. All incubations took place at room temperature. After 
blocking and washing, recombinant mouse KC or MIP-2 (R&D systems, UK) were diluted to 
Table 3.1 Details of all the primary and secondary antibodies used in western blotting. The table 
includes the estimated MW of antigens and dilutions used for the detection of target proteins in cell 
lysates and lung homogenates. p-p38, phosphorylated-p38 mitogen activated protein kinase (MAPK) 
and p-p65, phosphorylated p65 (i.e. activated subunit of NFB). 
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form standards with a range of 15 – 1000pg/ml. Standards and unknown samples were 
added to appropriate wells in duplicate. Samples were diluted so that predicted mediator 
concentrations would fall within the limits of the standard curve. Wells were washed after 2 
h and 100l of 50ng/ml mouse biotinylated KC or MIP-2 detection antibody (R&D systems) 
was added for a further 2 h. After washing, 100l streptavidin-HRP solution (R&D systems), 
diluted 1 in 200 ‘PBS + 1% BSA’ was added to each well for 20 min. After a final wash, 100l 
of substrate solution, containing H2O2 and tetramethylbenzidine in 1:1 ratio (R&D systems) 
was added and plates were then protected from the light for 30 min. The reaction was 
stopped with 2N sulphuric acid (Sigma) and the Optical Density (OD) was determined within 
10 min using the MRX II colorimetric reader (Dynex Technologies, Worthing, UK) at 450nm 
absorbance. The Revelation program was used to convert OD values into ‘pg/ml’ of KC and 
MIP-2, with reference to the standard curve. 
 
 
3.6 EVALUATION OF CELL VIABILITY 
 
3.6.1 Mitochondrial activity 
Mitochondrial activity was determined as an index of cell viability by colorimetric MTT 
assay, as described previously 291. Briefly, the assay is based on the reduction of MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) to a blue formazan dye by the 
functional mitochondria of viable cells. Upon termination of the experiment, the media was 
discarded from plates, and cells were incubated with MEM containing 0.5mg/ml of MTT 
(Calbiochem, Nottingham, UK) for 2 h at 37°C in an atmosphere of 5% CO2. The solution was 
aspirated and DMSO was added to dissolve the blue-coloured formazan particles. Samples 
were mixed and ODs were measured by the colorimetric reader at 595nm. Average values 
were calculated from samples tested in quadruplets.  
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3.6.2 Assessment of apoptosis 
Cell death can be broadly classified as apoptotic or non-apoptotic. Apoptosis is a 
programmed cell death where the cell itself activates and executes its own death, through a 
series of physical and biochemical changes in the cytoplasm, nucleus and cell membrane. In 
contrast, necrosis is a non-regulated, passive form of cell death caused by forced 
destruction of vital cellular machinery without activation of any specific cellular pathway. 
 
Annexin V/PI staining 
Levels of apoptosis and necrosis were determined by flow cytometry following staining with 
fluorescent probes Annexin V-FITC and propidium iodide (PI), components of the Annexin-V 
Apoptosis Detection kit (Sigma), as previously described 292. The procedure involves the 
binding of Annexin-V to phosphatidylserine - a phospholipid which in viable cells is found on 
the cytoplasmic side of the plasma membrane, but externalises upon induction of apoptosis. 
While plasma membrane integrity is maintained in early apoptotic cells, that of late 
apoptotic and necrotic cells is completely compromised, allowing PI to enter the cell and 
bind to the cellular DNA. 
 
In brief, cells were harvested by trypsinisation and centrifuged at 1800rpm for 7 min. Cells 
treated with staurosporine (1g/ml) or H2O2 (0.8mM) served as positive controls for 
apoptosis and necrosis, respectively, as recommended by Sigma and documented previously 
293. Untreated cells served as negative controls. The pellets were resuspended in 500l of 1x 
binding buffer (10x binding buffer: 100mM HEPES/NaOH, pH 7.5, containing 1.4M NaCl and 
25mM CaCl2, was supplied by Sigma). Cell suspensions were incubated with 2µl of Annexin-
V and PI in the dark at room temperature, for 10 min, after which samples were run through 
the FACSCalibur flow cytometer. 10,000 events were recorded for each sample. Samples 
were excited by the 488nm argon ion laser and fluorescence signals were detected at 525 
and 620nm for FITC and PI detection, respectively.  
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Caspase involvement 
Generally apoptosis involves activation of distinct caspase cascades. To complement the 
assessment of apoptosis by FACS, we used a pharmacological approach to inhibit caspase 
activity and then investigated the impact of this on cell viability. To this extent, cells were 
treated in the presence or absence of 100µM zVAD, a broad spectrum caspase inhibitor and 
cell viability was assessed by MTT assay. Cells were treated with TNFα and cycloheximide 
(Sigma) over 24 h as a positive control of apoptosis 294. 
 
 
3.7 FLOW CYTOMETRY 
Flow cytometry, also referred to as ‘fluorescence-activated cell sorting’ (FACS) is a sensitive 
technique that uses immunofluorescence to measure expression of cell-associated or 
intracellular antigens on a per cell basis within single or heterogeneous cell populations. 
Such detailed analysis cannot be achieved with western blotting or ELISA. In addition, cells 
can be stained simultaneously with several antibodies (conjugated to different fluorescent 
dyes) enabling the quantitative detection of a number of target antigens in a given sample. 
The flow cytometer analyses a sample cell suspension by passing cells through a laser beam 
and capturing the light that emerges from each cell as it passes through. From this, 
correlated data about individual cell size, granularity and fluorescence intensity can be 
collated.  In this project, FACS was used to: distinguish between apoptotic and necrotic cells 
through staining with Annexin V and PI (as described in 3.6); assess intracellular oxidative 
stress (as described in 3.8); and quantitatively measure expression of adhesion molecules 
CD54 (ICAM-1) and CD106 (VCAM-1) as markers of inflammatory gene upregulation, as 
described below.  
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3.7.1 Cell surface antigen staining protocol 
Following experimentation, cells were collected by trypsinisation and centrifuged for 7 min 
at 1800rpm. Cell pellets were resuspended in 50l FACS Wash Buffer (FWB) (DPBS 
supplemented with 2% FCS, 5mM EDTA and 0.1% sodium azide) and stained for 20 min, in 
the dark at 4°C with fluorophore-conjugated anti-mouse monoclonal antibodies for either 
CD54 (ICAM-1) and CD106 (VCAM-1) or their appropriate isotype-matched controls. All 
antibodies were diluted in FWB at optimum concentrations, determined by titration. Final 
antibody concentrations are in shown in Table 3.2. Following staining, samples were washed 
with FWB to remove unbound antibodies and resuspended in 300µl FWB.  
 
 
 
3.7.2 Acquisition and analysis  
Samples were acquired on a FACSCalibur flow cytometer using CellQuest software (BD 
Biosciences) or a Cyan ADP Analyzer flow cytometer using Summit software (Beckman 
Coulter, Buckinghamshire, UK). For all samples, acquisition was stopped after 10,000 events 
had been recorded. Data were analysed with FlowJo software (version 8.8.6, Tree Star, 
Ashland, Oregon, US). The main cell population, based on size and granularity, was gated on 
a forward scatter, side scatter (FSC-SSC) plot and any background fluorescence 
(characterized by a low forward and side scatter) was excluded from the analysis as cellular 
debris.  
 
Antibody 
 
Final 
concentration 
 
Isotype Control 
 
Final 
concentration 
 
Conjugated 
fluorophore 
 
Anti-mouse VCAM 
(AbD Serotec) 
 
1g/ml 
 
Anti-IgG2a        
(BD biosciences) 
 
1g/ml 
 
FITC        
(detected in FL1) 
 
Anti-mouse ICAM 
(BD biosciences) 
 
0.25g/ml 
 
Anti-IgG2b        
(BD biosciences) 
 
0.25g/ml 
 
PE             
(detected in FL2) 
Table 3.2 ICAM-1 and VCAM-1 antibodies and their isotype-matched controls used in FACS 
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The apoptotic and necrotic cell populations were quantitatively analysed using quadrant 
statistics, with the log of Annexin V and PI fluorescence displayed on the x- and y- axis and 
detected in FL1 and FL2 channels respectively. By contrast, ROS production is reported as 
the Mean Fluorescence Intensity (MFI)/geometric mean of the DCF or DHR123 fluorescence 
emitted by cells (detected in FL1). Expression of cell-surface proteins ICAM-1 and VCAM-1 
(detected by antibodies conjugated to PE and FITC, detected in FL2 and FL1 respectively) is 
also reported as MFI with the appropriate isotype control subtracted. 
 
 
3.8 ASSESSMENT OF OXIDATIVE STRESS 
It is widely recognised that real-time detection of ROS/RNS proves challenging due to their 
low concentration and high reactivity. As such, we employed a series of techniques to assess 
the overall levels of intracellular oxidative stress and the potential involvement of key ROS. 
 
3.8.1 Redox-sensitive fluorescent probes 
The cell permeable, non-fluorescent dyes 2’7’-dichlorodihydrofluorescein (H2DCF-DA) and 
dihydrorhodamine123 (DHR) (both from Invitrogen) were used as detectors of a broad 
range of intracellular oxidizing reactions, as described previously 295. After diffusing into the 
cells, intracellular esterases cleave off the diacetate group from the former probe H2DCF-
DA, trapping the dye, which is oxidised to 2’7’-dichlorofluorescein (DCF) in the presence of 
ROS. The latter probe turns into rhodamine123 (DHR123) in the presence of free radicals 
and localises mainly in the mitochondria. Cells were pre-incubated for 30 min at 37°C with 
either 20µM H2DCF-DA or 5µM DHR123 and subsequently exposed to treatments. 
Incubation in media alone or H2O2 served as negative and positive controls, respectively. 
Wells were then washed (x4) with PBS, to remove any remaining extracellular probe, and 
cells were harvested by trypsinisation. After collection and centrifugation (1800rpm, 7 min), 
cells were resuspended in FWB and analysed as described in 3.7. 
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3.8.2 Carbonylation assay 
Primary ROS can oxidise lipids, reducing sugars and amino acids forming secondary oxidative 
products which can often propagate oxidative stress and injury. As described in 1.4, lipid 
peroxidation products represent a major group of secondary oxidants and include 
hydroperoxides and LDAs, such as MDA and 4-HNE. These compounds can be toxic to many 
biomolecules and are responsible for much of the pathology associated with oxidative 
stress, however they are highly reactive and often difficult to measure due to low sensitivity 
and specificity of the methods available. Due to their high reactivity towards specific amino 
acid groups (such as lysine, cysteine sulfhydryl and histadine imidazole groups 296), they 
have the capacity to readily form carbonyl adducts on proteins. As a result, aldehyde-
derived protein adducts, which are stable products, have been extensively investigated. To 
study the level of protein carbonylation in this project we employed the 2,4-
dinitrophenylhydrazine (DNPH)-based procedure 297.  This involves derivatisation of carbonyl 
groups with 2,4-DNPH, which leads to formation of a stable DNP hydrazone product which 
can then be detected by spectrophotometric assay. 
 
Briefly, 200l protein sample (approx 0.1mg) was taken into 500l of 4mg/ml BSA. To this, 
700ml of 0.1% DNPH (Sigma) prepared in 2M HCl, was added and incubated for 1 h at room 
temperature. Corresponding blanks served as negative controls. The derivatized proteins 
were precipitated by addition of 500l of 30% trichloroacetic acid (Sigma) and stored on ice 
for 30 min. Samples were then centrifuged at 14,000rpm for 5 min at 4°C. The pellets were 
washed (x3) with 500l of ethanol:ethyl acetate (1:1 v/v) and finally dissolved in 1ml 8M 
guanidine–hydrochloride, 13mM EDTA and 133mM Tris pH 7.4. The ODs were measured 
using a colorimeter at 365nm and results were calculated as nmol carbonyl/mg of protein 
using an extinction coefficient of 21mM-1/cm-1. 
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3.9 METABOLIC ANALYSIS 
 
3.9.1 Adenine nucleotide assessment: HPLC and UV detection  
The balance of ATP and other purine nucleotides (such as ADP, AMP, NAD⁺, NADH) is 
important in regulating many biological functions. It is well recognised that the ATP/ADP 
ratio reflects the cellular energy levels 298, which can impact on many cellular processes. The 
NAD⁺/NADH ratio plays a key role in regulating the intracellular redox state. Since many 
metabolic enzymes (such as those involved in glycolysis) are regulated by the NAD⁺/NADH 
ratio, it is often considered as a read-out of the metabolic state. Furthermore, it has been 
well documented that the NAD⁺/NADH ratio fluctuates in response to a change in 
metabolism 299, which is likely to occur following stress. 
 
To investigate the perturbation of energy balance and redox state, intracellular levels of 
adenine nucleotides were measured by reversed-phase HPLC (high performance liquid 
chromatography) coupled with UV detection, a sensitive and specific technique. Extraction 
was carried out as described previously 300. Briefly, following treatment, cells were washed 
and samples were extracted with 200l of ice-cold perchloric acid (0.4M) of which 150l 
was neutralized with equimolar KOH (approximately 30l of 2M base) (purchased from 
Sigma). KClO4 was then precipitated by centrifugation (13,000 rpm for 3 min at 4°C) and the 
supernatant/extract was retained and stored at −80 °C for subsequent analysis.  
 
Levels of ATP, ADP, AMP, NAD and ADPR (a product of NADH following acid precipitation) 
were analyzed using the Agilent HPLC 1100 system, equipped with a diode array UV 
detector. This was controlled by a computer system with a Chemstation software program 
for data processing. The mobile phase used was 0.1 M potassium dihydrogen phosphate (pH 
6.0) with 0.15 M potassium chloride as phase A and 15% acetonitrile as phase B. Using the 
Hypersil BDS column (3u particles, 15cm x 4.6 mm size) and a flow rate 0.9ml/min, the peaks 
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of ATP, ADP, and AMP were eluted at retention times 3.46, 3.86, and 5.69 min, respectively. 
The concentration of each nucleotide was determined in a 20μl sample extract and finally 
expressed in terms of ‘nmol nucleotide/ml extract’ with reference to standards.  
 
3.9.2 Metabonomics 
Global metabolic analysis is the latest research ‘omics’ and profiling platform being applied 
to understand and predict normal or altered biological responses, particularly to toxins or 
therapeutic compounds. Advances in such analytical technologies make it possible to 
identify and quantify hundreds of metabolites from a small sample, in a short period of 
time, allowing specific and global assessment of metabolic response to insult. To gain 
further insight into potential metabolic perturbations associated with oxidative lung injury 
and GST inhibition, we adopted a nuclear magnetic resonance (NMR)-based metabonomics 
profiling approach 301. 
 
Preparation of cell extracts 
Aqueous and organic metabolites were extracted from MLE cells using a 
chloroform/methanol extraction method. Briefly, frozen pellets were resuspended in 300μl 
of deuterated chloroform-methanol mixture (2:1 vol/vol) (Sigma) in which the hydrogen 
atom ("H") is replaced with deuterium (heavy hydrogen) isotope ("D"). This way the H atoms 
found within the solvents are distinguishable from those contained within the analyte – 
from which the NMR spectra are created. After vortexing, 300μl of ultrapure water (D2O) 
was added and samples were centrifuged at 16 000g for 5 min. Centrifugation resulted in 
the formation of two layers within each tube – the upper layer corresponded to the 
aqueous phase, while the lower one was the organic phase. This exploratory study focussed 
on the water-soluble metabolic profile. The aqueous layer was pipetted into glass NMR 
tubes (507-HP, GOSS Scientific Instruments Ltd) and 200µl of D2O was then added to ensure 
the sample volume was sufficiently large for detection by the NMR probe. Although the 
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organic phase would be of interest to this study, the lipid-derived metabolites are more 
complex and are generally explored by other techniques. Nevertheless, the organic layers 
were processed, by lyophilising overnight and re-dissolving in CDCl3, and then stored. To 
normalise samples, the protein concentration of MLE cell pellets was determined using the 
BCA protein assay and metabolite concentration was adjusted appropriately. Prior to 
sample preparation, all reagents were screened for contaminants (by 1D 1H NMR 
spectroscopy) that may interfere with the downstream spectroscopic analysis.  
 
1H NMR Spectroscopy: data acquisition and processing 
NMR spectra were acquired for cell extract samples on a Bruker DRX600 spectrometer 
(Bruker Biospin, Rheinstetten, Germany) operating at 600.13-MHz 1H NMR frequency and 
283K. The 1D Carr-Purcell-Meiboom-Gill (CPMG) pulse sequence was applied during 
spectroscopy to measure spin-spin (T2) relaxation times. The external reference, 
trimethylsilyl propionic- 2,2,3,3-d4 acid (TMSP, 0.5 mmol/l), was used for metabolite 
quantification of fully relaxed 1H-NMR spectra and as a 1H chemical shift reference (0 ppm). 
The acquired NMR spectra were thus calibrated to TMSP peak at 0 ppm and automatically 
corrected for phase and baseline distortions using NMRPROC V.03 software, to ensure 
correct orientation of peaks and a horizontal/straight baseline. All subsequent data 
processing and analysis was conducted using MetaSpectra software, written and compiled 
within MATLAB (Student 2007, The MathsWorks, USA). 
 
NMR spectra analysis 
The spectra were normalised to protein content of respective samples and were then 
analysed in two different ways. Firstly, the global metabolic phenotype of treatment groups 
was compared by principal component analysis (PCA), also referred to as ‘pattern 
recognition’ analysis. Spectra were divided and signal integral computed in δ 0.01 intervals 
across the chemical shift range δ 0.24-9.96. After removal of the regions containing the 
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residual water signal, δ=4.7-5.2 (ppm) and the extremes of the spectrum (δ<0.8 and δ>8.0 
ppm) to avoid the effect of baseline noise, we were left with a data table of 765 spectral 
variables. The NMR spectral data were imported into SIMCA-P (version 11, Umetrics, 
Sweden) which was used to generate all PCA models and scores plots. From these plots, 
conclusions were drawn with respect to the identity and relative levels of metabolites 
differing between samples. 
 
Secondly, isolated spectral regions/resonances, which related to specific metabolite signals, 
were defined through visual inspection. As is common in 1H-NMR spectroscopy, a single 
metabolite can be responsible for multiple resonances at different parts of the spectra 
depending on its chemical structure, thus specific metabolite assignment was made using 
the Madison Metabolomics Consortium Database 302. A typical NMR spectra is presented in 
Figure 3.2. Following peak assignment, peak areas were determined and reported as fold 
change relative to control, as opposed to absolute values.  
 
Choline(s)
Creatine
Aspartate
Glutamate
Lactate + 
L-threonine
 
 Figure 3.2 A typical nuclear magnetic resonance (NMR) spectra. Important metabolites have been 
assigned to specific peaks in relation to their chemical shift (ppm) displayed on the x axis of the plot. 
The area under the peak is representative of the level of each metabolite. This can be compared 
between treatments.  
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3.10 EX VIVO ISOLATED PERFUSED LUNG & SAMPLING 
All procedures were approved by the United Kingdom Home Office in accordance with the 
Animals (Scientific Procedures) Act 1986, United Kingdom. Male C57BL6 mice (Charles River 
Laboratories, Margate, UK) aged 8 to 12 weeks were used for the ex vivo experiments. 
 
3.10.1 Animal preparation, ventilation and perfusion 
Mice were anaesthetised by an intraperitoneal injection of ketamine (133.3mg/kg) and 
xylazine (13.3mg/kg). After induction of anaesthesia, a tracheostomy was performed to 
allow insertion of an endotracheal tube for ventilation. Mice were then ventilated with a 
custom-made jet ventilator using positive pressure ventilation, as described previously 303. 
Medical air supplemented with 5% CO2 was supplied at a respiratory rate of 80 breaths min
-
1. A low tidal volume (VT) of 8ml/kg, used to minimise lung injury development, was supplied 
by volume-controlled ventilation. To avoid atelectasis, a positive end-expiratory pressure 
(PEEP) of 2.5-3cmH2O and deep inflations of 20cmH2O for 5 seconds, every 5 min, were used 
throughout the experiments. This system has been routinely used in our laboratory. After a 
midline laparotomy and thoracotomy, heparin (100 IU/body) was injected intravenously to 
prevent blood coagulation. Mice were then exsanguinated by transection of the inferior 
vena cava following which the lower half of the body was severed.  
 
In order to perfuse the lungs, the main pulmonary artery (PA) and left atrium (LA) were 
cannulated with stainless steel cannulas via the right and left ventricles (across the 
pulmonary and mitral valves, respectively). The perfusate consisted of RPMI 1640 without 
phenol red (Invitrogen) supplemented with 4% BSA and NaCl (Sigma) to increase osmolarity, 
as previously described 304. Perfusate pH was adjusted to pH 7.35-7.45 at the start of the 
perfusion by addition of sodium bicarbonate (B Braun, Sheffield, UK). At the start of and 
throughout perfusion, temperature was maintained at 37°C using the heating circuit buried 
in the IPL plexiglass chamber.  
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Lungs were perfused using a constant flow Ismatec REGLO Digital Tubing pump 
(Laboratoriumstechnik GmbH, Wertheim-Mondfeld, Germany) at 25ml kg-1min-1 in a non-
recirculating manner. The pulmonary arterial pressure (PAP) and left atrial pressure (LAP) 
were monitored at the side port of the cannulas. The left atrial pressure was kept constant 
at 2.5mmHg by adjusting the height of the reservoir level. A 15-minute ‘equilibration’ period 
was carried out to ensure washout of residual blood and a non-recirculating perfusion (+/- 
EA) was sustained to allow the continuous supply of fresh perfusate to the lung. Effluate 
was also collected from the reservoir for gas and pH analysis at baseline and at termination. 
Further effluate samples were collected at 30 minute-intervals and stored at -80°C for ELISA 
analysis at a later date.  
 
Figure 3.3 Schematic of the mouse isolated perfused lung perfusion circuit. Mice were 
anaesthetised, tracheostomised and ventilated (with a low VT of 8ml/kg) using a custom-made 
mouse ventilator. After thoracotomy and exsanguination, the pulmonary artery and left atrium 
were cannulated and lungs were perfused in a non-recirculating manner as shown above. The 
perfusate is drawn up by peristaltic pumps and travels through the heat exchanger (maintained at 
37°C) and the bubble trap to remove any bubbles. Perfusate enters the pulmonary circulation via 
the pulmonary artery and leaves via the left atrium. Upon leaving the pulmonary circulation, 
effluate enters the reservoir, where it can be sampled or discarded as waste. In all experiments, a 
non-recirculating circuit was employed for 90 min, (which included the initial 15 min equilibration 
period), after which the system was changed to a recirculating circuit for 30 min, where the effluate 
from the reservoir was pumped to rejoin the circuit at the heat exchanger. 
 
 123 
3.10.2 Respiratory mechanics 
The airway pressures, including the peak inspiratory pressure (PIP) and the PEEP were 
monitored continually via transducers, while the gas flow was measured by a 
pneumotachometer. Both pieces of equipment were connected to a PowerLab data 
acquisition system (AD Instruments, Chalgrove, UK). Data was analysed using Chart software 
(version 5.5.6, AD Instruments). Respiratory mechanics, including respiratory system 
elastance (Ers) and resistance (Rrs) were determined by end-inflation occlusion 303 at 5 
minute-intervals immediately prior to regular deep inflations. In brief, this involved a 
constant flow of gas being delivered to the lungs (as done in normal mechanical ventilation), 
followed by a short inspiratory pause (zero flow) of 225 milliseconds (as illustrated in Figure 
3.4A). This was achieved by closure of the inspiratory solenoid valve, with the expiratory 
valve still occluded. During this period, the lungs remain inflated with a constant VT. A 
typical pressure trace is displayed in Figure 3.4B.  
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Figure 3.4 Typical flow and 
pressure traces from an ex vivo 
mouse mechanical ventilation 
system. These were achieved by 
end-inflation occlusion, during 
which we generated (A) a flow trace 
using a differential pressure 
transducer within the pneumo-
tachometer and (B) a pressure trace 
using pressure transducers. On the 
gas flow trace, zero drift could be 
corrected and VT accurately 
measured as the area under the 
curve, while the PIP and Pplat were 
accurately measured on the 
pressure trace. 
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Evaluation of the changes in pressure during this inspiratory pause allowed accurate 
measurement of respiratory system mechanics throughout the experiments. For instance, 
Ers and Rrs of the lungs were computed using the standard formulae: 
 
A.  ELASTANCE (Ers) = Volume  /  (Pplat - PEEP) 
B.  RESISTANCE (Rrs) = (PIP – Pplat) / Flow 
 
Ventilation was generally carried out for 2 h but was terminated prematurely if PIP 
increased by >30% (indicating substantial oedema development). Bronchoalveolar lavage 
fluid (BALF) and lungs were then collected and harvested, respectively, and either 
immediately used to measure permeability or stored at -80°C for ELISA and protein analysis. 
 
3.10.3 Assessment of permeability 
The pulmonary endothelial/epithelial permeability was assessed, using an adaptation of a 
previously reported fluorescence-based method for measuring vascular leak into the 
alveolar space 305,306. Following 90 min perfusion, the system was switched to a recirculating 
circuit and 100l of 1mg/ml Alexa Fluor 594 (fluorescence)-conjugated BSA (Invitrogen) was 
added to the reservoir. Following 30 min the perfusate was collected from the reservoir and 
stored in the dark. The circuit was then switched to a non-recirculating system for 5 min, in 
order to wash out the residual fluorescence from the lung vasculature.  
 
BALF 
BALF was obtained as described previously 307. Sterile saline (750μl) was flushed into the 
lungs via an endotracheal tube and gently sucked out. This was repeated twice. Samples 
were immediately centrifuged at 1500 rpm for 5 min at 4°C. Supernatants were either: 
immediately used for permeability index measurements; or aliquoted and stored at -80°C 
for analysis by ELISA or protein assay.  
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Lungs 
Lungs were excised, rinsed briefly in saline and swabbed gently with tissue to remove 
surplus blood. Lungs were then homogenised using GentleMACS tissue dissociator (Miltenyi 
Biotec Ltd, Bisley, UK) and incubated in the dark with 2ml of normal saline containing 
0.5mg/ml collagenase type IV (Sigma) (for 30 min at 37°C) to ensure release of tissue-
sequestered dye. After further homogenisation, lung suspensions were centrifuged (at 
4000g for 5 min) and supernatants were collected.  
 
Fluorescence levels of perfusate, BALF and lung homogenate supernatants were measured 
using fluorescence plate reader (Flx-800, Bio-tek Instruments Inc., UK) at absorption 590nm 
and emission wavelength 622nm. An index of endothelial and epithelial barrier permeability 
was estimated by the ratio of lung:perfusate and lavage fluid:perfusate fluorescent signal, 
respectively. 
 
 
3.11 STATISTICAL ANALYSIS 
Data are reported as the mean of repeated experiments ± standard deviation (SD). The 
majority of statistical analyses were performed using Prism software (version 4.0, GraphPad, 
La Jolla, USA). Metabonomics data was analysed by SPSS 17 (Chicago, USA). Comparison of 
three or more variables was carried out by either one-way analysis of variance (ANOVA) or 
repeated measure two-way ANOVA with multi-comparisons/post-hoc tests, including 
Bonferroni, where appropriate. Statistical significance of metabonomics data was 
assessed by Kruskal-Wallis test and post-hoc two-tailed Mann-Whitney U test. A p value 
<0.05 was considered significant.  
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Chapter 4: 
THE IMPACT OF GLOBAL GST 
INHIBITION ON LUNG CELL 
SURVIVAL 
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SUMMARY 
Pulmonary IR induces oxidative stress which is characterized by the excessive formation 
(and inefficient breakdown) of ROS and RNS. Ischemia, defined as a limited blood supply to 
a tissue, results in cellular deprivation of crucial metabolic substrates (including O2 and 
glucose), and the accumulation of metabolic waste products. Furthermore it is recognised 
that the reintroduction of O2 augments production of reactive species. Normally the 
intracellular antioxidant defence systems serve to minimise ROS-induced damage. While the 
clinical importance of diminished endogenous GST expression and activity is emerging, the 
precise role of GST activity in such conditions remains unknown.  
 
In this chapter, we wanted to gain further insights into the mechanisms by which GST 
polymorphisms impact on cellular response to stress. To do this, we studied the influence of 
pharmacological inhibitors (EA and CA) on lung cell injury in models relevant to ALI. Both EA 
and CA resulted in a concentration- and time-dependent reduction in the viability of MLE, 
A549 and primary mouse endothelial cells, although the tolerance varied among these cell 
types. As described in Chapter 2: Project Design, stress components of IR were reproduced 
by a number of in vitro models, where cells were exposed to (i) chemical oxidative stress, (ii) 
Hx/Rx and (iii) metabolic stress (substrate depletion). We found that chemical stressors H2O2 
and tBH reduced MLE cell viability in a concentration-dependent manner and presence of 
GST inhibitors (at subtoxic concentrations) significantly enhanced such injury. Although MLE 
and A549 cells were remarkably tolerant to Hx/Rx, stress-induced injury was revealed in the 
presence of GST inhibitor EA. Cells exposed to graded substrate deprivation demonstrated a 
time-dependent and graded decrease in viability. As in the other stress models, the 
presence of EA enhanced cell injury. Collectively, these observations highlight the 
importance of GST enzymes in the survival response of pulmonary cells to various stress 
components of IR. 
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4.1 BACKGROUND 
A considerable number of clinical and experimental studies strongly suggest that oxidant-
mediated tissue injury is a major player in the pathogenesis of ALI and ARDS. It is well 
recognised that excessive ROS accumulation, including that of •O2
-, H2O2,
 and •OH-, results 
in oxidative damage to major cellular components such as lipids, proteins, and DNA. If 
normal protective mechanisms of the cell are overwhelmed lipid peroxidation specifically 
can result in acute cell injury. Oxidation of PUFAs (a principal component of cell 
membranes) by abstraction of a hydrogen atom, initiates a chain of events leading to the 
formation of peroxyl species and lipid hydroperoxides. This sequence of events is illustrated 
in Figure 1.3 (General Introduction). Subsequent generation of LDAs that are reported to 
behave like secondary toxic messengers, can propagate oxidative injury through further 
oxidation of intracellular macromolecules and induction of apoptotic cell death pathways 
308. In such oxidative conditions, injury can also be amplified by the consumption of soluble 
antioxidants, such as Vitamin E, ascorbate and GSH, which form part of the first line of 
defence. A decreased antioxidant capacity often accompanies cell injury in inflammatory 
lung diseases. Furthermore, the products of lipid peroxidation reactions display increased 
chemical stability and thus have much longer life-times and are able to diffuse greater 
distances compared with their precursor ROS.  
 
The importance of antioxidant defence mechanisms in the protection of tissues against 
oxidative stress has been readily emphasised. Thus, attempts to attenuate lung injury have 
included the restoration of the oxidant/antioxidant balance by augmenting the intracellular 
pool of antioxidants. Numerous experimental animal studies have demonstrated the 
efficacy of antioxidant therapy in attenuating IRI including superoxide dismutase, catalase, 
vitamin E 309. Some antioxidants (such as NAC) have been shown to protect pulmonary cells 
from oxidative injury and ameliorate inflammation 310. One study, modelling ALI in rats, also 
demonstrated that NAC administration significantly attenuated the LPS-induced increases in 
 129 
both lung permeability and lipid peroxidation 311. Furthermore, NAC has been tested as a 
treatment in cystic fibrosis, COPD and in ARDS patients. Although the latter was a small 
clinical trial, intravenous NAC was associated with improved cardio-respiratory functions in 
ARDS patients 312. Despite many outstanding results in in vitro and in vivo studies, NAC 
antioxidant treatment has had limited therapeutic success in clinical practice. It is 
speculated that clinical ineffectiveness of antioxidant therapy is partly because oxidative 
stress is not the only factor affecting the pathogenesis of lung diseases. 
 
Over the past decade a large proportion of antioxidant investigations have focussed on the 
role of GSH and GPx in the removal of a broad spectrum of ROS in oxidative inflammatory 
conditions. However, more recently GSTs have sparked interest as key players responsible 
for the detoxification of secondary oxidative stress products such as lipid hydroperoxides 
and LDAs. Studies have addressed this from two angles. Firstly, overexpression of 
endogenous GST shows protection in pulmonary inflammation, for instance administration 
of recombinant GSTP1 has been found to effectively suppress LPS-induced acute 
inflammation 313. Secondly, the clinical importance of diminished endogenous GST 
expression and activity is also emerging. Initial investigations suggest that genetic variability 
(polymorphisms) in GST isoforms, that affect GST expression and activity, are likely to 
contribute to inter-individual differences in response to xenobiotics and clearance of 
oxidative stress products and thus may determine susceptibility to various inflammatory 
pathologies such as childhood/adult asthma and the outcome of ALI 4. One such study 
investigated the effects of NAC treatment on 27 ICU patients with ALI/ARDS and evaluated 
the outcome of patients with GST polymorphisms. The results showed an association 
between GSTM1 null, and GST M1 and T1 double null polymorphisms with increased 
mortality in control group. Furthermore, NAC treatment significantly lowered the mortality 
rate and improved oxygenation in ARDS patients with such polymorphisms 275. It has also 
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been suggested that donor GSTM1 null and GSTP1 Ile105 polymorphisms dramatically 
increased the development of PGD following lung transplantation 7. 
 
In light of the above, we hypothesised that GST activity is a major determinant of the 
survival response to oxidative stress in pulmonary cells and thus the severity and outcome 
of ALI-related disorders such as IRI. 
 
 
4.2 AIMS 
Our primary objective of this chapter was to investigate the impact of reduced GST activity 
on the survival response of pulmonary epithelial cells in various oxidative and metabolic 
stress models - simulating one or more aspects of ischemia-reperfusion. 
 
The specific aims were to: 
 
a) quantify intracellular GST activity and identify GST protein expression in mouse and 
human lung epithelial cells; 
 
b) evaluate the influence of pharmacological GST inhibitors on the survival of cells 
maintained under normal conditions; 
 
c) establish different stress models in lung epithelial cells to mimic aspects of IR such as 
oxidative stress, hypoxia/reoxygenation (Hx/Rx) and substrate deprivation; and 
 
d) explore the influence of GST attenuation on the viability of cells exposed to various 
stress models. 
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4.3 PROTOCOLS 
In the early phase of experimentation we established a quantitative GST activity assay, as 
described in 3.3. We used this to assess the level of GST activity in lysates collected from 
increasing numbers of MLE and A549 cells. To then explore the efficiency of GST inhibition, 
purified bovine liver GST or MLE cell lysates were incubated with GST inhibitors EA and CA. 
Increasing concentrations of GST inhibitors were incubated with 350mUnits purified GST 
(comparable to that found in approximately 2x10⁶ MLE cells) at 37°C for 2 h. Similarly, MLE 
cell lysates, acquired by sonication and permeabilisation (as described in 3.5) of 
2x10⁶untreated MLE cells, were also incubated with increasing concentrations of EA and CA 
in the same conditions. Following incubation, the degree of GST inhibition was assessed by 
the GST activity assay. This enabled us to determine the extent of (i) pure GST activity 
attenuation, and (ii) global GST inhibition in an environment of cellular constituents.  
 
In addition to the assessment of intracellular GST activity, we investigated the expression 
levels of GST and  proteins (the two most abundant GST isoforms in lung cells), by 
western blotting. MLE and A549 cells (1x106) were harvested and lysates prepared as above. 
Supernatants were also prepared from mouse lungs by homogenisation and centrifugation 
at 4000g for 5 min, as described in 3.10. Samples were loaded at 60g of protein per well of 
the gel and the western blotting procedure was carried out as described in 3.5. Membranes 
were probed with either anti-GST or GST primary antibodies, followed by anti-goat HRP-
conjugated secondary antibody, details of which are shown in Table 3.1. 
 
In order to study the influence of GST inhibition by EA and CA, initial concentration-response 
and time-course experiments were carried out with MLE cells.  Cells were seeded at 
5x10⁴/well of 96-well plates and reached a confluent state within 24 h. Cells were then 
incubated with increasing concentrations of EA (0-0.3mM) and CA (0-5mM) in a volume of 
150l FCS-free media. This media was used only during experiments, to reduce proliferation 
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and to standardise experimental conditions by avoiding the use of variable serum products 
such as FCS. After increasing time periods, mitochondrial activity was measured as in index 
of cell viability, by the MTT assay. The effect of increasing EA concentrations on cell viability 
was also investigated in human A549 and primary mouse endothelial cells (MULEC).  
 
The nature of EA-induced cell death specifically, was defined by Annexin V and PI staining 
and detection by FACS. MLE cells were seeded at 5x10⁵/well of 24-well plates and incubated 
overnight to allow cells to adhere and proliferate. Cells were exposed to 400l of either: 
FCS-free media (as an untreated negative control); 0.8mM H2O2 (as a positive necrosis-
inducer); or 0.3mM EA. After 1, 3 and 5 h treatment, cells were harvested, stained and 
acquired by FACS as described in 3.6. To build on the above findings and evaluate the 
involvement of caspases in EA-induced injury, MLE cells were pre-incubated with a broad 
caspase inhibitor zVAD, prior to incubation with EA. As caspases are key mediators of the 
apoptotic pathway, we hypothesised that if EA-induced cell injury was mediated by caspase-
driven mechanisms, zVAD pre-incubation would attenuate cell injury. Thus, cells were pre-
incubated with 0.1mM zVAD, before treatment with 0-0.3mM EA over a 5 h period. As a 
positive control of apoptosis, cells were treated with 100ng/ml TNFα and 5µM 
cycloheximide (a protein synthesis inhibitor) for 24 h, following pre-incubation with 0.1mM 
zVAD. 
 
In order to address our principal objective of this chapter, we set out to explore multiple 
aspects of IRI in in vitro stress models. Cells were seeded at 5x10⁴/well in 96-well plates and 
experiments commenced 24 h later. Immediately prior to experimentation, media was 
replaced and cells were exposed to either: 
 
a. Chemical reactive species H2O2 and tBH at increasing concentrations of 0-0.8mM and 
0-1.4mM respectively, in a volume of 150l over 5 h; 
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b. Hypoxia and reoxygenation (Hx/Rx). A hypoxic environment was established by 
deoxygenating the cell culture medium via bubbling with 95% N2 and 5% CO2 gas 
mixture and by placing culture plates in a hypoxic chamber, already equilibrated with 
this gas mixture. Cells immersed in 150l media/well were exposed to hypoxic 
conditions for 12 or 24 h. Subsequently, media was exchanged for fresh, pre-
warmed, oxygenated media and plates were placed in the normoxic incubator for 
increasing periods of reoxygenation (2, 6, 12, 24 h); or 
 
c. Metabolic stress. Graded substrate deprivation was achieved by using: full medium 
(lacking FCS) or Balanced Salt Solution (BSS) based on HEPES buffer that contained 
NaCl, KCl, MgSO4, NaH2PO4, CaCl2 and NaCO3, with or without 3000mg/L glucose and 
lacking essential substrates (which would otherwise be present in complete culture 
media). Cells were exposed to 150l of such media/well for 5 h. 
 
To evaluate whether GST enzymes are involved in the modulation of particular or multiple 
oxidant-triggered pathways, MLE (and in some instances A549) cells were exposed to one of 
the mentioned stressors in combination with EA or CA. Cells maintained in optimal 
conditions with physiological GST activity served as controls. Upon termination of 
experiments, cell viability was measured by MTT. 
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4.4 RESULTS 
 
4.4.1 Efficacy of pharmacological GST inhibition 
We found that GST activity was fairly proportional to MLE and A549 cell density. For 
instance, the GST activity (measured as the increase in fluorescence units per minute, 
FU/min) in 2x106 and 4x106 cells, rose from 374 to 764 and 256 to 511 for MLE and A549 
cells, respectively, after subtracting the background fluorescence. These data validated the 
assay’s ability to detect quantitative changes in GST activity.  
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Figure 4.1 GST activity in MLE and A549 cell lysates harvested from increasing numbers of cells. 
N=3. 
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We also explored the protein expression of GST and  isoforms in cell lysates and mouse 
lung homogenate by western blotting (Figure 4.2). While GST was not detected in A549 
cells and only weakly in MLE cell lysates, it was expressed much more strongly in the mouse 
lung homogenate. These results may indicate that GST expression is abundant in murine 
pulmonary cells other than epithelial cells. Alternatively, as is common in cell culture, 
epithelial cells may lose GST expression during isolation and culturing. By contrast, GST, 
which was absent in MLE cells and only weakly detected in the whole lung homogenate, was 
strongly detected in A549 cells. 
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The efficacy of GST inhibition following incubation with our GST inhibitors was then 
explored and results are shown in Figure 4.3. We found that nearly complete inhibition (89 
±4.9 % attenuation) of pure bovine GST activity was achieved by 0.1mM EA. In contrast, 
inhibition by CA remained incomplete, with 10-fold higher concentrations achieving 42 ±8.9 
% attenuation. While both EA and CA affected purified and MLE cell-derived GST, it 
appeared that GST inhibition was slightly less in the cell lysates. 
Figure 4.2 Representative blot of GST  and  protein expression in MLE and A549 cell lysates and 
whole mouse lung homogenate. N=2. 
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These results demonstrate that both agents have the ability to attenuate the activity of GST 
present in a purified form and in a biological/cellular setting. It appears that under identical 
conditions EA is a significantly more potent and efficient inhibitor of GST, therefore for the 
majority of subsequent experiments I used EA as a prototype for GST attenuation. Based on 
these data, cultured cells were exposed to EA or CA over large concentration ranges of: 0–
0.3mM or 0–2mM, respectively.  
Figure 4.3 Influence of (A) EA and (B) CA on GST activity of purified GST (350mUnits) and MLE 
cell lysates (prepared from 2x106 cells). N=3. *p<0.05 vs. vehicle control. 
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4.4.2 Cellular injury resulting from GST inhibition  
Unexpectedly, exposure to EA and CA, at the higher concentrations, produced pronounced 
morphological changes over time. In the case of EA these were evident after 3-4 h of 
incubation whereas with CA this was observed after 18-24 h. Assessment of cell viability by 
the MTT assay, demonstrated that both GST inhibitors compromised cell viability in a 
concentration-dependent manner (Figure 4.4). After 5 h exposure to EA, cell viability fell 
from 92 ±7.1 to 13 ±6.5 % of untreated control at 0.1mM and 0.3mM, respectively. Similar 
findings were obtained following 24 h treatment with CA, which led to a 50% fall in cell 
viability at 0.8mM. 
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 Figure 4.4 Influence of GST inhibitors (A) EA and (B) CA on MLE cell viability. Cells were exposed to 
5 and 24 h incubation with GST inhibitors, respectively. N=6; *p<0.05 vs. untreated control. 
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To explore if EA-induced cytotoxicity was applicable to other cell types in the mouse lung or 
to human lung cells, primary mouse lung endothelial and the human A549 cells were 
incubated with the GST inhibitor in a similar concentration range. Figure 4.5 shows that 
within the same time frame (5 h) both mouse endothelial and human epithelial cells 
exhibited considerable resistance to the cytotoxic effect of EA, with viability falling to 74 
±7.4 % and 96 ±4.8 % of the vehicle control respectively, in the presence of 0.3mM EA. 
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Figure 4.5 Influence of EA on viability of MLE (□), primary mouse lung endothelial (MULEC)(    ) and 
human lung epithelial (A549) (▲) cells after 5 h incubation. N=3-6. 
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However, subsequent experiments demonstrated that exposure of A549 cells to EA over 
longer time periods also led to morphological changes and resulted in a similar 
concentration-dependent cytotoxicity. Complete loss of cell viability was only evident 
following 72 h incubation with 0.3mM EA, as illustrated in the figure below.  
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Thus, despite A549 cells displaying significantly more resistance to the cytotoxic effects of 
EA after 5 h incubation, compared to that displayed by mouse pulmonary cells, GST 
inhibition by EA does induce cytotoxicity, albeit after longer time-periods. 
 
Figure 4.6 Influence of EA on viability of A549 cells following 72 h incubation. N=3; *p<0.05 vs. 
vehicle control. 
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4.4.3 Definition of cell death 
The nature of EA-induced cell death was assessed by Annexin V and PI staining and FACS 
analysis (Figure 4.7). Of the ‘FSC-SSC’ gated population (A), 89.9% of cells were viable in 
untreated cell sample (B) which decreased to 73.8% and 17.4% following exposure to 
0.3mM EA for 3 and 5 h, respectively (C and D). These values were determined by quadrant 
statistics after arbitrary gates were applied. Such treatment caused a significant increase in 
the percentage of cells fluorescing both Annexin V and PI from 1.5% in untreated cells to 
54.4% in cells exposed to EA for 5 h. Furthermore, there was a 20-fold increase in cells 
exhibiting only Annexin V fluorescence after 5 h EA treatment compared with untreated 
control, illustrating an apoptotic cell population. H2O2 and staurosporine treatment served 
as putative positive controls for necrosis and apoptosis and resulted in a significant increase 
in cells fluorescing PI, or PI and Annexin V, respectively (data not shown). 
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Figure 4.7 MLE cell death evaluation by FACS following 
Annexin-V (Ann-V) and PI staining. (A) A representative 
FSC/SSC gating strategy used to gate the population of 
interest and exclude cell debris from the analysis. The gated 
cell population was then acquired for Ann V and PI staining, 
as described in methods, following exposure to (B) no 
treatment, (C) EA for 3 h, and (D) EA for 5 h. Quadrant gates 
were applied to determine the percentage of cells that 
were: viable (Ann V- and PI-negative); apoptotic (Ann V-
positive and PI-negative); necrotic (PI-positive); or 
apoptotic/necrotic (Ann V- and PI-positive). N=3. 
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Having encountered a population of apoptotic cells following EA exposure, we investigated 
if apoptosis is mediated by caspases or a caspase-independent mechanism, by incubating 
cells with the broad-spectrum caspase inhibitor zVAD. Pre-incubation of MLE cells with zVAD 
had no influence on EA-induced cell death (Figure 4.8A), as the concentration-dependent 
decrease in viability was similar to that observed in previous experiments. For instance, the 
viability of cells exposed to 200M EA was not affected by caspase inhibition. In contrast, 
we found that the presence of zVAD attenuated cytotoxicity induced by TNFα/cycloheximde 
treatment (a positive control of apoptosis) (24.5% vs. 4.5% cell viability in the presence or 
absence of the caspase inhibitor, respectively and as shown in Figure 4.8B). 
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Figure 4.8 Influence of caspase inhibitor zVAD on stress-induced MLE cell death. MLE cells were 
exposed to stresses (A) EA- and (B) TNFα/cycloheximide for 5 and 24 h, respectively. N=3-6;                
* p<0.05 vs. vehicle control (i.e. in the absence of zVAD) 
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4.4.4 Potentiation of stress-induced injury following GST inhibition 
 
A. Chemically induced stress 
Exposure of cells to H2O2 or tBH alone also caused a concentration-dependent reduction in 
viability (Figure 4.9). We observed a reduction from 89 ±5.1 to 64 ±24.4 % viability following 
5 h of treatment with 0.3 and 0.5mM H2O2 compared to untreated controls (A or B). Over 
the same time frame, 0.6mM and 1.2mM tBH reduced cell viability to 86 ±9.1 and 71 ±2.9 % 
(respectively), of the untreated control (C).  
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These stress-induced cytotoxic effects were significantly potentiated by sub-toxic 
concentrations of GST inhibitors. As compared with untreated controls, cell viability fell from 
64 ±24.4 % after 0.5mM H2O2 treatment to 26 ±14.4 % and 31 ±5.1 % in the presence of EA 
and CA respectively (A + B). Similarly, EA exacerbated tBH-induced cell injury, reducing cell 
viability from 71 ±4.1 % to 23 ±14.4 % following 1mM tBH treatment, as compared to 
untreated controls. 
 
B. Hypoxia/reoxygenation (Hx/Rx) 
Both MLE and A549 cells, maintained in FCS-free culture medium with no GST inhibitors, 
tolerated up to 24 h of Hx followed by up to 24 h Rx remarkably well. Data collected 
following 24 h Hx and 6 h Rx are illustrated in Figure 4.10 A and B, for MLE and A549 cells, 
respectively. No morphological changes were observed upon termination of Hx, nor 
following increasing periods of Rx. Furthermore, Hx alone had no effect on mitochondrial 
activity, as measured by the MTT assay.  
 
Figure 4.9 Impact of GST inhibitors on chemical stress-induced injury. Cells were exposed (for 5 h) 
to increasing concentrations of hydrogen peroxide (H2O2) ± 0.1mM EA (A) or 0.5mM CA (B) and tert-
butyl hydroperoxide (tBH) ± 0.1mM EA (C). N=4-6; *p<0.05 vs. vehicle control (-EA or -CA). 
 
 144 
Nevertheless, Hx/Rx injury was unmasked in both cell lines in the presence of GST inhibitor 
EA. MLE cell viability was reduced by 18% of Hx/Rx control in the presence of 25M EA 
which had no impact on survival of cells maintained in normoxic conditions (Nx). In contrast, 
exposure of normoxic cells to 50M EA reduced cell viability to 65% of untreated control 
cells, while cells exposed to Hx/Rx, with equivalent concentrations of EA, experienced more 
severe injury and viability fell to 25% of hypoxic control cells (maintained in EA-free media). 
A549 cells were significantly more resistant to the cytotoxic effects of Hx/Rx in the presence 
of EA. However EA (albeit at increased concentrations of 200M) still unmasked Hx/Rx-
induced injury, as observed in MLE cells. 
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 Figure 4.10 Effect of EA on MLE and A549 cells exposed to hypoxia/reoxygenation. (A) MLE and         
(B) A549 cell exposure to Hx (24 h) and Rx (6 h) in combination with increasing concentrations of 
GST inhibitor EA. N=4; *p<0.05 vs. vehicle controls (-EA), †p<0.05 vs. normoxic controls. 
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C. Metabolic stress conditions 
Graded substrate deprivation (i.e. removal of serum, tissue culture constituents and 
glucose) led to a time-dependent and graded decrease in cell viability in both MLE and A549 
cells (as shown in Figure 4.11 and 4.12, respectively). Removal of normal metabolic 
components of growth medium, but in the presence of glucose, MLE cell survival was 
reduced to 70 ±7.3 % and 36 ±9.4 % of untreated control after 12 and 24 h respectively (A + 
B). Additional removal of glucose was cytotoxic to nearly all cells after 24 h. In complete 
media, EA led to MLE cell injury and was seen to enhance metabolic stress-induced 
cytotoxicity at both 12 and 24 h (as highlighted in A + B). 
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 Figure 4.11 Influence of metabolic stress on MLE cell viability and impact of GST inhibitor EA 
(50M). Cells were exposed to (A) 12 h or (B) 24 h of: complete media (-FCS) or Balanced Salt 
Solution (BSS) deprived of essential media-containing metabolites ± glucose. N=3; *p<0.05 vs. 
vehicle control (in the absence of EA but in equivalent media conditions).  
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A549 cells demonstrated increased resistance to these metabolic stresses; for instance 24 h 
incubation with glucose-supplemented BSS only reduced cell viability to 78 ±8.6 % of 
untreated control, however significant cytotoxicity was seen after treatment with BSS alone, 
where viability was reduced to 36 ±11.2 % of control (B). While A549 cells were resistant to 
EA under the same conditions, EA greatly potentiated BSS-induced cytotoxicity after 24 h 
incubation (as highlighted in B). 
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Figure 4.12 Influence of metabolic stress on A549 cell viability and impact of GST inhibitor EA 
(50M). Cells were exposed to (A) 12 h or (B) 24 h of: complete media (-FCS) or Balanced Salt 
Solution (BSS) deprived of essential media-containing metabolites ± glucose. N=3; *p<0.05 vs. 
vehicle control (in the absence of EA but in equivalent media conditions).  
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4.5 DISCUSSION 
To study the efficiency of EA and CA as GST inhibitors, I evaluated their effects on the 
activity of both purified, commercially available GST preparations, and soluble GST obtained 
from lysates of MLE cells. Lysates were used to explore if inhibition was applicable in the 
biological milieu. I found that EA was a more potent and effective inhibitor of purified GST, 
although higher concentrations of CA also achieved significant inhibition. Importantly, both 
inhibitors achieved similar levels of GST inhibition in MLE cell lysates, as compared to pure 
bovine GST (albeit at higher concentrations). This indicates that endogenous factors and cell 
constituents (at least those present in the cell lysates) had little effect on the ability of EA 
and CA to inhibit GST enzyme activity. While there are suggestions in the literature that EA 
may be a more specific GST inhibitor 283, my data showing near-complete inhibition of total 
endogenous GST activity in MLE cell lysates suggests that EA acts a broad spectrum GST 
inhibitor rather than targeting specific GST isoforms.   
 
Pilot studies revealed concentration and time-dependent cellular injury by both EA and CA 
alone even in the absence of concomitant stresses. This was evident after a relatively short 
incubation with EA (5 h), but required a longer exposure to CA (24 h). While GST inhibitor-
induced cell death was unexpected, such a response is not unprecedented. Similar 
observations have been reported recently with 2 different cancer cell lines and the authors 
advocated EA as a potential anticancer treatment 314,315. My data with MLE cells therefore 
may indicate that endogenous GST activity is indispensable for normal homeostasis, viability 
and growth of these cells. Alternatively, EA- and CA-induced toxicity may be independent of 
GST inhibition and could result from non-specific effects of these reactive substances. In 
particular, EA has been shown to deplete cellular GSH 316 - a major player of redox 
homeostasis, thus such events may contribute to its toxicity in our MLE cells. It can be 
argued however, that in the latter case the non-specific effects of these substances should 
affect most cells in the same way. In this regard, I found that mouse primary lung 
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endothelial cells and even more so, the human A549 cells were unaffected by identical EA 
treatment under a similar time frame. Their increased resistance clearly suggests that EA-
induced cell injury is a cell specific phenomenon and it must relate to how particular cells 
handle EA-induced injurious events. Relevant to the GST story is the observation that some 
cancer cells exhibit nuclear GST activity and such compartmentalisation and increased 
activity contributes to resistance against various cellular stresses 317. Furthermore, western 
blots revealed higher GST expression in A549 cells, specifically GST (as illustrated in Figure 
4.2)  318. Thus both cell type-specific sensitivity and resistance to EA (and CA) may relate to 
endogenous antioxidant status and particularly to the differential expression of GST π.  
 
4.5.1 EA-induced cell death appears to be both apoptotic and necrotic 
Apoptosis of lung epithelial cells represents a potentially important mechanism contributing 
to the loss of this cell type in the development of ALI. Two previous studies have attempted 
to define EA-induced cell death in human leukaemia 314 and colon cancer cell lines 315 but 
data is conflicting. While the former study claims that cell death is mediated by an apoptotic 
pathway, the latter supports a non-apoptotic cell death.  
 
To investigate whether EA-induced MLE cell death was of apoptotic nature, we stained cells 
with Annexin-V and PI and assessed apoptosis by flow cytometry. Following 5 h exposure to 
EA, we observed a slight increase in the percentage of purely apoptotic cells (Annexin V 
uptake in the absence of PI labelling) whereas the majority of cells exhibited both Annexin V 
and PI fluorescence, representing a late apoptotic/necrotic cell death. It is often difficult to 
differentiate the type of cell death in such a population, as purely apoptotic cells can rapidly 
become permeable as cell death progresses, allowing cell entry of PI and it’s binding to DNA. 
Nonetheless there is evidence that EA induces a degree of apoptosis. To explore the 
involvement of caspases (key players in the classical apoptotic pathway), cells were pre-
incubated with the caspase inhibitor zVAD. We found that EA-induced cytotoxicity within 
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the 5 h incubation period was unaffected by pre-incubation with zVAD. This observation 
suggests that EA-induced injury is unlikely to be driven by a classical caspase-mediated 
apoptotic pathway. By contrast, similar experiments where cells were exposed to 
TNFα/cycloheximide (a positive control for caspase-mediated cell death), showed significant 
attenuation of cell death in the presence of zVAD.  
 
While it is difficult to make definite conclusions from the latter set of results, collectively our 
data suggest that apoptosis may occur in a caspase-independent manner, which has been 
previously reported in studies unrelated to EA 319,320. The nature of apoptotic signals from 
mitochondria has been well documented, one of which is the release of apoptosis-inducing 
factor (AIF). During mammalian cell apoptosis AIF is released into the cytosol, translocates 
to the nucleus and induces chromatin condensation and DNA fragmentation 321. The pro-
apoptotic effects of AIF are not suppressed by pharmacological caspase inhibitor zVAD, 
indicating that AIF can trigger apoptosis in a caspase-independent manner 322.  
 
4.5.2 GST attenuation enhances/unmasks stress-induced injury 
After characterising the influence of GST inhibitors EA and CA under normal conditions, we 
explored the effect of attenuated GST activity on the survival response of cells to various 
stress components of IR. I initiated experiments with the idea that GST inhibition would 
exacerbate cell injury in stress conditions. Among these I considered exposing cells to: (A) 
two chemical oxidative stressors, H202 or tBH; (B) Hx/Rx; and (C) metabolic stress. 
 
A. Chemical oxidative stressors 
The chemical stressors H2O2 and tBH are widely used as prototypes of simulated oxidative 
stress. As previously reported in other cell types, we also observed concentration-
dependent cytotoxic effects of these agents in MLE cells and have clearly demonstrated that 
presence of GST inhibitors EA and/or CA potentiates peroxide–induced cytotoxicity. 
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Interestingly CA, which was found to be the less potent GST inhibitor, potentiated H2O2-
induced cytotoxicity to a greater extent than EA. This may be related to the differential 
specificity of these inhibitors to the various GST isoforms, which in turn vary in their ability 
to detoxify specific oxidative stress products.  
 
B. Hypoxia/reoxygenation 
Hx/Rx alone had no effect on mitochondrial activity in both MLE and A549 cells, indicating 
their high level of tolerance to extended periods of both Hx and Rx. This disagrees with data 
suggesting that Hx triggers apoptosome formation through the production of ROS 74,84. 
However, these cells may have activated adaptive survival mechanisms in response to Hx, 
for instance epithelial cells are known to maintain anaerobic glycolysis and upregulate 
glucose transporters and enzymes during Hx in order to maintain ATP levels 323,324. 
Nonetheless, presence of EA revealed the detrimental effects of Hx/Rx in both mouse and 
human lung epithelial cells. This suggests that intrinsic survival mechanisms protecting 
against Hx/Rx-induced injury depend on an EA-sensitive pathway which may involve GST 
enzymes. 
 
C. Metabolic stress (graded substrate deprivation) 
Considerable damage was seen following 24 h incubation of MLE and A549 cells with BSS 
supplemented with L-glucose. This was exacerbated by complete removal of glucose, 
indicating the importance of glucose and essential metabolites/factors (found in full media) 
for cell survival in physiological conditions. Interestingly, EA treatment potentiated cell 
injury induced by these metabolic stresses both in the MLE cells and the more resistant 
A549 cells.  
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It is important to acknowledge that there are limitations to these models with respect to IR 
simulation.  For example, cells in all cases were cultured in serum-containing medium before 
the start of the experiment, which would aid cell survival in stress conditions, particularly 
during periods of substrate deprivation. Furthermore, ischemia is generally associated with 
acidosis and lactate accumulation and our metabolic stress conditions do not take these into 
consideration 288. In addition, our Hx/Rx model consisted of anoxia (< 0.1% O2) followed by 
normoxia, however in the clinical setting of lung transplantation cells are exposed to a 
hypoxic environment during preservation, followed by a period of hyperoxia upon 
reperfusion. It is well acknowledged that hyperoxic ventilation can be harmful to the lungs 
and exacerbate injury, which is most likely due to the subsequent overproduction of ROS. In 
light of this, it may have been more clinically relevant to use a hypoxia/hyperoxia stress 
model. 
 
It is also worth noting that A549 cells were consistently more resistant to cytotoxic effects of 
oxidative and metabolic stresses compared to that displayed by MLE cells. Moreover, the 
cytotoxic effect of EA was only observed when A549 cells were exposed to significantly 
higher levels of EA. As discussed previously, this may be related to an elevated endogenous 
antioxidant capacity or increased levels of specific antioxidants such as GST isoform, the 
expression of which was found to be considerably higher in A549 cells. This may explain the 
increased resistance and the need for higher concentrations of EA to achieve equivalent GST 
attenuation in A549 cells. These data suggest that GST specifically may be important in the 
increased protection of cells against stress. However, lung carcinoma-derived A549 cells 
have previously been reported as having elevated levels of several antioxidants such as 
catalase and GSH 325,326 thus displaying an array of increased antioxidant defence capacity 
compared with other cell lines 327. This too could be a reason for increased cellular 
resistance. 
 
 152 
Despite these limitations, it is clear that cell injury was exacerbated or unmasked in the 
presence of subtoxic concentrations of EA in all models. Thus, these observations are 
compatible with our original hypothesis that these phenomena are related to GST inhibition 
by EA. In this scenario, removal of an important intracellular antioxidant player could lead to 
an increase in the levels of intracellular ROS. In combination with defined oxidant- or 
specific metabolic-stresses, ROS may accumulate further, resulting in increased redox-
signalling and more cell injury/death. The exact mechanisms involved in EA-induced 
cytotoxicity and potentiation of that induced by oxidative and metabolic stresses are 
explored in subsequent chapters. 
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Chapter 5:  
ROLE OF OXIDATIVE STRESS IN 
CELLULAR RESPONSE TO GST 
INHIBITION 
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SUMMARY 
In the previous chapter we reported that cell injury was exacerbated or unmasked in the 
presence of subtoxic concentrations of EA and CA in cells exposed to stress. The exact 
mechanisms by which GST attenuation potentiates cell injury in these metabolic and 
oxidative stress conditions remain unknown. However these observations are compatible 
with our original hypothesis. We believed that removal of an important intracellular 
antioxidant player such as GST may lead to a significant increase in intracellular ROS, which 
in combination with specific metabolic- or oxidative- stress could cause direct damage to 
intracellular macromolecules and could trigger activation of various signal transduction 
pathways. Both endpoints can ultimately lead to severe cell injury or death.  
 
In this chapter we explore the role of oxidative stress in cellular response to GST inhibition 
in multiple and complementary ways. Firstly, we monitored intracellular ROS accumulation; 
secondly, intracellular biochemical indices of intracellular redox state were assessed; and 
thirdly, attempts were made to identify which ROS in particular (and which sources) were 
potential mediators of such cell death. We reasoned that GST-inhibitor induced cell injury 
may be attenuated by antioxidants targeting broader or more specific reactive species or 
further aggravated by depletion of defined endogenous antioxidant pathways. This line of 
research is further motivated by a previous report suggesting that H2O2 was the mediator of 
EA-induced toxicity in a cancer cell line 314. Another study also suggested a potential role of 
oxidative stress in EA-induced injury 315 however neither group investigated the 
phenomenon in detail.  
 
To investigate this possibility in lung epithelial cells we firstly employed redox-sensitive 
fluorescent dyes to quantitatively measure ROS. To identify abnormalties in redox state, 
intracellular NAD⁺ and NADH were measured by HPLC and UV detection and the ratios 
between these nucleotides were calculated. Finally a series of pharmacological inhibitors 
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and assays were employed to determine the importance of ROS/RNS in EA-induced cell 
injury and evaluate the specific nature of reactive species involved.  
 
We found that there was a significant increase in the fluorescence of redox-sensitive probes 
following exposure of cells to EA, which was prevented in the presence of NAC. 
Furthermore, this broad spectrum antioxidant completely abolished both EA and CA-
induced cell death. We also found that EA alone reduced redox state in a concentration-
dependent manner and enhanced changes in redox state induced by H2O2. While the 
principal oxidative mediator of EA-induced cell death remains unidentified, we observed an 
increase in the levels of secondary oxidant protein carbonyls (downstream products of lipid 
peroxidation), when H2O2 and EA treatments were combined. Collectively these results, 
suggest that inhibition of GST renders the cells susceptible to significant increases in 
reactive species, even in the absence of underlying stress (such as H2O2 or Hx/Rx). 
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5.1 BACKGROUND 
Two major factors are considered important in IRI. Firstly, it is well established that hypoxia 
or ischemia can itself produce tissue injury and secondly, a large body of evidence suggests 
that the burst of ROS generation upon reoxygenation is also (and perhaps more) damaging. 
Although low levels are necessary for important cellular functions, at higher concentrations 
ROS can be harmful therefore the ‘ROS burst’ is considered an essential mediator of Hx/Rx 
injury. This is supported by the observation that various chemical and enzymatic 
antioxidants appear to protect against the tissue damage seen with reperfusion 328. 
 
Thus, in vitro exposure of cells to chemical agents such as H2O2, Hx/Rx or metabolic stress is 
thought to mimic the state of oxidative stress seen in IRI, where cell damage is caused by an 
overabundance of oxidants, and an overwhelmed antioxidant defence system. This rise in 
oxidative species can be quantified in several complementary ways, however it must be 
recognised that ROS/RNS are highly reactive molecules and their specific detection can 
sometimes be challenging. Quantitative values of reactive species can be evaluated through 
the use of redox-sensitive probes and detection by flow cytometry. Alternatively, variations 
in the overall balance between production and consumption of intracellular reactive species 
can lead to alterations in cellular redox state. This is a term used to describe the ratio of the 
interconvertible oxidised and reduced form of a specific redox couple, such as NAD⁺/NADH 
ratio. It is a measurement that reflects both metabolic activity and health of cells and 
determines the interconversion of important intracellular metabolites, such as lactate and 
pyruvate.  Alterations in redox state can disturb several homeostatic processes required for 
cell survival and adaptation to stress. 
 
Accumulating reactive species can react with nucleic acids, lipids, proteins and sugars, thus 
damaging important cellular components. Lipid peroxidation in particular can cause 
significant damage due to its self-propagating nature, which drives further oxidative 
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reactions until the substrate is consumed or free radical propagation is terminated. This 
occurs when two free radicals react with each other and produce a non-radical species. The 
oxidised products generated are not only capable of inflicting structural damage on 
membranes but are also chemically reactive and can covalently modify other 
macromolecules. For instance β-scission of oxyl radicals (LO•) generates lipid-derived 
aldehydes (LDAs), such as MDA, 4-HNE and acrolein, also referred to as reactive carbonyl 
compounds. These can readily modify proteins by forming adducts on thiol residues and 
free amino groups generating protein carbonyls. Accumulation of these particular secondary 
oxidative stress products can mediate the production of advanced lipoxidation and 
glycoxidation end products and a state of carbonyl overload, referred to as carbonyl stress 
329. Importantly, they are relatively more stable than LDAs and are thus commonly used as 
markers of oxidative stress. 
 
Endogenous oxidative stress products, such as LDAs generated during lipid peroxidation, are 
a major class of GST substrates. We therefore postulated that exposure of cells to 
oxidative/metabolic stress in combination with reduced GST activity (due to EA/CA 
treatment in vitro or GST polymorphisms in vivo), would lead to an accumulation of LDAs. 
These can not only cause extensive intracellular structural damage but can also disturb 
essential intracellular processes/enzyme systems such as the mitochondrial ETC or NADPH 
oxidase. Disruption of these can lead to further release of primary ROS. Thus, the cross-talk 
between intracellular ROS generators may exacerbate oxidative stress which may enhance 
stress-induced injury in the event of reduced GST activity.  
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5.2 AIMS 
Our principal aim in this chapter was to explore the role of oxidative stress in GST inhibitor-
induced cell death. In particular I wanted to: 
 
a. quantitatively assess levels of intracellular reactive species following GST inhibition; 
 
b. evaluate the influence of EA on intracellular global redox state, reflected as 
NAD+/NADH balance in biological systems; and 
 
c. determine the nature of specific reactive species involved in EA-induced cell death 
(i.e. evaluate involvement of primary and secondary oxidants, such as H2O2 and 
protein carbonyls, respectively). 
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5.3 PROTOCOLS  
The level of reactive species, generated in cells exposed to increasing concentrations of GST 
inhibitor EA or 0.8mM H2O2 (used as a positive control of oxidative stress), was determined 
with redox-sensitive fluorescent probes and flow cytometry. For this set of experiments MLE 
and A549 cells were seeded in separate 24-well plates at 5x105/well. Confluency was 
reached within 24 h and cells were pre-incubated for 30 min at 37°C with 200µl of either 
5mM DHR or 20µM H2DCF-DA. Cells were subsequently exposed to 200µl of treatments or 
media alone (which served as a negative control) for 1 h. Preliminary experiments revealed 
that prolonged incubations did not enhance fluorescence further, but actually led to a 
decrease in fluorescence, perhaps due to leakage of dyes. Following treatment cells were 
washed (x4) with PBS to remove any remaining extracellular probe and harvested by 
trypsinisation. After collection and centrifugation (1800rpm, 7 min), cells were resuspended 
in FACS Wash Buffer (FWB) and the fluorescence of cells was analysed by FACS (as described 
in 3.7). The direct influence of EA on probe fluorescence was determined by incubation of 
DHR or H2DCF-DA with medium containing EA (in the absence of cells) in a black 96-well 
plate. Fluorescence was detected using a fluorescent plate reader over a time-course of 3 h. 
 
Evaluation of intracellular oxidative stress also involved assessment of global cellular redox 
state through analysis of cellular NAD⁺/NADH ratios. MLE cells were seeded in 24-well plates 
at 5x105/well. Following 24 h, cells were exposed to a) EA (0.1mM) or H2O2 (0.8mM), alone 
or combined, over increasing time periods (1, 3, or 5 h), or b) EA alone at increasing 
concentrations over 1 h. Intracellular NAD⁺/NADH ratios were analysed as described in 3.9. 
Briefly, cell samples were extracted using perchloric acid (0.4M) and neutralized with KOH 
(2M). KClO4 was then precipitated by centrifugation and the supernatant was retained for 
subsequent analysis. Nucleotide levels were assessed by HPLC and UV detection. NAD⁺ is 
retained as an intact molecule during extraction and absorbs strongly in UV at 254nm. 
NADH is completely converted to adenosine diphosphoribose (ADPR) in the acidic 
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environment and also absorbs in UV at 254nm. Analysis of chromatogram peaks of NAD and 
ADPR enabled calculation of NAD⁺/NADH ratio. 
  
We then investigated the role of ROS in GST inhibitor-induced cytotoxicity and whether it is 
the principal mediator in EA or CA-induced cell death. MLE and A549 cells (seeded in 96-well 
plates at 5x10⁴/well and incubated overnight) were pre-incubated with 200µl of NAC 
(10mM) for 1 h at 37°C. Cells were then exposed to an additional 200µl of EA (5 h) or CA (24 
h). This was added to the existing NAC-containing media. Cells were exposed to increasing 
concentrations of EA and CA, equivalent to those described in Chapter 4. Mitochondrial 
activity of the cells was subsequently assessed by MTT assay as an index of cell viability. 
 
It has been postulated that EA-induced cell death is mediated specifically by H2O2 
314. To 
substantiate these findings, we modulated intracellular activity of the major H2O2 scavenger 
catalase and assessed the effects on cell viability. Catalase was either enhanced or 
attenuated by a 30 min pre-incubation of EA-treated MLE cells with cell permeable a) PEG-
conjugated catalase (5000Units/ml) or b) the catalase inhibitor aminotriazole (ATZ, 10mM) 
respectively. To identify involvement of other specific reactive species (•O2¯ and NO) in EA-
induced cell injury, cells were pre-incubated with a number of other pharmacological 
inhibitors targeting specific ROS scavengers or generators (shown in Table 5.1). 
Concentrations of such inhibitors were chosen following titration experiments and in light of 
previous studies documented in the literature. As in previous NAC experiments, cells were 
then exposed to increasing concentrations of EA over a 5 h period, after which cell viability 
was evaluated by the MTT assay. 
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We also explored the possibility of secondary oxidants being the prime candidates for EA-
induced cell injury. Since LDAs are very reactive and generally difficult to measure, we 
decided to assess the influence of GST inhibition on protein carbonyl formation, a 
downstream product of lipid peroxidation. The excessive formation of such carbonyl groups 
(referred to as ‘carbonyl stress’) is often used as a marker of intracellular oxidative stress. 
There are different assays to measure carbonyl stress. We employed one of the most 
common methods, involving spectrophotometry following reaction with 2,4-DNPH, as 
described in detail in 3.8. The treatment conditions employed for this set of experiments 
were equivalent to those used for redox state analysis. MLE cells (seeded in 24-well plates at 
5x105/well) were exposed to a) EA (0.1mM) or H2O2 (0.8mM), alone or combined, over 
increasing time periods (1, 3, or 5 h), or b) EA alone at increasing concentrations over 1 h. 
Following treatment, wells were washed and harvested by trypsinisation. Protein samples 
were prepared using lysis buffer and proteins were quantified with the protein assay (as 
described in 3.5). A sample containing approximately 0.1mg protein was then used in the 
detection of protein carbonyl levels, as described in detail in 3.8.   
Specific ROS Scavenger Generator Inhibitor 
Final 
concentration 
Hydrogen peroxide 
(H2O2) 
Catalase - Aminotriazole                     
(ATZ) 
10mM 
Superoxide anion 
(•O2¯) 
Superoxide 
dismutase 
(SOD) 
- Diethyldithio-carbamate 
(DETC) 
1mM 
Superoxide anion 
(•O2¯)  
NADPH 
Oxidase 
Diphenylene-iodonium      
(DPI) 
5 – 15µM 
Nitric oxide 
(NO)  
NO 
synthase 
(NOS) 
N-Nitro-L-Arginine Methyl 
Ester hydrochloride 
(L-NAME) 
10mM 
Table 5.1 Pharmacological agents employed to inhibit specific ROS scavengers/generators. 
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5.4 RESULTS 
 
5.4.1 Quantitative measure of reactive oxygen species 
As H2O2 is a primary product of intracellular oxidative stress, MLE cells were incubated with 
H2O2 (0.8mM) as a positive control. As shown in Figure 5.1A, there was a significant increase 
in DHR123 fluorescence, (6-fold) as compared with untreated control. An increase in DCF 
fluorescence was also seen (Figure 5.1B), however this is not significant.  
0
50
100
150
200
C H2O2 
D
H
R
1
2
3
  [
M
F
I]
0
20
40
60
80
C H2O2 
D
C
F
 [M
F
I]
A
B
*
 
 
 
 
Exposure of MLE cells to EA (1 h) increased the MFI of both DHR123 and DCF (Figure 5.2 A + 
B). A concentration-dependent increase in fluorescence was seen in DHR123-loaded cells 
with an over 2-fold increase in ROS following 0.3mM EA treatment, as compared with basal 
Figure 5.1 Influence of 0.8mM H2O2 (1 h) on the fluorescence of ROS- or RNS- sensitive probes in 
MLE cells. (A) DHR123 (light grey) and (B) DCF (dark grey). N=5-7; *p<0.05 vs. untreated control. 
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fluorescence levels. In contrast with H2O2 treatment, a 30-fold increase in fluorescence of 
DCF resulted from 0.1mM EA incubation as compared with basal fluorescence levels. 
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When A549 cells were pre-loaded with the 2 fluorescent probes prior to incubation with 
0.3mM EA, there was no change in DHR123 fluorescence, however that of DCF increased 2-
fold over the 1 h treatment, as shown in Figure 5.6 (A + B respectively). Importantly, we 
found that autofluorescence of the dyes themselves (over 3 h) was minimal, as measured by 
a black 96-well plate reader. Furthermore, the presence of EA had negligible direct effects 
on DHR123 and DCF fluorescence (data not shown). 
Figure 5.2 Influence of EA (1 h) on the fluorescence of ROS-sensitive probes in MLE cells.              
(A) DHR123 (light grey) and (B) DCF (dark grey). N=5-7; *p<0.05 vs. untreated control. 
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5.4.2 Influence of GST inhibition on intracellular redox state 
Initial experiments were conducted to evaluate the influence of increasing concentrations of 
EA on intracellular redox state. To ensure no significant cytotoxicity, a short time period of 1 
h was selected for these experiments. As demonstrated in Figure 5.3A, EA alone induced a 
significant concentration-dependent decrease in NAD⁺/NADH ratios which fell from 75% to 
11% of untreated control following exposure to 0.1 and 0.3mM EA, respectively. Such 
treatment did not result in morphological changes or a reduction in cell viability.  
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Figure 5.3 Influence of EA on NAD⁺/NADH ratio as an index of intracellular redox state.                    
(A) Influence of increasing concentrations of EA (1 h) on NAD⁺/NADH ratios. (B) Effect of EA (+/-H2O2 
stress) for 3 h on NAD⁺/NADH ratio.  N=3; *p<0.05 vs. untreated control.  
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We then investigated if EA affected redox state after longer exposure times (of 3 and 5 h) 
and in combination with H2O2. Similarly to the 1 h exposure, 0.1mM EA failed to alter redox 
state after 3 or 5 h treatment. However, H2O2 significantly reduced NAD⁺/NADH ratio 
demonstrating definite intracellular redox changes and oxidative stress under our 
experimental conditions. Moreover, EA tended to enhance H2O2-induced decrease in 
NAD⁺/NADH ratio (28% vs. 43% of untreated control (Figure 5.3B), although this did not 
achieve statistical significance. Collectively these data suggest that GST inhibitor EA perturbs 
intracellular redox balance at higher concentrations, while subtoxic concentrations 
exacerbate H2O2-induced intracellular oxidative stress. 
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5.4.3 Role of general and specific ROS in GST inhibitor-induced cell injury 
Pre-incubation with the broad-spectrum antioxidant NAC fully protected MLE cells from 
injury and death induced by GST inhibitors EA and CA (Figure 5.4 A + B, respectively). This 
protective behaviour of NAC was also observed in mouse primary endothelial and A549 cells 
exposed to EA for longer periods of time (data not shown). 
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Figure 5.4 Influence of NAC on GST inhibitor-induced MLE cell death. Cells pre-incubated with NAC 
are represented by the dotted line in (A) EA- and (B) CA- induced cell death, after 5 and 24 h 
treatment, respectively. N=5-7; *p<0.05 vs. vehicle control (in the absence of NAC). 
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Furthermore, addition of NAC during the loading phase of DHR and H2DCF-DA (30 min prior 
to EA exposure), completely abolished EA-induced increase in ROS (Figure 5.5). 
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Similarly, NAC pre-incubation in A549 cells abolished EA-induced increase in DCF 
fluorescence, while having no effect on basal level of fluorescence, as shown in Figure 5.6B. 
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Figure 5.5 Influence of NAC on EA-induced increase in (A) DHR123 and (B) DCF fluorescence.     
MLE cells were incubated with EA for 1 h. N=4; *p<0.05 vs. vehicle control (in the absence of NAC). 
 
 
 
Figure 5.6 Influence of NAC on (A) DHR123 and (B) DCF fluorescence in A549 cells exposed to EA    
(1 h). N=3; *p<0.05 vs. vehicle control (in the absence of NAC). 
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Several reagents (specific antioxidants and the direct inhibitors of antioxidants or ROS 
generators) were employed to identify specific mediators of GST inhibitor-induced cell 
death. We found that EA-induced injury was only weakly attenuated by PEG-catalase, which 
conversely was able to abolish cytotoxicity induced by H2O2 in similar conditions (as 
illustrated in Figure 5.7 A + B, respectively). Catalase inhibition by ATZ also had no influence 
on the EA-cytotoxicity (data not shown). Such data suggest that H2O2 is not responsible for 
cell injury/death after EA exposure which contradicts previous studies by Wang et al., who 
reported that EA-induced cell death is mediated by H2O2.  
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Figure 5.7 Influence of catalase on (A) EA- and (B) H2O2-induced MLE cell death. Cells were treated 
for 5 h and catalase groups are represented by the dotted line. N=3-6; *p<0.05 vs. vehicle control (in 
the absence of catalase). 
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In a further attempt to identify the involvement of specific ROS, EA-treated cells were also 
pre-incubated with the inhibitors: L-NAME, DPI and DETC, targeting ROS generators NOS and 
NADPH oxidase and endogenous antioxidant SOD, respectively. L-NAME and DPI had no 
impact on EA-induced cell death (data not shown). However, DETC reduced cell viability 
alone (i.e. in the absence of EA) and appeared to enhance EA-induced cytotoxicity at higher 
concentrations of the GST inhibitor: 30.7 vs. 64.8 and 14.2 vs. 35.7 % cell viability in the 
presence vs. absence of DETC, for 200 and 250M EA respectively (Figure 5.8B).  
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Figure 5.8 Influence of SOD inhibitor DETC on EA-induced MLE cell death, after 5 h treatment. Cell 
viability illustrated in (A) as optical density (OD) following MTT assay and (B) as % of untreated 
control (with no EA treatment). Presence of SOD inhibitor is represented by the dotted line. N=4; 
*p<0.05 vs. appropriate vehicle control. 
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5.4.4 Assessment of protein carbonyl formation 
To investigate the involvement of secondary oxidative products and as an additional marker 
of oxidative stress, intracellular carbonyls were monitored spectrophotometrically following 
reaction with 2,4-DNPH. While exposure of cells to subtoxic concentrations of EA alone did 
not affect levels of protein carbonylation, EA significantly enhanced H2O2-induced increase in 
protein carbonyls from 2 to 4-fold, as compared to untreated control after 5 h of treatment 
(Figure 5.9). 
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Figure 5.9 Influence of EA (0.1mM) and/or H2O2 (0.8mM) on protein carbonyl levels after 5 h 
treatment. N=3; *p<0.05 vs. untreated control. 
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5.5 DISCUSSION  
Central to our hypothesis is the notion that EA-induced cell injury involves an increase in 
intracellular oxidative stress, which is responsible for bringing about ultimate cell injury. 
Support for this hypothesis stems from previous studies in cancer cells, where ROS 
accumulation has been implicated in EA-induced cell death 314. Hence, I directed my focus 
towards: 
i) direct assessment of ROS accumulation with redox-sensitive fluorescent probes; 
ii) evaluation of global cellular redox state following EA exposure; and 
iii) identification of the specific reactive species involved.   
 
5.5.1 EA treatment causes intracellular ROS accumulation 
DHR123 and DCF fluorescence was relatively low in untreated cells, which probably 
represents the basal oxidative stress and dye fluorescence. The ROS involved in intracellular 
signalling are generally at low concentration, short-lived and tightly spatially regulated. It is 
therefore unlikely that these redox-sensitive dyes or any other currently available method 
for quantifying ROS is sensitive or specific enough to detect “signalling ROS” per se. 
However, the principal finding of these series of experiments is that EA causes a significant 
increase in both DHR123 and DCF (2- and 30-fold increase, respectively) fluorescence in MLE 
cells. This increased fluorescence should reflect intracellular mechanisms, as EA had no 
comparable effect on these dyes in the absence of cells. These data provide direct evidence 
that EA induces intracellular events that within the first hour of exposure increases steady 
state levels of intracellular reactive species.  
 
It should be appreciated that that these dyes efficiently detect a broad range of intracellular 
oxidising reactions as opposed to specific oxidative players 295. However, the various 
experimental protocols used in our preliminary studies (such as varying the relationship 
between EA exposure and loading the cells with the dye, extending time course experiments 
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and comparing to H2O2-induced fluorescence responses) and the responses obtained with 
different cells, provide some further insight into the mechanisms of ROS generation. For 
instance, we noted that at early time points H2O2 mainly caused a significant increase in 
DHR fluorescence, but less pronounced increase in DCF fluorescence, suggesting that this 
event required generation of secondary oxidants during exposure to H2O2. Furthermore, EA 
treatment of A549 cells resulted in a small (3-fold) increase in DCF fluorescence but there 
was no detectable change in DHR123 fluorescence.  
 
While these data are difficult to reconcile, a possible interpretation is that stress (albeit EA 
or primary oxidant H2O2) induces several different waves of cell-specific ROS generation and 
accumulation of distinct reactive species. Our working hypothesis is that DHR123 is more 
sensitive perhaps to primary oxidants that accumulate soon after H2O2 exposure. On the 
other hand, DCF may be more sensitive to secondary oxidants (such as LDAs) which 
accumulate as a result of GST activity attenuation but not in cells exposed to H2O2 for short 
periods of time. In this scenario, H2O2 and EA-induced cell injury requires a threshold level 
of these oxidants and the resistance of A549 cells to EA-induced cytotoxicity may be 
explained by either attenuated production of primary oxidants and/or effective handling of 
these primary and secondary oxidants by GST dependent and independent mechanisms. 
 
5.5.2 Redox State (NAD⁺/NADH) 
To complement ROS quantification data, we also determined the effect of EA on global 
cellular redox state. The term redox state, used widely in the research field of free radicals 
and oxidative stress, is a measurement that reflects both the metabolic activity and health 
of cells and can be determined by relative changes in several intracellular redox couples. 
There are many redox couples in a cell that work together to maintain a steady intracellular 
redox environment, for instance the NAD⁺/NADH ratio is considered to be an important 
indicator of redox state and controls the activity of several key intracellular metabolic 
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enzymes such as glyceraldehyde 3-phosphate dehydrogenase and pyruvate dehydrogenase. 
A disturbance in NAD⁺/NADH ratio is indicative of the variations in the intracellular redox 
environment, often resulting from oxidative stress. Our data show that EA, administered at 
low concentrations but for prolonged time periods (5 h), did not affect NAD⁺/NADH ratios, 
however it tended to enhance the reduction induced by H2O2 treatment. In addition, the 
concentration-dependent change in NAD⁺/NADH ratios, observed after 1 h exposure to EA, 
reflects a significant decrease in intracellular redox state. These data correlate with earlier 
findings, from the assessment of redox-sensitive probe fluourescence, and suggest that GST 
inhibitor EA (0.3mM) can result in a rapid increase in ROS (within 1 h), while at low 
concentrations (over 5 h) can exacerbate H2O2 stress-induced modification of redox state. 
 
Another redox couple, whose ratio is commonly assessed to give an indication of 
intracellular redox state, is GSH/GSSG. Using a metabonomics approach, we also evaluated 
the impact of stress and GST attenuation on levels of reduced and oxidised glutathione, 
relative to control treatment. Data from these preliminary experiments correlate with those 
presented in this chapter and will be discussed in Chapter 6. 
 
5.5.3 ROS: primary mediators of EA-induced cell injury 
In order to establish if this increase in intracellular ROS was an association or a cause of cell 
injury, cells were pre-incubated with the broad spectrum antioxidant NAC. This completely 
prevented both EA-induced increase in ROS as well as the resulting MLE and A549 cell 
death. Moreover, NAC also prevented CA-induced MLE cell death. One possible explanation 
is that NAC chemically interacts with EA and CA extracellularly, preventing their intracellular 
‘GST inhibitor’ actions. Although we cannot exclude this possibility with absolute certainty, 
the fact that NAC attenuated the effects of two chemically distinct pharmacological GST 
inhibitors makes this scenario less likely. This conclusion is also supported by Aizawa et al., 
who suggested that the influence of NAC was not related to direct interaction with EA 315.  
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We can envision at least two possible mechanisms for the protection by NAC. Firstly, as a 
precursor of GSH, NAC may augment intracellular GSH levels which may overcome 
competitive GST inhibition enforced by EA and CA. Alternatively, NAC or GSH may aid the 
reduction of primary and/or secondary intracellular oxidants (accumulated in response to 
GST inhibition) in a GST-independent manner. In any instance, our combined data on ROS 
accumulation and prevention by NAC strongly suggest intracellular oxidative stress as the 
main mechanism of EA-induced cell death in both MLE and A549 cells.  
 
Primary ROS/RNS 
EA-induced oxidative stress may arise through direct inhibition of GST leading to an 
accumulation of intracellular ROS (most probably secondary oxidants) or through direct 
activation of ROS producing pathways. On the basis of at least one previous study 314, we 
considered H2O2 to be central to EA and CA-induced cell injury, as well as other intracellular 
ROS and RNS recognised as having deleterious effects on cell survival and response to stress. 
The basic redox biochemistry targeted with the various inhibitors and antioxidants is 
illustrated below, followed by a discussion of the NO, •O2¯ and H2O2 pathway involvement 
in EA-induced cell injury. 
 
•O2‾NO H2O2
NADPH oxidaseNOS
SOD
catalase
2H2O + O2ONOO‾
ATZ
DETC
DPIL-NAME
 
Figure 5.10 A basic schematic of redox biochemistry. It includes the main ‘primary’ reactive species 
(in red boxes), the enzymes involved in their metabolism (in black text) and their respective 
inhibitors (in blue text). 
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We hypothesised that inhibition of particular ROS and RNS generating pathways (such as 
NOS and NADPH oxidase) and supplementation of endogenous pathways by exogenous 
substances (including catalase) should attenuate EA-induced cell injury. On the other hand, 
inhibition of endogenous antioxidants (such as SOD and catalase) should augment such 
injury.  
 
To probe the NO pathway and the potential interaction between NO and •O2¯ (forming 
ONOO‾), I employed the widely used NOS inhibitor, L-NAME. Pre-incubation of MLE cells 
with L-NAME had no protective effect on EA-induced cell death, suggesting that NO and its 
derived reactive species, primarily ONOO‾, are unlikely mediators of EA-induced cell injury. 
 
As a result we turned our focus to the superoxide (•O2¯) pathway, which has previously 
been implicated in the cellular response to stress. While •O2¯ itself is not highly reactive, its 
downstream product H2O2 is often considered a key effector in cell injury. Thus to dissect 
the role of the •O2¯ in GST inhibition-induced cell death, I initially explored the possibility of 
NADPH oxidase activation (one of the main sources of •O2¯) and subsequent ROS 
generation, as a major pathway in EA-induced injury. However, pre-incubation of cells with 
the NADPH oxidase inhibitor DPI, did not attenuate EA-induced cytotoxicity. Instead, DPI 
itself induced a concentration-dependent cell injury, even in the absence of EA. DPI-induced 
cell death has previously been documented, where several hours of DPI incubation resulted 
in mitochondrial •O2¯ production leading to a decrease in mitochondrial membrane 
potential, a release of cytochrome C and ultimately the induction of apoptosis 330. 
Independent studies also imply that stress-induced injury to the mitochondrial electron 
transfer chain can result in the release of •O2¯ radical from mitochondrial complex I, which 
could be a major factor in cell injury 328. 
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To further investigate the role of •O2¯ in EA-induced cell injury, we then explored the 
influence of the SOD inhibitor DETC. DETC resulted in an overall decrease in cell viability 
alone, confirming that endogenous SOD is essential for cell survival. Furthermore, DETC 
appeared to potentiate EA-induced cytotoxicity, indicating that •O2¯ may be involved in EA-
induced responses and that SOD plays a somewhat protective role in EA-induced cell injury.  
 
The final pathway investigated was that involving H2O2. While it is a relatively more stable 
and diffusible species, it can be converted to singlet oxygen (¹O2*) and •OH¯ radical 
following its iron-mediated reduction. Such radicals are exceedingly strong and 
indiscriminate oxidants that are often recognised as the primary mediators of oxidative 
stress-associated tissue injury 170. We found that EA-induced cytotoxicity was not 
attenuated by pre-incubation with the major H2O2 scavenger catalase, or its cell permeable 
PEG-conjugated form. Furthermore, inhibition of endogenous catalase by aminotriazole 
(ATZ) had no further deleterious effect. Thus, in contrast to previous investigations into EA-
induced cell death in some cancer cells 314, my data suggest that H2O2 is unlikely a mediator 
of such injury.  
 
In light of this previous set of data, with more time, it would have been interesting to 
investigate the influence of altering the activity of additional antioxidants such as 
Glutathione Peroxidase (GPx). As illustrated in Figure 1.6 (page 70), this is another major 
intracellular antioxidant responsible for mediating reduction of H2O2 and a limited number 
of lipid hydroperoxides. Therefore, modulation of GPx activity (through its overexpression or 
inhibition) in addition to catalase supplementation may have provided further information 
regarding the nature of the reactive species involved in EA-induced cell death.    
 
 177 
Secondary oxidative stress species 
Involvement of secondary oxidation products (i.e. protein carbonyls) in GST inhibitor-
induced cell death was also investigated. Accumulation of such molecules should precede 
and correlate with the time and concentration-dependent injury caused by EA and CA. They 
should also contribute to DHR and DCF fluorescence and should be sensitive to NAC. While 
protein carbonyl levels were unaffected by subtoxic concentrations of EA alone, the increase 
induced by H2O2 was potentiated by this GST inhibitor, suggesting that GST may be key in 
attenuating the degree of protein carbonylation in stress conditions. These actions are most 
probably mediated by the scavenging of lipid peroxidation products, disabling them from 
further oxidative reactions which would otherwise mediate or exacerbate cellular injury. It is 
difficult to determine the precise contribution that ‘carbonyl stress’ plays towards the 
cytotoxicity observed after EA exposure, however these data indicate that GST plays a 
protective role against formation of these damaging proteins in cells exposed to stress. 
 
In summary, there is a strong correlation between the rapid accumulation of ROS (detected 
as DHR123 and DCF fluorescence) and the time- and concentration-dependent injury caused 
by EA and CA, in a cell-type specific manner. Protection of cell injury by NAC further supports 
the principal role of oxidative stress in GST inhibitor-induced cell death, and assessment of 
redox state strengthens the role of oxidative stress in potentiating H2O2-induced injury. 
Despite inconclusive results about the specific primary oxidants mediating GST inhibitor-
induced cell injury, there is evidence of •O2¯ involvement whose deleterious effects are 
attenuated by SOD. Investigation of downstream secondary oxidative stress products as 
potential mediators of cell death highlighted that GST inhibition significantly potentiates 
H2O2-induced increase in protein carbonylation. Collectively, these data suggest a pivotal 
role of GST in maintaining a stable intracellular redox state, particularly in stress conditions. 
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Chapter 6: 
METABOLIC RESPONSE TO GST 
INHIBITION 
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SUMMARY 
Recent clinical evidence suggests that polymorphisms in GST genes would affect their 
function as antioxidant enzymes which may contribute to inter-individual differences in the 
response to oxidative stress. We have so far demonstrated that inhibition of GST by EA 
induces cytotoxicity in several cell types in a concentration-dependent manner and have 
postulated that oxidative stress is a major player in such cell death. As discussed in Chapter 
1, oxidants can cause direct injury to intracellular macromolecules, which can in turn affect 
the structure and function of key organelles such as the mitochondria. Disruption to 
mitochondrial activity can be catastrophic for cellular function, as it affects the production 
of the cell’s major energy carrier ATP. If ATP is depleted, several critical intracellular 
mechanisms may be disrupted, ultimately leading to cell injury and death. The changes in 
global metabolism and in the levels of specific metabolites in response to oxidative stress 
and GST inhibition also remain unknown. In addition, EA, as a pharmacological inhibitor, 
may have other intracellular side-effects, for instance it may cause direct structural damage 
of the mitochondria or alterations of metabolic profile, which may contribute towards 
cellular injury, independently of GST inhibition. 
 
In this chapter, we evaluated potential underlying mechanisms of EA-induced cytotoxicity 
such as the disruption of mitochondrial function and alterations in global metabolic events. 
We initially investigated the impact of GST inhibitor EA on the intracellular energy state (i.e. 
mitochondrial energetics) of cells maintained in optimal or stressed conditions. This was 
done by assessment of cellular nucleotide pools using HPLC and UV detection. In contrast to 
H2O2, EA exposure alone had no impact on intracellular ATP/ADP ratios, suggesting that EA 
is unlikely to directly damage the mitochondria. We found that H2O2 causes a rapid and 
profound fall in cellular ATP, but that EA had little impact on H2O2-induced ATP depletion.  
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A metabonomic approach was adopted to characterise the global metabolic response of 
cells exposed to these defined oxidative stresses. Following the experiments, the samples 
were processed and analysed by NMR spectroscopy, by Dr Piers Boshier, who also carried 
out the metabonomic analysis (as mentioned in Acknowledgements). NMR spectra revealed 
significant changes in the metabolic response to EA or H2O2 alone or in combination, as 
compared with the control group. The levels of several metabolites, such as glutamine, 
pyruvate and lactate, were found to significantly change during the course of both 
treatments and were more pronounced when treatments were combined. This is most 
probably due to the oxidative stress-induced disturbances of intracellular metabolic 
pathways. It is possible that such alterations may in turn activate signalling pathways which 
could play a role in cell death or inflammatory gene expression, which will be evaluated in 
the following chapter.  
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6.1 BACKGROUND 
The importance of mitochondrial injury in IRI (or other oxidative conditions) may be due to 
the fact that these organelles generate large amounts of ROS by themselves, thus in 
stressed conditions they may be more exposed to ROS-mediated damage. Despite 
mitochondria being perhaps intrinsically more ‘resistant’ to ROS than other organelles, they 
are still susceptible to oxidative damage, whether it be induced by ROS from an extracellular 
oxidative stress or that generated continuously by the mitochondrial respiratory chain 331. 
During energy production (of ATP), most of the O2 consumed by the mitochondria is 
reduced fully to water, but 1-4% is reduced incompletely to give •O2¯, which can 
subsequently generate other ROS such as H2O2 and •OH¯. This typically occurs at Complex I 
and III of the respiratory chain. If the function of one or more of these respiratory chain 
complexes is impaired for any reason, or if the mitochondrial antioxidant defence 
mechanisms are compromised, the production of free radicals increases and can impact on 
the mitochondrial function by causing perhaps irreversible oxidative damage to 
macromolecules such as mitochondrial DNA, membrane lipids and proteins. For instance, 
reoxygenation following hypoxia has been shown to compromise mitochondrial electron 
flow in endothelial cells and trigger production of ROS by complex III 332.  
 
In addition to the highly reactive and relatively short-lived ROS such as the hydroxyl radicals, 
their diffusible aldehyde oxidation products have a much longer lifespan and are capable of 
propagating ROS-initiated injury. As discussed, aldehydes (such as MDA and 4-HNE) 
generated from oxidised lipids, are themselves responsible for forming adducts on lipids, 
proteins and DNA, ultimately affecting the structure and function of macromolecules and 
key organelles. As such, they have been detected in almost all tissues that have experienced 
oxidative injury and are often found in ischemic, and failing hearts; in apoptotic cells; and in 
damaged mitochondria 333. For instance, 4-HNE adduct formation has been shown to: (i) 
impair ATP-generating ability in the mitochondria 334 and (ii) induce opening of mitochondria 
 182 
permeability transition (MPT) pores 335. In the event of GST activity attenuation, as a result 
of GST polymorphisms or GST inhibition in vitro, we would expect GST substrates such as 4-
HNE to accumulate in underlying stress conditions. This in turn could directly damage 
essential organelles such as the mitochondria, affecting not only apoptotic pathways but 
also metabolism, energy production, cellular functions and their ability to repair damaged 
macromolecules. 
 
A large number of studies have associated mitochondrial dysfunction caused by ROS to both 
accidental cell death (necrosis) and programmed cell death (apoptosis) 336. The latter is 
often induced by the opening of the MPT pores and the release of cytochrome C (from its 
binding to cardiolipin) and other pro-apoptotic proteins, which can trigger caspase 
activation and ultimately apoptosis. It is important to remember that mitochondria produce 
> 90% of our cellular energy (in the form of ATP), therefore structural injury may not only 
induce apoptotic pathways, but also affect their important role in energy metabolism. For 
instance, direct damage to mitochondrial proteins involved in the tricarboxylic acid (TCA) 
cycle or ETC (the two closely coordinated metabolic processes involved in energy 
production), can decrease their affinity for substrates and/or coenzymes and thereby 
decrease the efficiency by which ATP is produced 337. As such, impairment of mitochondrial 
function leads to an imbalance in intracellular energy status, reflected as ‘ATP/ADP ratio’, 
which can also contribute towards ROS-mediated cell death 338.  
 
Aside from GST inhibition and subsequent increase in ROS, we have not excluded the fact 
that GST inhibitor EA may display non-specific effects, targeting mitochondrial components 
or other metabolic compounds which may ultimately lead to cell injury and death. Several 
medications are now considered a major cause of mitochondrial damage, which may explain 
their adverse effects in the clinical setting 339. Some have been found to directly inhibit 
mitochondrial DNA transcription of ETC complexes, damage ETC components, and inhibit 
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enzymes required in glycolysis. Indirectly, pharmacological agents may damage 
mitochondria by decreasing the levels of endogenous antioxidants (such as GSH) or by 
inducing the production of free radicals and/or the accumulation of harmful metabolites 339.  
 
In addition to ROS-mediated damage of important cellular organelles, IRI is also known to 
involve a spectrum of important metabolic changes, the full extent and exact nature of 
which remain unknown. A number of recent studies have used a metabonomics approach to 
investigate the global metabolic alterations associated sepsis 340,341 and severe trauma 342. 
These studies confirmed in principle that such methods can distinguish between the 
metabolic phenotypes of critically ill patients and healthy controls. This novel and unique 
way of defining the ‘metabolome’ is termed metabonomics and is specifically defined as 
‘‘the quantitative measurement of the time-related multiparametric response of living 
systems to pathophysiological stimuli’’ 343. Metabonomics typically requires the acquisition 
of biofluids or tissue samples from the system under investigation. These samples are then 
profiled by one of a number of analytical techniques, although nuclear magnetic resonance 
(NMR) spectroscopy and mass spectrometry are predominantly used. Furthermore, 1H-NMR 
can quantify multiple metabolites from a single sample and can be used for liquid or solid 
samples with minimal sample preparation. By using advanced statistical methods as well as 
pattern recognition techniques the vast quantity of data obtained from these techniques 
can be effectively summarised for the purpose of data comparison. 
 
Metabolic derangement is often observed during cellular injury, thus we decided that NMR-
based metabonomics may be useful for further investigating the potential mechanisms 
driving EA-induced cell injury. It is possible that attenuation of GST and subsequent 
accumulation of lipid hydroperoxides and LDAs could modulate important cellular 
metabolites. It is also plausible that EA itself may cause disturbances in the metabolic profile 
of MLE cells, rendering them more susceptible to injury, in a GST-independent manner. 
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Thus, NMR spectroscopy was employed to investigate the complex metabolic signatures of 
MLE cells following exposure to stress (H2O2) or GST inhibition. The impact of EA on the 
metabolic response to stress was also explored. 
 
We hypothesised that exposure of lung epithelial cells to episodes of defined cellular stress - 
characteristic of ischemia reperfusion, will induce global metabolic disturbances, the 
footprints of which may be identified by fluid phase metabonomics. Alteration of 
intracellular metabolism associated with reduced antioxidant (GST) enzyme activities is 
expected to augment the baseline metabolic response to oxidative stress. These metabolic 
derangements may contribute towards MLE cell injury. 
 
 
6.2 AIMS 
The aims of this chapter were to:  
 
a. determine the influence of GST inhibitor EA on intracellular energy state in the 
absence and presence of oxidant stress (H2O2), via evaluation of intracellular ATP and 
ADP by HPLC and UV detection;  
 
b. define the global metabolic response to oxidative lung cell injury (associated with 
cellular models of IRI) by adopting metabonomic profiling techniques; and 
 
c. characterise the influence of GST inhibition (by EA) on the global and specific 
metabolic response in cells exposed to optimal or oxidative stress conditions. 
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6.3 PROTOCOLS 
 
6.3.1 Intracellular energy status assessed by HPLC and UV detection 
Cells were seeded in 24-well plates at a density of 5x105/well. Upon confluency (after 24 h) 
cells were washed and exposed to 400l fresh FCS-free media containing various 
treatments. In one experimental study, cells were exposed to media alone or media 
supplemented with EA (0.1mM) and/or H2O2 (0.8mM) for increasing intervals (1, 3, or 5 h). 
In a second experiment, cells were exposed to increasing concentrations of EA (0, 0.1, 0.2, 
0.3mM) for 1 h. Cellular extracts were then prepared using perchloric acid (0.4M) followed 
by  neutralisation with KOH (2M) as described in Chapter 3.9. Levels of ATP and ADP were 
measured by HPLC with UV detection at 254nm. Concentrations of ATP and ADP 
(determined by analysis of chromatogram peaks) were used to calculate ATP/ADP ratio for 
each cellular extract sample, which is a well established index of intracellular energy state. 
 
6.3.2 Metabonomic profiling 
To define the oxidative stress metabolome in lung epithelial cells and the impact of GST 
inhibitor EA, preliminary metabonomic analysis studies were carried out in collaboration 
with the Biomolecular Medicine Department of Imperial College. MLE cells were seeded at a 
density of 8x106/75cm2 culture flask and incubated with complete media for 2 days at 37°C 
until confluent (reaching approximately 25 x 106 cells/flask). Cells were washed and exposed 
to fresh FCS-free media alone, or that containing EA (0.1mM) and/or H2O2 (0.8mM) over 
increasing time periods (1, 3, or 5 h). Such treatments were found to be subtoxic, as judged 
by parallel MTT assay. These time-dependent experiments were intended to reveal the 
metabolic responses to oxidative stress in the presence or absence of GST activity at both 
early and later time points. Following treatment, cells were trypsinised and washed (x2) in 
cell medium. Cells were then centrifuged at 1800 rpm for 7 min and following removal of 
the supernatant, the pellets were stored at -80oC. 
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The preparation of aqueous and organic cell extracts and the methodology used for data 
acquisition, processing and analysis in NMR Spectroscopy are described in detail in 3.9. 
Briefly, NMR spectra of cell extracts were acquired on a Bruker DRX600 spectrometer 
operating at 600.13-MHz 1H NMR frequency. The CPMG pulse sequence was applied during 
spectroscopy to measure spin-spin (T2) relaxation times. Raw spectra were calibrated to the 
TMSP internal standard resonance (0ppm) and automatically corrected for phase and 
baseline distortions using NMRPROC V.03 software and imported into MetaSpectra 
software. 
 
Spectra were subsequently normalised to protein concentration (determined for each cell 
pellet by the BCA protein assay) and analysed in two different ways. Firstly, the global 
metabolic phenotype of treatment groups was compared by principal component analysis, 
(PCA). Usually it is difficult to perceive the pattern of element associations by direct 
examination of chemical data due to the great number of elements and analyses involved. 
However an effective way to identify and demonstrate this is by PCA, a mathematical 
technique of multivariate analysis. Our NMR data consisted of 765 spectral variables, 
following removal of residual water signals and the extremes of the spectrum (to avoid the 
effect of baseline noise). This data was then imported into SIMCA-P (version 11) and used to 
generate all PCA models and scores plots. From these, we were able to draw preliminary 
conclusions with respect to the identity and relative levels of metabolites differing between 
samples. Secondly, isolated spectral regions/metabolite signals were defined through visual 
inspection, and specific metabolite assignment was carried out using the Madison 
Metabolomics Consortium Database 302. Following peak allocations, the peak areas were 
calculated and reported as fold change relative to control, as opposed to absolute values.  
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6.4 RESULTS 
 
6.4.1 Influence of EA on mitochondrial energetic 
Adenine nucleotide content was measured by HPLC and UV detection and ratios of ATP/ADP 
were calculated as an index of intracellular energy state. We found that 5 h exposure to EA 
had no effect on ATP/ADP ratio as compared to untreated control (Figure 6.1A). By contrast 
exposure of cells to H2O2, which was used as a positive control, significantly reduced 
ATP/ADP ratio from 12.3 4.42 to 4.7 3.1. Data suggests that the presence of EA may 
enhance the H2O2-induced decrease in ATP/ADP ratio, however this was not significant.  
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Figure 6.1 Ratios of ATP/ADP in MLE cell extracts following exposure to a number of stresses.      
(A) 5 h exposure to EA (0.1mM) or H2O2 (0.8mM) either alone or in combination; and (B) 1 h 
exposure to increasing concentrations of EA. N=3; *p<0.05 vs. untreated control. 
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The ATP/ADP ratios were also unaffected by increasing EA concentrations over the course of 
1 h (Figure 6.1B). These data suggest that EA-induced cell death is unlikely due to disruption 
of energy metabolism (i.e. mitochondrial energetics) or direct toxicity to the mitochondria.  
 
6.4.2 Metabonomic profile of cells exposed to stress and GST inhibition 
NMR spectroscopy was carried out following separation of the aqueous and organic phases 
of MLE cell extracts. PCA was performed on the acquired data to summarise, in the form of 
scores plots (Figure 6.2), the global metabolic changes of cells exposed to GST inhibitor or 
oxidative stress, alone or combined, compared to cells maintained in control conditions.  
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 Figure 6.2 Scores plots from Principal Component Analysis (PCA). These show (A) class separation 
of MLE cell extracts after 5 h exposure to EA, H2O2, individually or combined, as compared to 
control; and (B) time and treatment-dependent class separation. N=3. 
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Represented in Figure 6.2A is a PCA scores plot of extracts taken from MLE cells exposed to 
control conditions, EA, H2O2, and EA + H2O2 over 5 h. Despite the low ‘n’ number, the plot 
illustrates a reasonable clustering according to treatment group and separates the 
metabolic profiles of treated and non-treated cells, showing that cells exposed to EA and 
H2O2 behave in a diametrically different manner. A time-dependent separation within the 
same treatment groups was also observed, as shown in Figure 6.2B. This is likely to reflect 
changes in metabolism with increasing exposure to treatments.  
 
Supporting the results of the multivariate analysis above, visual inspection of spectra 
(generated from samples collected following 5 h of treatment), confirmed significant 
differences in 118 of the 201 definable signals, many of which could be assigned to common 
metabolites. Below are original spectra showing the impact of EA and H2O2 alone and in 
combination on the level of glutamine (A) and an unknown metabolite (B). Presence of EA 
visibly enhanced H2O2-induced changes in both of these metabolites. 
A B
 
 
 
Integration of peak intensities revealed that both EA and H2O2 alone and combined induced 
a significant change in a large number of intracellular metabolites following 5 h treatment, 
as illustrated in Table 6.1.  
Figure 6.3 Original spectra of (A) glutamine and (B) an unknown metabolite after EA and H2O2 
treatment (5 h). Control conditions (black), EA (blue), H2O2 (yellow) and EA and H2O2 combined (red). 
 190 
  p<0.05 
Kruskal-Wallis  118/201 
Mann-Whitney U                     
(*1-sided p-value) 
Control vs. EA 101/201 
Control vs. H2O2 96/201 
Control vs. EA + H202 115/201 
 
 
 
Interestingly GST inhibitor EA enhanced the H2O2-induced change in a large number of 
metabolites. The intensities of a selection of metabolites found to increase significantly are 
reported in Table 6.2 and are represented as fold-change, compared to control. 
 
EA H2O2 EA + H2O2
Phenylalanine 1.5 2.0 3.2 (1, 4)
Tyramine 1.5 1.9 3.5 (1)(4)
Oxidised glutathione 1.3 1.2 1.6 (1)(4)
Glutamine 1.6 2.1 4.5 (1)(2)(3)(4)
Threonine 2.0 2.4 4.2 (1)(2)(3)(4)
Aspartate 1.1 1.2 1.6 (1)(3)(4)
Pyruvate 1.4 1.1 1.6 (1)(2)(3)(4)
Free choline 1.1 1.3 1.5 (1)(2)(3)(4)
Alanine 1.2 1.2 1.4 (1)(4)
Lactate 1.4 1.6 2.2 (1)(4)
Glycerophosphocholine 1.3 1.0 1.8 (2)(3)(4)
Phosphocholine 0.9 1.4 1.4 (2)(3)
(1) EA and H2O2 and EA + H2O2 vs. control; p<0.05
(2) EA vs. H2O2; p<0.05
(3) EA vs. EA+H2O2; p<0.05
(4) H2O2 vs. EA+H2O2; p<0.05
 
Table 6.2 Fold-change of selected metabolites significantly affected by EA and oxidative stress. 
Cells were exposed to either or both of these treatments over a 5 h period. All metabolites listed 
were found to increase. N=3; p<0.05 calculated by Mann-Whitney U Test (2-tailed). 
 
Table 6.1 NMR spectral regions showing significant differences following EA and H2O2treatment. 
Observed differences were both positive and negative.  
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As shown in Table 6.2, the largest fold-increases, following exposure of cells to H2O2 (5 h), 
were found in phenylalanine (2.0), tyramine (1.9), glutamine (2.1) and threonine (2.4). Co-
treatment of MLE cells with H2O2 and EA, led to a further increase in these four molecules: 
phenylalanine (3.2), tyramine (3.5), glutamine (4.5) and threonine (4.2), as well as an array 
of other metabolites. This increase in metabolites, following exposure to H2O2 in the 
presence of EA as compared to exposure to H2O2 alone, was found to be significant (as 
indicated in the final column of the table by (4)). This data suggest that these are principal 
metabolites affected in MLE cells exposed to such stresses. In addition, significant changes 
in the level of pyruvate and lactate, following both EA and H2O2 exposure, indicate 
disruption of normal aerobic metabolism. It was observed that lactate specifically increased 
by 1.4 and 1.6-fold following exposure to EA and H2O2, respectively, but by 2.2-fold when 
combined. The conversion of pyruvate into lactate takes place in the mitochondria usually in 
anaerobic conditions when there is insufficient NAD⁺ to drive pyruvate decarboxylation into 
Acetyl CoA, which is required in the TCA cycle in the production of ATP (as illustrated in 
Figure 6.5).  
 
All choline metabolites: free cholines; phosphocholine; and glycerophosphocholine (GPC) 
demonstrate a general increasing trend correlating with the duration of exposure to 
oxidative stresses, with the largest fold-increase in GPC following GST inhibition in 
combination with H2O2 exposure. The meaning of this data will be explored in the discussion 
(6.5). 
 
It is possible that EA-induced cell death is related to EA-induced depletion of reduced 
glutathione (GSH) - a major, low molecular weight antioxidant molecule. To investigate this, 
we specifically assessed the levels of reduced and oxidised forms of glutathione after 1 and 
5 h exposure to the different treatments. Table 6.3 shows the treatment and time-
dependent fold-changes of GSH and GSSG.  
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H2O2 EA H2O2 + EA
1 hour GSH 0.78 0.66 0.54 (1)(4)
GSSG 0.63 0.57 0.52 (1)
5 hours GSH 0.63 1.08 0.64 (1)(2)
GSSG 1.17 1.33 1.64 (1)(3)(4)
(1) EA and H2O2 and EA + H2O2 vs. control; p<0.05
(2) EA vs. H2O2; p<0.05
(3) EA vs. EA+H2O2; p<0.05
(4) H2O2 vs. EA+H2O2; p<0.05
 
 
 
 
A slight reduction in GSH levels was observed after 1 h exposure to H2O2, yet at the later 
time-point GSH had fallen by 0.6-fold as compared to the untreated control cells, which was 
matched by an increase in GSSG. In contrast, EA exposure resulted in an early decrease in 
GSH, which was then higher than control levels by 5 h. Therefore, despite EA causing an 
initial decrease in GSH, this was not observed at the later time point. Interestingly, exposure 
of cells to both oxidative stress and GST inhibitor over 5 h resulted in a decrease in GSH (as 
observed following H2O2 alone) but a significant increase in GSSG.  
 
The results shown in Table 6.3 (above) are graphically illustrated as box plots in Figure 6.4 
(below). These plots depict the small but significant differences in levels of both oxidised 
and reduced glutathione in each of the three sample groups as compared to control, 
following 1 and 5 h exposure. While NMR can be quantitative, this is very complicated and 
the majority of people are more interested in the relative as opposed to absolute values. 
Therefore, we determined the levels of metabolites by integration of spectral peaks (i.e. 
measuring the area under the curve) and presented our data as intensity relative to control 
treatment (on y axis). 
Table 6.3 Fold-change of GSH and GSSG in response to oxidative stress or GST inhibition. Changes 
induced by all treatments vs. control were significant (1). N=3; p<0.05 calculated by Mann-Whitney 
U Test (2-tailed). 
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Figure 6.4 Box plots representing the fold change of GSH and GSSG (reduced and oxidised 
glutathione, respectively) after stress treatments. Cells were exposed to oxidant H2O2 or GST 
inhibitor alone or in combination for 1 and 5 h. All changes were significant vs. control treatment 
using Kruskal-Wallis test: p<0.05. 
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6.5 DISCUSSION 
Oxidative stress can induce both apoptosis and necrosis, and while the ultimate outcome of 
these are the same their processes differ significantly in terms of both structure and 
metabolic processes of cells 344. For instance, necrotic cell death is characterized by the loss 
of metabolic functions, where cells cease to produce proteins and ATP. This could result 
from lipid peroxidation of the mitochondrial membrane which would interfere with the 
generation of ATP. This is vital for cell function as it provides the energy required for many 
cellular reactions, thus its depletion rapidly leads to the breakdown of the cell’s ion balance 
which affects numerous cellular processes. This is often accompanied by damage to the cell 
membrane, lack of repair and subsequent loss of integrity resulting in cell death.  
 
Under certain conditions, oxidative stress may also induce apoptosis 345, where cells actively 
participate in activating cascades of biochemical reactions that result in a controlled cell 
death. Mitochondria specifically have attracted considerable attention in recent years, for 
their key role in apoptotic cell death. Briefly, the mitochondrial apoptosis pathway is 
defined by the mitochondrial outer membrane permeabilization (MOMP) 346, which can be 
driven by accumulation of free radicals, impaired calcium buffering and the opening of the 
MPT pore. The latter can be triggered by multiple extracellular stimuli and specifically leads 
to (i) loss of mitochondrial ions as they equilibrate across this membrane; and (ii) swelling of 
the matrix as water enters. In all cases, the resulting MOMP precipitates the death of the 
cell through two potential mechanisms. The most common involves the mitochondrial 
release of proteins, such as Cytochrome C and AIF, which can either activate caspases that 
orchestrate downstream events often associated with apoptosis, or induce caspase-
independent cell death. Secondly, MOMP can result in the loss of mitochondrial functions, 
namely cellular respiration, the process whereby biochemical energy in the form of 
carbohydrates, lipids and proteins is converted via a series of catabolic reactions to the 
universal energy carrier ATP. 
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In our investigation into the underlying mechanisms of EA-induced cell death, whether 
necrotic or apoptotic in nature, we considered that GST inhibition could lead to increased 
aldehydes, which may result in global cellular damage and ATP depletion or have a directly 
toxic effect on the mitochondria and in turn disturb mitochondrial energetics. To explore this 
possibility, we assessed the ATP/ADP ratios in extracts taken from cells exposed to either EA, 
H2O2, alone or combined. We have demonstrated that mitochondrial dysfunction is unlikely 
to be the principal mediator of EA-induced cell death as ATP/ADP ratios remained constant, 
despite exposure to increasing concentrations of the GST inhibitor. These data suggest that 
the intracellular energy state and thus the mitochondria are not directly affected by EA. 
 
GST inhibition may modulate the level of other metabolites involved in essential cellular 
processes, thus preliminary experiments were also carried out to assess the metabolic 
response of MLE cells exposed to a defined oxidative stress and/or GST inhibition. We 
hypothesised that differences in the levels of selected metabolites may result from inhibition 
of normal cell metabolism and cell cycle arrest, either induced by the oxidant H2O2 or the 
intracellular oxidative environment resulting from GST inhibition (and hence accumulation of 
secondary oxidation products). It is possible that the short timescale of exposures and the 
relatively high concentration of H2O2 and EA employed may have enhanced these changes. 
However, several findings that we have reported provide some speculative insight into the 
metabolic pathways altered in response to such forms of oxidative stress. Initial examination 
of the acquired 1H NMR datasets using PCA provide preliminary evidence that extract 
samples taken from cells exposed to oxidant stress and/or EA could be separated based on 
their global metabolic phenotype. Despite the small number of experiments carried out, 
these data indicate that the metabolic response to the various stresses separates treatment 
groups from the controls and from each other (as observed with EA and H2O2, as individual 
or combined treatments). Also, there is a gradual change associated with time of exposure 
that may reflect either progressive metabolic derangement or ongoing apoptosis.  
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The variability in the intensities of resonances assigned to several metabolites was then 
explored. Levels of glucose, pyruvate, lactate and alanine were specifically evaluated due to 
their involvement in cellular respiration and intracellular pathways of energy metabolism.  
 
Under aerobic conditions cellular respiration can be divided into three main steps, (i) 
glycolysis, (ii) the tricarboxylic acid (TCA) cycle and (iii) oxidative phosphorylation, as 
illustrated in Figure 6.5 3. Glycolysis is the central cytosolic pathway for the conversion of 
glucose into free energy (ATP), and also produces NADH and pyruvate 347. When there is an 
adequate supply of O2, pyruvate is converted to acetyl-CoA, which enters the TCA cycle, 
leading to the production of NADH, CO2 and a large amount of ATP 
347. Alternatively, under 
anaerobic conditions pyruvate is converted to lactate in a process that regenerates cofactors 
necessary for glycolysis 347. Spectral analysis revealed significant (but very modest) increases 
in the level of pyruvate and lactate in treatment as compared with control groups. This 
suggests that pyruvate synthesis is unaffected by such oxidative stress, but its consumption 
via pyruvate decarboxylation is reduced. Disruption of normal pyruvate metabolism in cells 
exposed to H2O2 or GST inhibitor EA are most likely responsible for raised lactate levels. 
While increased lactate is conventionally thought to indicate anaerobic metabolism, non-
hypoxic hyperlactatemia may also occur as a result of: accelerated aerobic glycolysis that 
exceeds the oxidative capacity of the mitochondria; and excessive proteolysis and 
conversion of amino acids to pyruvate 348,349. Furthermore, alanine levels significantly 
increased following exposure to oxidative stresses. As one of the most abundant amino acids 
within the body, alanine is known to undergo reversible transamination to form pyruvate, 
thus influencing a number of metabolic pathways including glycolysis and the TCA cycle 
341,350. Our findings show that levels of phenylalanine also increased which may indicate the 
disturbance of a dynamic balance between the processes of protein catabolism and 
synthesis. 
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The observed increase in choline metabolites in response to H2O2 and GST inhibitor 
exposure was small, but may suggest an increased phospholipid metabolism. These findings 
appear to contradict those reported by Holm et al., who demonstrate that the treatment of 
Figure 6.5 An illustration of the major metabolic pathways involved in cellular respiration:             
1) Glycolysis; 2) Transamination; 3) Anaerobic fermentation; 4) Pyruvate decarboxylation; 5) 
Tricarboxylic acid (TCA) or Krebs cycle; and 6) Respiratory chain and oxidative phosphorylation. 
(Figure is adopted from the PhD thesis of Dr Piers Boshier 3, with modifications) 
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AEII cells with H2O2 results in a concentration-dependent decrease in phosphtidylcholine 
synthesis 351. The same authors identified that the activity of glycerol-3-phosphate 
acyltransferase, an enzyme involved in the early stages of phospholipid synthesis was 
likewise decreased as a result of H2O2 exposure. However, it has also been reported that 
chronic inflammatory processes are characterized by a significant decrease in the 
plasmalogen content (a membrane glycerophospholipid that is highly susceptible to 
oxidative damage 352) and concomitantly an accumulation of its oxidation products, such as 
glycerophosphocholine (GPC). Thus, our observations support our previous findings which 
suggest that, GST inhibition in cells exposed to H2O2 results in an enhanced level of 
intracellular oxidative stress, perhaps due to the accumulation of LDAs. Furthermore 
metabolites such as GPC are capable of disturbing the sensitive balance between apoptosis 
and necrosis 353. It is also important to note that a number of recent studies have found that 
choline treatment also reduced oxidative stress and attenuated the inflammatory response 
in mouse models of airway disease 354 and in patients with asthma 355. Therefore, their 
specific role under conditions of oxidative stress requires further detailed studies. 
 
Aside from metabolites involved in cellular respiration and oxidative metabolism, we also 
considered that EA may directly affect the levels of reduced glutathione (GSH) as depletion 
of this non-protein thiol would disrupt redox-sensitive pathways throughout the cell. A 
previous study carried out by Aizawa et al. found that the addition of NAC, (a precursor of 
GSH) to cells exposed to EA had no significant effect on the changes in GSH levels induced by 
EA. In our experiments it appeared that EA (in contrast to H2O2) caused a relatively early 
depletion of GSH which seemed to have recovered at later time points. Thus, our data 
indicate that it is unlikely that EA-induced cell death is mediated by GSH depletion. 
Evaluation of GSH/GSSG ratio could also be calculated as an index of redox state. This data 
would indicate, similarly to that of NAD⁺/NADH ratios (in Chapter 5), that attenuation of GST 
in the presence of oxidant stress potentiates the intracellular oxidative environment. 
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It is also acknowledged that glutamine, an important intermediate of GSH synthesis, is a key 
player in the cellular antioxidant defence system. This has been demonstrated in recent 
clinical studies which showed that administration of glutamine can maintain plasma GSH 
concentrations in states of increased oxidative stress, with potentially protective effects 356. 
In our experiments, glutamine exhibited the largest fold-increase (4.5) following 5 h 
exposure to both H2O2 and GST inhibition, suggesting that such oxidative stresses may have 
induced an upregulation in the synthesis/availability of glutamine. However, under similar 
conditions GSH levels decreased by 0.6-fold suggesting that the increased glutamine levels 
took part in cellular metabolic processes other than that replenishing GSH. 
 
In summary, we have demonstrated that GST inhibitor EA, even at high concentrations, does 
not disturb mitochondrial energetics and is therefore unlikely to directly damage the 
mitochondria, as opposed to H2O2, which caused a rapid and profound fall in cellular ATP. 
1H 
NMR-based metabonomics profiling has provided a preliminary insight into the metabolic 
pathways affected in cells exposed to oxidant stress and/or GST inhibition. Initial 
multivariate analysis of acquired dataset separated treatment groups on the basis of their 
global metabolic profiles. Our findings also reveal previously undetermined metabolic 
signatures of oxidative stress and GST inhibition in a time-dependent manner. In addition, 
the known metabolites impacted by such treatments were mainly those with close links to 
energy metabolism pathways or involved in the regulation of oxidative stress. It is clear that 
many oxidative stress-induced changes were augmented by GST inhibition as the most 
significant responses were seen following 5 h treatment with both H2O2 and EA. Further 
mechanistic-based interpretation of acquired metabonomics data would be required to 
correctly explain all observed changes in both assigned and currently unassigned 
intermediates.  
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Chapter 7:  
EFFECT OF GST INHIBITION ON 
REDOX SIGNALLING AND 
INFLAMMATORY GENE 
EXPRESSION 
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SUMMARY 
Traditionally, ROS are considered cytotoxic and are implicated in causing cell injury and 
death. This is most likely due to ROS-mediated damage of lipids, protein and nucleic acids, 
which can ultimately induce apoptotic or necrotic pathways. However it has also been 
suggested that at low concentrations, they may influence signalling pathways and play a 
major role in various aspects of cell function. Many studies have demonstrated a role of ROS 
in the pathogenesis of inflammatory diseases, where activation of key signalling molecules 
and transcription factors (such as p38 MAPK and NFB, respectively) orchestrates the 
expression of a spectrum of genes involved in the inflammatory response. This in turn can 
lead to the expression of cell death genes, production of cytokines and chemokines or 
expression of cell surface adhesion molecules, all of which can enhance the inflammatory 
response.  
 
We have so far found that attenuation of total intracellular GST, using inhibitor EA, is 
cytotoxic to cells and this appears to be mediated by oxidative stress, however the 
underlying signalling mechanisms mediating cytotoxicity remain unknown. An independent 
problem of IR, aside from cell injury and death, is the heightened inflammatory response 
and it is possible that oxidative stress associated with GST inhibition could play a role in 
inflammatory gene upregulation. Therefore, in this chapter we initially explored the 
involvement of major signalling molecules including MAPK and NFB in EA-induced cell 
death and the impact of GST attenuation on intracellular signalling molecule activation and 
inflammatory gene expression by focussing on chemokine release and adhesion molecule 
expression.  
 
We found that modulation of either p38 or NFB did not influence EA-induced cytotoxicity. 
While EA increased the phosphorylation of p38, it inhibited NFB activation over time but 
this did not result in inflammatory gene expression. To explore potential cooperative 
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interaction between oxidative stress and cytokine signalling, we investigated the effect of 
EA on TNF-induced gene expression. As expected, TNFα significantly upregulated KC release 
and ICAM-1 and VCAM-1 expression. Interestingly, GST inhibition had a tendency to further 
increase KC release and significantly increased VCAM-1 surface expression in cells exposed 
to TNFα.  
 
These findings suggest that accumulation of GST substrates (in the event of its 
inhibition/absence) may enhance p38 phosphorylation (amongst other redox-sensitive 
signalling molecules and transcription factors), which in turn may play a role in the 
upregulation of specific inflammatory genes such as VCAM-1.  
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7.1 BACKGROUND 
Excessive accumulation of ROS, in response to external or internal stress stimuli, is generally 
considered to be directly cytotoxic and has been implicated in mediating cell injury in a 
number of pulmonary disorders. Several lines of evidence also indicate that the intracellular 
redox status is a versatile control mechanism of signal transduction pathways and 
downstream gene expression 357,358. In this case, oxidative stress can also elicit specific 
cellular responses such as apoptosis and inflammatory gene upregulation via activation of 
redox-sensitive signalling molecules, such as MAPK signalling cascades.  
 
MAPKs are major intracellular signal transduction factors, through which signals from both 
environmental or intracellular stimuli are transmitted to the nucleus 359. Three groups of 
MAPKs have been characterized in mammalian cells; extracellular signal‐regulated kinases 
(ERK), c‐Jun NH2‐terminal kinase (JNK), and p38 MAPK (the latter of which are sometimes 
grouped and referred to as the stress-activated protein kinases, SAPKs). It appears that the 
environmental conditions determine the specific roles of these MAPKs and the outcome of 
oxidative stress. For instance, under mild oxidative stress ERK signalling is believed to 
promote cell survival, while SAPKs have been reported to mediate cell death 360. Although 
JNK and p38 activation can lead to cell death, the specific response seems to be cell-type 
and stimulus specific. For instance in malignant B and T lymphocytes the activation of such 
signalling molecules has been reported to have anti-apoptotic effects 361,362. Furthermore, 
this bi-functional role may be dependent on the magnitude and duration of the SAPK 
activation, as a transient activation can promote cell survival, whereas a larger, sustained 
activation tends to induce apoptosis, however the underlying mechanism remains unknown 
360. Signal transduction via phosphoinositide 3-kinase (PI3K) has also been implicated in the 
regulation of both cell survival and cell death under sustained oxidative stress conditions 363 
and the dual effects are likely the results of crosstalk with other signalling pathways, such as 
MAPKs 364. 
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The ROS-mediated modulation of MAPK activity not only influences cell survival and death 
pathways, but has also been reported to impact on inflammatory gene expression through 
activation of redox-sensitive transcription factors such as NFB and activator protein-1 (AP-
1). In mammals, the major NFB family members include NFB1 (p50), NFB2 (p52) and 
RelA (p65). These all contain a Rel homology domain (RHD) which enables DNA-binding, 
dimerization between the family members, and the association of NFB dimers with the 
inhibitor of kappa B (IB), which in turn keeps NFB in an inactive state. ROS can also 
mediate NFB activation by inducing phosphorylation of the p65 subunit directly or through 
activation of IB kinase (IKK), which phosphorylates IB and releases NFB. Irrespective of 
the pathway, dissociation of NFB from its inhibitor and translocation from the cytosol to 
the nucleus enables NFB to bind to DNA at specific promoter regions (following activation 
of intrinsic histone acetylase activity of co-activator molecules) and activate the 
transcription of target genes. Their products may be involved in cell survival (such as anti-
apoptotic genes, caspase inhibitors and antioxidants) or in the inflammatory response 365,366.  
 
Mounting experimental evidence suggests that ROS also have paradoxic effects on NFB 
regulation, whereby activation or inhibition of NFB activity depends on the level of ROS, 
type of stimuli, and cell type 189. For instance, a moderate increase of ROS often leads to 
NFB activation, while a severe increase could inactivate NFB via redox modifications such 
as S-glutathionylation and S-nitrosylation 367. An additional complexity of redox signalling is 
that oxidative stress may directly influence histone modifications, by inhibition of histone 
deacetylase activity or regulation of  transcription co-activators, such as ATF-2 and CBP, that 
possess intrinsic histone acetylase activity 368. Such changes are likely to result in chromatin 
remodelling which affects the binding of transcription factors (e.g. NFB and AP-1), to the 
DNA and ultimately modulates target gene expression 369. Furthermore, one study has 
shown that ROS enhanced IL-1β-induced inflammatory cytokine release (by reduction of 
HDAC activity) in human epithelial cells, highlighting an interaction between oxidative 
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stress-induced chromatin remodelling and existing cytokine signalling 370. This revealed a 
novel mechanism for the enhancement of inflammation. 
 
 
Addressing inflammatory gene expression in the lung specifically, redox-sensitive signalling 
molecules and transcription factors have been shown to regulate expression of both major 
chemokines (e.g. KC and MIP-2 in mice) and cell surface adhesion molecules ICAM-1 and 
VCAM-1 thus regulating leukocyte chemotaxis, recruitment and adhesion/migration of 
leukocytes in the lung. While upregulation of such adhesion molecules on the endothelium 
is clearly recognised as being key in mediating PMN transmigration (from the circulation into 
the lung) and initiating an inflammatory response, the functional relevance of adhesion 
molecule upregulation on the epithelium remains less clear. Nevertheless, several studies 
suggest that alveolar epithelial cells may directly participate in the inflammatory process via 
adhesion molecule upregulation 77. Both ICAM-1 and VCAM-1 are expressed constitutively 
on alveolar epithelial cells and promote neutrophil and lymphocyte/macrophage adhesion 
respectively. Interestingly, exposure of AEII cells to hypoxia has been reported to induce a 
two-fold increase in mRNA levels, followed by a modest increase in protein expression 
between 2 and 4 h. This was found to be a TNFα-dependent response and resulted in an 
increase in neutrophil and macrophage adherence to the epithelial cells 192. 
 
With relevance to this PhD, oxidative stress products, including the GST substrate 4-HNE, 
have been found to impact on JNK and p38 activation 371. In addition, one study revealed 
that GST inhibitor-induced cytotoxicity of human colon cancer cells was in fact increased 
with p38 inhibition 315, suggesting that this MAPK plays a protective role in such conditions, 
however data is limited and thus warrants further investigation. Secondly, as discussed, 
many studies have reported oxidative stress to be a primary mediator of increased 
inflammatory gene expression 372, however no study has investigated the direct link 
between GST polymorphisms, redox signalling and inflammatory gene expression in lung 
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cells. Thus we set out to investigate the impact of GST activity attenuation on these 
pathways with our principal hypothesis being that GST inhibition by EA would augment 
epithelial cell redox signalling in stress conditions and enhance inflammatory gene 
expression. 
 
 
7.2 AIMS 
The specific aims of this chapter were to: 
 
a) test the hypothesis that redox signal transduction molecules (such as p38, ERK and 
PI3K and transcription factor NFB) and resultant genetic effects are involved in EA-
induced cell death;  
 
b) investigate the influence of GST inhibition on redox-signalling, specifically p38 and 
NFB activation, in cells exposed to media or oxidative stress; and 
 
c) evaluate the impact of EA on inflammatory gene expression (specifically that of 
cytokines and adhesion molecules) in cells exposed to oxidative stress and/or the 
pro-inflammatory cytokine TNFα. 
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7.3 PROTOCOLS 
To investigate the role of specific signalling molecules in EA-induced cytotoxicity, we pre-
incubated MLE cells with a number of specific signalling molecule inhibitors. Cells were 
seeded in 24-well plates at a density of 2.5x105/well. Following overnight incubation cells 
were pre-incubated with two commonly used p38 inhibitors, SB203580 and SB202190 for 30 
min. To identify involvement of other signalling kinase molecules (specifically ERK and PI3K) 
in cell injury, cells were also pre-incubated with their respective pharmacological inhibitors 
(shown in Table 7.1). In addition, we evaluated involvement of downstream transcription 
factor NFB in EA-induced cytotoxicity, by pre-incubating cells with the potent proteosome 
inhibitor MG132 (which is known to inhibit both NFB formation and IB degradation). 
Concentrations of such inhibitors were chosen following titration experiments and in light of 
studies documented in the literature. Cells were then exposed to increasing concentrations 
of EA for 5 h, after which cell viability was evaluated by the MTT assay. 
 
 
 
The impact of oxidative stress (H2O2) and GST inhibitor EA on the activation of p38 and p65 
was investigated by assessment of their phosphorylated forms using western blotting. MLE 
cells were seeded in 24-well plates as described above and exposed to H2O2 (1mM) or EA 
(0.1mM) alone or in combination, in 400l media. Cells were harvested after 20, 40 and 60 
min incubation and lysates were prepared as described in Chapter 3.5. The western blotting 
procedure, also described in that chapter, was followed and membranes were probed with 
Signalling molecules Inhibitor Final concentration 
p38 SB203580 and SB202190 10M 
ERK U0196 10M 
PI3K LY294002 30µM 
NFB MG132 50M 
Table 7.1 Pharmacological inhibitors of specific signalling molecules and transcription factors. The 
final concentrations displayed were determined by titrations and from the literature. 
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primary antibodies against phosphorylated p38 or p65 and secondary anti-rabbit IgG HRP-
linked antibody. Following chemiluminescence exposure and visualisation, membranes were 
re-probed with antibodies against α-tubulin and β-actin and secondary anti-mouse IgG HRP-
linked antibody. Antibody details are described in Table 3.3. 
 
The impact of GST activity attenuation on inflammatory gene expression, specifically that of 
KC, MIP-2 and adhesion molecules ICAM-1 and VCAM-1, was also evaluated in cells exposed 
to control or stress conditions. For all experiments, MLE cells were seeded in 24-well plates 
at 2.5x105/well and incubated overnight. Cells were then exposed to oxidative stresses: 
H2O2 (5 h) or Hx (24 h)/Rx (6 h), as described in Chapter 4, either alone or in combination 
with the inflammatory cytokine TNFα, which served as a positive control. The specific 
concentration of TNFα was chosen after preliminary concentration-response experiments, 
in which adhesion molecule expression was determined after 5 h. A further set of 
experiments investigated the impact of GST inhibition, using a range of subtoxic 
concentrations of EA, on cellular response to TNFα. The impact of specific GST isoform 
attenuation was also investigated in Hx/Rx model however this involved RNAi technology, 
which will be described fully in Chapter 8.   
 
To quantify chemokine release, media was collected following incubation, centrifuged at 
1800rpm for 7 min (to remove any cell debris) and analysed for the presence of KC and MIP-
2 using an ‘in-house’ colorimetric sandwich ELISA. A detailed protocol of this is described in 
Chapter 3.5. For analysis of adhesion molecule expression, cells were trypsinised and re-
suspended in 300l FWB. The surface expression of ICAM-1 and VCAM-1 (which was 
unaffected by trypsinisation) was assessed using fluorophore-conjugated anti-mouse 
monoclonal antibodies for either CD54 and CD106 respectively, or their appropriate isotype-
matched controls using FACS (as described in Chapter 3.7). Sample acquisition was 
performed on a Cyan ADP Analyzer flow cytometer using Summit software. 
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7.4 RESULTS 
 
7.4.1 Role of redox signalling in EA-induced cell death 
It is important to note that in this series of experiments cytotoxicity was caused by 
significantly lower concentrations of EA over the 5 h time course, compared to that 
observed in experiments described in Chapter 4 and 6. For instance 100M EA was found to 
be subtoxic in earlier experiments but resulted in complete cell death in these experiments. 
This may be due to differences in ‘cell number’/confluency of cells exposed to EA. 
Alternatively, as these set of experiments were carried out towards the end of the PhD, 
differences in cell tolerance could be due to phenotype change or the effects of different 
serum components, which can affect cell proliferation. To maintain a constant treatment 
volume in all experiments, we exposed cells to a lower range of EA concentrations and 
found that the pattern of EA-induced cell death was similar to that previously reported. 
 
To explore potential mediators of GST inhibitor-induced cell death, cells were pre-incubated 
with various signalling molecule and transcription factor inhibitors or vehicle controls 
(containing equivalent volumes of DMSO). Initially we focussed on the p38 pathway and 
found that the presence of inhibitors SB203580 or SB202190 alone caused a slight reduction 
in the viability of cells at 0M EA. There was a tendency for the p38 inhibitors to enhance 
EA-induced cell death. For instance, 50M EA alone reduced MLE cell viability by 31%, yet 
the presence of SB203580 or SB202190 resulted in a decrease of 52% and 64% cell viability 
respectively. However these changes did not achieve statistical significance as the observed 
baseline differences were taken into consideration when interpreting these data (Figure 
7.1). Similarly, pharmacological inhibition of ERK and PI3K had no effect on cell viability of 
cells exposed to EA (data not shown).   
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We also explored the effect of NFB inhibition on EA-induced cytotoxicity. MG132 alone 
caused minimal injury and had little effect on EA-treated cells as illustrated in Figure 7.2. 
While cell viability following 50µM EA treatment was reduced from 69% to 55% in the 
absence and presence of MG132, respectively, as compared to the untreated control, these 
changes were not found to be significant. 
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Figure 7.1 Impact of p38 inhibitors SB203580 and SB202190 on viability of cells exposed to EA. 
Viability measured by MTT assay. N=4. 
Figure 7.2 Impact of NFB inhibition on viability of cells exposed to EA. Cell viability was measured 
by MTT assay. N=4. 
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7.4.2 EA-induced activation of p38 and NFB  
A representative blot of our findings (n=3) showing the band intensity of phosphorylated-
p38 (p-p38) (~43kDa), relative to the α-tubulin (~50kDa), used as an internal loading control, 
is illustrated in Figure 7.3. As expected, H2O2 alone induced a significant increase in p38 
phosphorylation. The highest levels were detected after just 20 min exposure, yet this 
steadily reduced over the 60 min incubation. In contrast, EA alone (at subtoxic 
concentrations) induced the maximum p38 phosphorylation after 60 min treatment. 
Exposure of cells to H2O2 stress in combination with GST inhibitor appeared to have an 
additive effect, whereby levels of p-p38 increased by >45% of those seen following H2O2 
exposure alone. 
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Figure 7.3 A representative western blot showing p-p38 (~43kDa) and α-tubulin (~50kDa) after 
H2O2 and EA treatment. N=3. 
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Activation of NFB was determined by detection of phosphorylated p65 (p-p65) using 
western blotting. A representative blot of our findings relative to β-actin, which served as an 
internal loading control, is illustrated in Figure 7.4. Exposure of cells to H2O2 alone resulted 
in a rapid increase (approximately 5-fold) in p65 phosphorylation, as compared to untreated 
control, to a level which was sustained throughout the 60 min period. By contrast EA alone 
had no influence on the levels of phosphorylated p65. Furthermore, it appears that EA 
attenuated H2O2-induced p65 activation over time, as a weaker band is observed after 60 
min of combined treatment, as compared to that seen after 20 min.  
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Figure 7.4 A representative western blot showing p-p65 (~65kDa) and β-actin (~45kDa) after H2O2 
and EA treatment. N=3. 
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7.4.3 Upregulation of inflammatory gene expression 
 
Impact of oxidative stress and inflammatory stress cytokine 
Exposure of cells to increasing concentrations of H2O2 for 5 h induced a small increment in 
KC release however this did not reach statistical significance (Figure 7.5A). The KC released 
from cells exposed to Nx or Hx, are shown in Figure 7.5B. Baseline release of KC over 24 
normoxia was 343 89 pg/ml and 24 h of hypoxia was found to induce a 4-fold increase in 
KC release to 1445 447 pg/ml. We found that 6 h Rx had no further influence on KC release 
into the medium (data not shown). MIP-2 was also measured following exposure of cells to 
these stressors, however levels expressed were below the detection limits of our assay. 
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Figure 7.5 Influence of (A) H2O2 (5 h) and (B) Hx (24 h) on release of KC from MLE cells.               
N=3; *p<0.05 vs. untreated control. 
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Similarly to KC results, surface expression of adhesion molecules ICAM-1 and VCAM-1 were 
not enhanced following H2O2 treatment. In contrast VCAM-1 expression tended to be 
reduced at higher H2O2 concentrations, for example the MFI was 19 4.4 vs. 14 2.2 in the 
absence or presence of 250M H2O2 (data not shown). Cell surface expression of ICAM-1 
and VCAM-1 was also assessed after Nx (24 or 30 h) or Hx +/- 6 h Rx. As expected, there was 
an increase in ICAM-1 expression on cells exposed to Hx compared with those incubated in 
Nx conditions (Figure 7.6A). By contrast, VCAM-1 expression appeared to be unaltered by Hx 
(Figure 7.6B). Similarly to experiments assessing cytokine levels, 6 h reoxygenation had no 
significant impact on ICAM-1 or VCAM-1 expression. 
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Figure 7.6 Influence of Hx/Rx on adhesion molecule expression on MLE cells: (A) ICAM-1 and (B) 
VCAM-1. N=3; *p<0.05 vs. untreated control. 
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Since oxidative stress (H2O2) alone produced negligible effect on inflammatory gene 
expression in MLE cells, we explored the possibility that oxidative stress would potentiate 
cytokine-induced inflammatory gene expression. Cells were initially exposed to increasing 
concentrations of TNFα alone (5 h), which served as a positive control 192. We found that 
TNFα significantly increased KC release in a concentration dependent manner, where 
treatment with 1 and 10ng/ml TNFα resulted in the release of 433 and 1348pg/ml KC (3-fold 
increase) (Figure 7.7A). TNFα was also found to induce a significant concentration-
dependent increase in both ICAM-1 and VCAM-1 cell surface expression (Figure 7.7 B+C, 
respectively). Results indicate that MLE cells do have the capacity to upregulate KC release 
and adhesion molecule expression in these stress conditions. 
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Figure 7.7 The concentration-dependent 
effect of TNFα (5 h) on inflammatory 
gene expression: (A) release of KC and (B 
+ C) expression of adhesion molecules 
ICAM-1 and VCAM-1, respectively. N=3; 
*p<0.05 vs. untreated control. 
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Investigation into the influence of oxidative stress (H2O2) on cells exposed to TNFα (1ng/ml) 
revealed that increasing concentrations of H2O2 had no significant effect on TNFα-induced 
increase in KC release, as illustrated in Figure 7.8.  
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Similarly, there was no evidence of potentiation by H2O2 of TNFα-induced adhesion 
molecule expression. To the contrary, exposure of cells to higher concentrations of H2O2 led 
to a significant decrease in TNFα-stimulated ICAM-1 and VCAM-1 cell surface expression 
(Figure 7.9 A + B, respectively). For instance, exposure of cells to 250M H2O2 resulted in a 
17% and 50% reduction in TNFα-induced ICAM-1 and VCAM-1 upregulation, respectively. 
 
Figure 7.8 Impact of oxidative stress (H2O2) on TNFα (1ng/ml)-induced KC release. N=3. 
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Figure 7.9 Impact of oxidative stress (H2O2) on TNFα (1ng/ml)-induced adhesion molecule 
upregulation: (A) ICAM-1 and (B) VCAM-1 expression. N=3; *p<0.05 vs. untreated control (in the 
absence of H2O2). 
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Influence of EA exposure on inflammatory gene expression 
Ultimately we wanted to explore the impact of GST activity attenuation on the inflammatory 
gene expression of stressed cells. Thus we investigated the influence of GST inhibitor EA 
alone or in combination with TNFα (1ng/ml) on specific aspects of the inflammatory 
response in MLE cells. EA alone, at 25M, induced a 2-fold increase in KC release, and at 
10M enhanced TNFα-induced KC release by 40%, however neither of these changes was 
found to be significant (Figure 7.10).  
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Interestingly, the presence of 10M EA significantly increased both ICAM-1 and VCAM-1 cell 
surface expression from 9.4 1.2 to 15.3 1.7 MFI and 27.0 3.6 to 35.2 4.9 MFI, 
respectively (Figure 7.11 A + B). At the same concentration, EA also enhanced VCAM-1 (but 
not ICAM-1) expression induced by TNFα, by 30% (from 107 5 to 140 18 MFI) as 
compared to cells exposed to TNFα alone, in the absence of EA. In all experiments, EA (at 
increasing concentrations) appears to induce a biphasic induction of inflammatory gene 
expression with the largest response following exposure to 10M of the GST inhibitor. 
Figure 7.10 Impact of EA on TNFα (1ng/ml)–induced release of KC. N=3. 
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Figure 7.11 Impact of EA on TNFα (1ng/ml)–induced adhesion molecule expression. (A) ICAM-1 and 
(B) VCAM-1 expression. N=3; *p<0.05 vs. untreated control (in the absence of EA). 
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7.5 DISCUSSION 
 
7.5.1 Potential mediators of EA-induced cell death 
In order to further characterise the cell death induced by EA, we investigated the impact of 
signalling molecule inhibition on EA-induced cytotoxicity. We hypothesised that inhibition of 
redox signalling molecules p38, ERK and PI3K would attenuate cellular injury induced by GST 
inhibition. It appeared that the presence of p38 inhibitors heightened EA-induced cell injury. 
This would suggest that p38 plays a protective role in cellular response to GST attenuation. 
However such changes were not significant and the inhibitors themselves caused a small 
degree of basal toxicity. It is important to note that in addition to the well-characterized role 
of p38 in the induction of cell death, recent studies have suggested that this signalling 
pathway also contributes to cell survival and the regulation of cell cycle checkpoints 373. This 
may explain why these inhibitors were slightly toxic to cells maintained in physiological 
conditions over 5 h. Pharmacological inhibition of ERK and PI3K, had no effect on viability of 
cells exposed to EA, thus it is unlikely that these specific redox-sensitive molecules are 
involved in modulating cell injury or survival during GST inhibition. 
 
Recent developments have suggested that the interaction between oxidised lipids, toll-like 
receptor (specifically TLR4) and downstream signalling targets (including NFB) is a key 
signalling pathway that controls the severity of acid- and virus-induced ALI 374. To investigate 
whether a similar mechanism occurs following GST inhibition, cells were pre-incubated with 
MG132, a selective inhibitor of the NFB, before exposure to increasing concentrations of 
EA. We found that attenuation of NFB had no significant effect on EA-induced cytotoxicity, 
suggesting that this major redox-sensitive transcription factor is not a mediator of GST 
inhibitor-induced cell death. However, it is difficult to make solid conclusions on the basis of 
these inhibitor experiments. For instance, we have not confirmed the precise efficiency of 
these inhibitors. Nevertheless these inhibitors are widely used in the literature. 
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7.5.2 Impact of GST attenuation on the activation of p38 and NFB 
We postulated that GST attenuation may activate common signalling molecules such as p38 
and the transcription factor NFB. Investigation into this revealed that EA alone resulted in a 
small increase in p38 phosphorylation. By contrast H2O2, used as a positive control, induced 
significant phosphorylation of p38 within 20 min. Interestingly, the presence of EA enhanced 
H2O2-induced activation of p38. These data could imply that accumulation of secondary 
oxidative stress products (as a result of GST inhibition) lends to the activation of members of 
the MAPK family. 
 
In addition to its role in cell survival and death pathways, p38 activation can also be involved 
in mediating transcription of pro/anti-inflammatory genes, via activation of downstream 
transcription factors, such as NFB. As expected, we found that H2O2 increased levels of 
phosphorylated p65 by approximately 4-fold within 20 min, however EA appeared to have 
no effect on p65 phosphorylation in any of the three independent experiments carried out. 
Moreover, EA attenuated H2O2-induced increase in p65 phosphorylation in a time-
dependent manner. This suggests that exposure of cells to EA has an inhibitory effect on 
NFB activation. Such findings are substantiated by evidence that ROS, such as 4-HNE, have 
been found to inhibit IKK activity through direct oxidation, S-glutathionylation, or S-
nitrosylation 375. As a result NFB remains bound to IB and is unable to translocate to the 
nucleus to initiate transcription. Another study reported that oxidative stress can inhibit 
NFB activation, by oxidising sulphydryl groups on the p65 and p50 subunits and therefore 
attenuating levels of phosphorylated subunits 367. In summary, exposure of cells to higher 
concentrations of EA over a shorter period of time may lead to a significant increase in 
oxidative stress (especially in the presence of H2O2) and consequently reduced NFB 
transactivation. Further experiments would be required to investigate these issues.  
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7.5.3 Inflammatory gene expression 
While EA appeared to inhibit NFB activation, EA-induced oxidative stress may activate 
additional redox-sensitive signalling pathways such as: JNK-GST which could affect other 
downstream transcription factors such as AP-1 and HIF-1α. Moreover, EA-induced ROS may 
directly modify a number of transcription factors and/or regulate gene expression through 
modulation of chromatin remodelling. For instance, histone deacetylase, which drives high-
affinity binding between the histones and DNA thus preventing transcription, was recently 
found to be redox-sensitive and is inhibited under oxidative stress conditions 369. Such 
modifications could lead to an upregulation of genes coding for ‘cell death’ and 
‘inflammatory’ products. Thus, we proceeded to investigate the potential role of GST in the 
inflammatory gene expression of MLE cells. 
 
Influence of oxidative stress 
Many inflammatory genes have NFB binding sites in their promoter/enhancer sequence 
and gel-mobility shift assays revealed NFB binding to such sequences is induced by stress 
such as H2O2. Thus, we expected cytokine production and adhesion molecule expression to 
increase following exposure of MLE cells to oxidative stressors H2O2 or Hx alone. In contrast 
to our hypothesis, despite rapid phosphorylation of p38 and significant activation of NFB 
following H2O2 treatment, neither cytokine nor adhesion molecule expression was 
increased. This finding contradicts the widely held view regarding the role of oxidative stress 
in NFB-related inflammatory gene regulation. However, it appears that this view is highly 
dependent on the downstream inflammatory mediators being investigated and on the 
specific cell type in question. For instance constitutive expression of ICAM-1 and VCAM-1 
are important for cell migration and are clearly upregulated in endothelial cells in response 
to stress (such as LPS, ROS), yet the epithelial cell response may differ from that of 
endothelial cells and leukocytes. While there is evidence that adhesion molecules are 
upregulated significantly on epithelial cells exposed to hypoxia, following TNFα release by 
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macrophages (in in vitro conditions), studies have generally failed to demonstrate an 
upregulation of adhesion molecules on alveolar epithelial cells following H2O2 treatment 
376. 
In addition, the increasingly appreciated dual regulatory role of NFB can result in either 
induced or attenuated gene expression. Thus it is possible that while NFB was significantly 
activated after 60 min H2O2, prolonged exposure (5 h) to such stress may have led to its 
inhibition. It is also possible that the observed activation of NFB resulted in the 
upregulation of other inflammatory/cell survival genes which were not assessed in our 
study. 
 
As anticipated, KC release was significantly upregulated after 24 h Hx, which was also found 
to significantly upregulate ICAM-1 (but not VCAM-1) expression indicating the action of 
specific hypoxia-mediated intracellular signalling pathways. This suggests that oxidative 
stress experienced during Hx is able to modulate the expression of inflammatory genes such 
as those coding for specific cytokines and adhesion molecules. The involvement of specific 
signalling molecules and transcription factors in Hx and H2O2-induced oxidative stress would 
require further investigation but this is beyond the scope of my project.  
 
Impact of stress (H2O2) or attenuated GST (EA) on cellular response to TNFα  
Despite minimal inflammatory gene expression following oxidative stress treatments, we 
were able to demonstrate that MLE cells, in our experimental conditions, were very 
responsive to the inflammatory stimulus TNFα. This positive control alone induced a high 
level of gene transcription in a concentration-dependent manner. However against this 
background, (oxidative stress and) GST inhibition failed to produce effective inflammatory 
gene upregulation, which may be due to a number of factors. As discussed earlier, this lack 
of inflammatory response may be related to excessive ROS accumulation and subsequent 
NFB inhibition. (For instance, H2O2 at increasing concentrations led to a decrease in TNFα-
induced increase in ICAM and VCAM expression). It is also possible that cell injury in 
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response to increased intracellular stress, may deplete intracellular energy stores required 
to drive processes involved in gene upregulation. Alternatively, prolonged treatment may 
induce shedding of adhesion molecules. This would be in line with other studies which state 
that oxidative stress triggers enzymatic shedding of adhesion molecules such as ICAM-1 377.  
 
Although there was some evidence that the presence of EA activated intracellular signalling, 
in terms of p38, it was found to generally inhibit rather than activate NFB, which may 
explain the small increase in inflammatory gene expression. However, EA did appear to 
significantly enhance TNFα-induced upregulation of VCAM. This suggests that GST inhibition 
and subsequent accumulation of GST substrates may be involved in at least one arm of the 
inflammatory response. It is also important to consider that epithelial-leukocyte interaction, 
which is lacking in our experimental model, plays a key role in the induction of inflammatory 
gene expression. This has been reported by Sharma et al., who demonstrated that alveolar 
type II cells, in conjunction with alveolar macrophage-produced TNFα, contribute to the 
initiation of acute pulmonary IRI via a pro-inflammatory cascade 280. Therefore, it is possible 
that oxidative stress, resulting from (H2O2 or) GST inhibition may modulate inflammatory 
gene expression to a greater extent in this setting. 
 
In summary, neither p38 nor NFB are mediators of EA-induced cytotoxicity, which 
contradicts expectations but supports the bifurcated nature of such pathways in different 
oxidative environments. We demonstrated that the GST inhibitor induced p38 activation, 
but attenuated that of NFB, especially in the presence of H2O2. Such NFB inhibition may 
be responsible for the lack of significant KC upregulation and small increases seen in ICAM-1 
and VCAM-1 expression following exposure of cells to EA alone or in combination with 
TNFα. Further investigation into the role of GSTs and their substrates in inflammatory gene 
expression was carried out following specific GST isoform attenuation (using siRNA 
technology) in Hx/Rx. This will be discussed in detail in Chapter 8. 
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Chapter 8: 
POST-TRANSCRIPTIONAL 
GST INHIBITION 
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SUMMARY 
Clinical studies have highlighted an association between GST (in particular  and ) 
polymorphisms and an individual’s outcome of and susceptibility to ALI 378. For instance, 
Moradi et al. observed that the GSTM1 polymorphism was associated with increased 
mortality in critically ill patients with ALI/ARDS.  It has also been suggested that donor GST 
null and GST Ile105 genotypes dramatically increased  the development of PGD following 
lung transplantation 7. On this basis we hypothesised that GST activity is a major 
determinant of the survival response to oxidative stress in lung epithelial cells and thus the 
severity and outcome of ALI. We have attempted to reproduce GST polymorphisms through 
attenuation of GST expression with pharmacological inhibitors, EA and CA. As reported in 
Chapter 4, we found that subtoxic concentrations of such GST inhibitors render various cell 
types more susceptible to stress.  
 
In this chapter we wanted to expand our studies beyond global pharmacological GST 
inhibition and explore the role of individual GST isoforms in stress. In particular, we focussed 
on polymorphisms that are implicated in the development and susceptibility to various 
inflammatory lung disorders. RNA interference (RNAi) technique was used to attenuate GST 
 (M1) and  (P1) expression in MLE cells. The efficiency of RNAi was assessed by 
complementary means, including siRNA-mediated RNA and protein knockdown, and 
inhibition of GST activity. Selective and efficient knockdown (> 85%) of GST and GST RNA 
was achieved and at 48 h post-transfection protein expression was not detected. Global GST 
activity was found to be significantly reduced after GST siRNA transfection, however this 
had no effect on the viability of cells in physiological or stressed conditions. In contrast, GST 
siRNA transfection did not affect overall GST activity, yet was found to reduce cell viability in 
normal conditions and enhanced stress-induced injury. The impact of specific GST  and  
attenuation on inflammatory gene expression in cells exposed to Hx, was also investigated. 
While 24 h Hx induced an increase in KC release, this was unaffected by GST knockdown. 
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ICAM expression was also higher following Hx particularly in cells with attenuated GST. 
Conversely, VCAM expression was not affected by either Hx or specific GST isoform 
knockdown. Thus it is likely that alternate intracellular pathways are responsible for VCAM 
and ICAM upregulation in stressed conditions.  
 
These observations highlight the specific importance of the GST isoform in the survival of 
and inflammatory expression in mouse lung epithelial cells exposed to both physiological 
conditions and two independent stresses. These findings may have important implications in 
clinical ALI syndromes. 
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8.1 BACKGROUND 
Individuals vary in their ability to withstand oxidative stress, perhaps primarily as a result of 
differences in the activities of antioxidant enzymes such as GSTs, which form part of a 
complex system of cell defences against toxins and oxidation. Recent evidence suggests that 
genetic polymorphisms (arising from single base pair changes or entire deletion of genes) of 
these cytoprotective enzymes influence the development of and predisposition to many 
diverse diseases 379. Clinical associations between GSTM1 and P1 polymorphisms specifically 
and various acute and chronic lung pathologies have been recently reported, as discussed in 
1.7 of the General Introduction. In brief, some polymorphisms (for example that of the 
GSTM1 gene) can result in a null allele, with no formation of the enzyme product. 
Individuals that are "double-null" homozygotes for GSTM1 are associated with increased 
frequencies in several pathologies including decreased childhood lung function 380, 
increased childhood respiratory infections 381 and childhood bronchial asthma 382. 
Alternatively, genetic variance can arise from a base substitution for example a common 
GSTP1 polymorphism occurs at codon 105 which encodes either a ile or val (ile105val) 
amino acid. This variance resides within the enzymatic cleft and influences the efficiency of 
the enzyme activity. Although the data remains conflicting regarding the enzymatic 
efficiency of these variants, mounting evidence suggests that individuals exhibiting the GST 
Val105 isoform have decreased ROS clearance and increased tissue injury. This could 
therefore be a key contributor towards decreased lung function and increased risk or 
severity of respiratory pathologies such as infections, asthma, COPD and ALI 265,269,272,381.  
 
It appears that molecular epidemiological data support the view that allelism in specific GST 
genes mediates susceptibility to and outcome of different diseases. While the exact 
mechanisms underlying these effects remain unclear, the apparently diverse range of 
pathologies influenced by these polymorphisms suggests that these specific GST enzymes 
influence biochemical pathways that are common to many cells. Better understanding of 
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such mechanisms and effects should enhance our understanding of these disease processes 
and possibly highlight potential treatment strategies. In light of these recent studies, we 
hypothesised that attenuated levels of specific GST isoforms (as is the case in patients with 
GST polymorphisms) could enhance cellular response to stress in terms of both cellular 
death and inflammatory gene expression. 
 
 
8.2 AIMS 
My overall objective of this chapter was to determine whether the specific GST isoforms  
and  are involved in mediating cellular response to stress.  
 
In order to investigate this, we wanted to: 
 
a) establish in vitro models of GST  and  knockdown using siRNA targeting specific 
GST isoforms, and optimise the RNAi protocol to ensure efficient knockdown while 
minimising cytotoxicity; 
 
b) explore the impact of specific GST isoform attenuation on viability and inflammatory 
gene expression of cells maintained under normal conditions. This was achieved by 
assessment of: mitochondrial activity as an index of cell viability (as described in 3.6) 
and gene expression of cytokine KC and cell adhesion molecules (as described in 
Chapter 7); and 
 
c) explore the influence of specific GST isoform attenuation on the viability and 
inflammatory response of cells exposed to stress models of IR, as described in 
Chapter 4. These included: chemical oxidative stress H2O2 and Hx/Rx. 
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8.3 PROTOCOLS 
 
8.3.1 RNA interference (RNAi) considerations 
The role of specific GST isoforms in cellular response to stress was investigated following 
post-transcriptional attenuation of GST  and  by RNAi. As described in Chapter 2.2: 
Project design, this process involves delivery of double-stranded small interfering RNA 
molecules (siRNAs) of approximately 20-25 base pairs into the cell. In brief, complementary 
pairing of siRNA with target mRNA mediates its cleavage and thus the mRNA can no longer 
be translated into protein. Hence the RNAi process leads to sequence-specific, post-
transcriptional gene-silencing. A number of factors were considered prior to siRNA 
transfection and explored fully to ensure successful siRNA-induced gene silencing:  
 
Target sequence selection and siRNA design 
In contrast to the five GST isoforms present in human tissues, there are seven -class GSTs 
in the mouse. A study carried out by Mitchell et al. in 1997, reported that the GSTM1 
isoenzyme was the major GST expressed in lung, forming approximately 44% of soluble GSTs 
383, as opposed to 15% made up by GSTM2. Since the former isoenzyme is more abundant 
and also appears to be more documented in the literature, we decided to silence GSTM1 in 
MLE cells. The  class GST is the most ubiquitous of the human GST family, and is 
abundantly expressed in the lung. While human tissues express a single isoenzyme of GST, 
there are two GST genes (P1 and P2) in mice, found on chromosome 19. We chose to 
target GSTP1 as it is the more catalytically active isoenzyme 384 and makes up approximately 
20% of soluble pulmonary GSTs, while GSTP2 is expressed at relatively low levels.  
 
We chose to use ON-TARGETplus siRNA in the scrambled (control), M1 and P1 forms. Each 
of these comprise of a mixture of four siRNAs within a single reagent, providing advantages 
in both potency and specificity, which in turn optimise silencing. As such, this siRNA is 
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guaranteed to silence the gene of interest by >75% while reducing off-target effects that 
may lead to toxicity or false phenotypes.  
 
Optimal delivery techniques 
Common approaches for RNAi delivery are viral (adeno-associated virus and lentivirus), non-
viral lipid/polymer-based (Effectene, SuperFect and Lipofectamine 2000) and physical 
(particle-mediated gene transfer (PMGF)) methods. Their respective merits and difficulties 
have been well documented 385-387. Since we were interested in transient knockdown of 
specific GST isoforms (<7 days) and MLEs are a fast-growing, robust and adherent cell line, it 
was recommended that we use the lipid-mediated transfection reagent Lipofectamine 2000. 
Furthermore, previous studies have reported that siRNA transfection of MLEs using 
Lipofectamine has been more successful than that mediated by adeno-associated viral 
transfer or PMGF 388. Prior to transfection with GST siRNA, preliminary studies were carried 
out with green-fluorescent protein (GFP)-linked DNA plasmid to explore the level of 
transfection efficiency of MLE cells. The degree of transfection was then visualised using UV 
microscopy and such data suggested that lipofectamine-mediated delivery of siRNA would 
be suitable for this lung epithelial cell line.  
 
In addition to a high transfection efficiency is important to assess the injury induced by the 
chosen transfection reagent as many have been found to cause cytotoxicity 389. Minimizing 
such cytotoxicity is essential for accurate interpretation of RNAi experiment results, as 
cytotoxic effects might be difficult to distinguish from a phenotype resulting from target 
gene knockdown. Many studies have reported a relatively low level of cytotoxicity following 
lipofectamine-mediated transfection. We also carried out preliminary optimisation 
experiments in an attempt to achieve the highest level of gene-silencing while using low 
levels of transfection reagent. 
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Appropriate controls 
We decided that the most suitable control for our experiments was siRNA transfection with 
non-specific (scrambled) siRNAs, complexed with lipofectamine. Studies have previously 
shown that transfection with this control siRNA resulted in no discernible reduction in the 
protein levels of 22 target proteins tested, suggesting no off-target effects 390. However, it 
was important to replicate the process of transfection with both siRNA and lipofectamine in 
control cells. 
 
8.3.2 SiRNA transfection protocol  
In light of the above, our protocol was optimised in preliminary experiments (where 
concentrations of siRNA and lipofectamine, and the length of incubations were varied) to 
ensure maximum GST knockdown whilst minimising cytotoxicity caused by transfection. 
MLE cells, seeded in 24-well plates, were transfected upon reaching 30-40% confluency. 
Immediately prior to transfection, existing media was removed, wells were washed with 
DPBS and 400l of pre-warmed media was placed in each well. This media was free of 
serum (FCS) and antibiotics (PSG) and was used in the initial transfection steps to maximise 
transfection efficiency.  
 
The siRNA was then delivered using Lipofectamine 2000 vector system in accordance with 
the manufacturer’s protocol. In brief, for each well of cells transfected, 20pmol of either 
scrambled, GSTM1 or GSTP1 siRNA (resuspended in RNAase free water) and 1l 
lipofectamine were separately diluted in 50l DMEM/F-12 media (free of FCS and PSG) and 
incubated for 5 min. The lipofectamine solution was then added to each siRNA solution in a 
1:1 ratio, and incubated for a further 30 min. Subsequently, 100l of each solution was 
added to appropriate wells. The siRNA-lipofectamine media was removed 5 h later, each 
well was washed with DPBS and 400l complete fresh media were added. Following 48 or 
72 h incubation at 37°C, cells were either collected to investigate knockdown efficiency or 
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used for experiments. All experiments comprised of cells which were: non-transfected (i.e. 
incubated in media which lacked siRNA and lipofectamine) which served as inter-
experimental controls; transfected with scrambled siRNA (plus lipofectamine) to account for 
any off-target effects; or transfected with GSTM1 and/or P1 siRNA.  
 
8.3.3 Determination of knockdown efficiency 
In order to determine the efficiency of siRNA-mediated GST knockdown, both RNA and 
protein expression of GSTs were monitored 48 and 72 h post-transfection. GST activity was 
also measured following transfection with GST  or  siRNA, alone or combined.  
 
RNA knockdown: Polymerase Chain Reaction (PCR) 
Reverse transcriptase quantitative (or real-time) polymerase chain reaction (RT-qPCR) is an 
accurate and efficient way of assessing mRNA levels of specific genes. It involves the 
exponential amplification of specific short DNA sequences (usually 100 to 600 bases in 
length) within a longer double stranded DNA molecule and the continuous monitoring of 
fluorophore fluorescence during the generation of PCR products. In brief, TaqMan qPCR 
exploits the 5'-3' exonuclease activity of Taq polymerase to hydrolyze an oligonucleotide 
that is hybridized to the target amplicon, as first described by Holland et al. in 1991 391. The 
reaction requires an appropriate buffer and TaqMan probes, which are oligonucleotides 
designed to hybridize to an internal region of the target PCR product. They have a 
fluorescent reporter dye (eg. FAM or VIC) attached to the 5' end and a quencher moiety 
coupled to the 3' end. When the probe is intact, the fluorescence emission of the reporter 
dye is quenched due to its physical proximity to the quencher moiety, a phenomenon 
referred to as Förster-type energy transfer (FRET) 392, thus preventing the detection of 
fluorescent signal from the probe. During PCR, the TaqMan probe anneals specifically to a 
complementary sequence between the forward and reverse primer sites on the target DNA 
sequence, as shown in Figure 8.1.  
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In the extension phase of PCR, the 5' exonuclease activity of Taq polymerase hydrolyzes the 
TaqMan probe, cleaving the reporter from the quencher. This separation decouples the 
fluorescent and quenching dyes, preventing FRET and thus the fluorescence increase/cycle 
(measured by a laser-based instrument system) is proportional to the amount of probe 
cleaved. Therefore, a major advantage of this technique is its ability to quantify, in real time, 
the PCR amplicons produced in each sample/cycle as the reaction proceeds. Furthermore 
very small quantities of target nucleic acid are required at the start of qPCR and data 
analysis is performed automatically in the absence of user intervention.  
 
In order to carry out RT-qPCR we initially extracted cellular RNA, performed reverse 
transcription (synthesising cDNA from RNA) and amplified the target cDNA sequence as 
described briefly in 3.4: Materials & Methods. This chapter contains a more detailed 
protocol of these steps.  
Figure 8.1 PCR amplification process using the inherent 5 exonuclease activity of Taq polymerase 
(Image taken from e-oligos.com, Gene Link, USA) 
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RNA extraction 
Total RNA was isolated from transfected cells using an RNeasy Mini kit. In brief, cell samples 
were lysed with a buffer containing guanidinium isothiocyanate and β-mercaptoethanol, 
temporary and irreversible reducing agents, respectively. These denature RNases by 
reducing disulfide bonds and destroying the native conformation required for enzyme 
functionality. Cell lysates were then loaded into a QIAshredder homogenizer, placed in a 
collection tube and centrifuged at 1300rpm for 2 min. Ethanol (70%) was added to the 
homogenized lysates (to provide ideal binding conditions) and loaded onto the RNeasy silica 
membrane within the ‘spin column’ allowing RNA binding. To minimise DNAse 
contamination, each sample was incubated with DNase solution for 15 min. The columns 
were washed with buffer to remove contaminants and 30l of RNase-free water was used 
to elute a concentrated RNA sample, free of genomic DNA. RNA extracts were stored at -
80°C until further use to avoid degradation. Care was taken throughout the procedure to 
ensure that an RNAse-free (and in later steps a DNAse-free) environment was maintained. 
 
Reverse transcription 
Following quantification of RNA (using spectrophotometry at 260nm), single-stranded cDNA 
was synthesized from 2g RNA using TaqMan RT-PCR kit reagents listed in Table 3.1.  
 
Master Mix reagents Volume (µl) Final concentration 
10X TaqMan RT Buffer 1.0 1X 
MgCl2 (25mM) 2.2 5.5mM 
dNTP Mixture 2.0 500µM/dNTPs 
Random Hexamers (50 μM) 0.5 2.5µM 
RNase Inhibitor (20 U/μl) 0.2 0.4U/µl 
Reverse Transcriptase (50 U/μl) 0.625 1.25U/µl 
RNA extract*  - 2.0µg 
RNase-free water* - (up to 10µl)  
 
 
Table 8.1 Master mix reagents included in the TaqMan Reverse Transcriptase-PCR kit. The table 
includes the volumes required for reverse transcription of a single RNA extract (to give a total 
volume of 10µl reaction) and the final concentration of each component. Components (*) were 
added at the end. 
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A master mix was made with these reagents and the volume of each was adjusted to the 
number of RNA extracts. It was then vortexed and aliquoted into MicroAmp Optical tubes at 
6.525µl/tube, after which RNA extract (2µg) and an appropriate volume of RNase-free water 
was added to make a total of 10µl/tube. The samples were run through the following 
thermal cycler parameters: 25°C for 10 min (to aid primer-RNA template binding), 48°C for 
30 min (to stimulate reverse transcription) and 95°C for 5 min (to inactivate reverse 
transcriptase). All cDNA samples were vortexed and stored at -20°C. 
 
Real-time/Quantitative Polymerase Chain Reaction (qPCR) 
Amplification of cDNA was carried out using the TaqMan Gene Expression Master Mix, 
containing DNA polymerase, oligonucleotides, the enzyme uracil DNA glycosylase (UDG) (to 
prevent contamination of carryover PCR product), MgCl2 (to ensure efficient polymerase 
and primer DNA-binding), and forward/reverse primers. We used FAM-linked TaqMan 
probes Mm00833915_g1 and Mm00496606_m1, targeted against mouse GSTM1 and P1, 
respectively. These were added to separate PCR Master Mixes as shown in Table 8.2. 
Eukaryotic 18S rRNA probe was also employed as an internal control. 
 
 Components of PCR Master Mix 
 
 
Volume (µl) 
2X TaqMan Master Mix 10 
Target TaqMan probe (for either: GSTm1/p1/DNA plasmid) 1  
18S rRNA TaqMan probe 1 
Water 7 
*cDNA sample/ DNA Plasmid / water 1 
TOTAL 20µl 
 
 
 
Table 8.2 Components of TaqMan Polymerase Chain Reaction master mix (20µl per sample). (*) 
were not incorporated into the master mix but were added to the appropriate tubes immediately 
prior to PCR. 
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The PCR master mix was vortexed and aliquoted into MicroAmp Optical tubes (19µl/tube) 
and 1µl of cDNA samples, DNA plasmid (as positive control) or water (as negative control) 
was then added to appropriate master mix solutions. Tubes were inserted into the PCR 
machine and the following thermal cycling conditions were employed: initial 2 min at 50°C 
to ensure optimal UDG enzyme activity, followed by 10 min at 95°C required to activate the 
DNA polymerase. Thereafter, 40 cycles of denaturation (15 s at 95°C), and annealing 
/extension (1 min at 60°C) were carried out.  
 
Data was collected using the ABI PRISM 7700 and Sequence Detection System (SDS) 1.9.1 
and qPCR data was presented as fluorescence plotted against the number of cycles. Results 
were analysed, as described in Chapter 3.4 and shown on an amplification plot, similar to 
that represented in Figure 3.1. Relative quantification of target cDNA was performed using 
the comparative cycle threshold (CT) method. The CT value of the target cDNA was 
normalised against that of the 18S rRNA (the internal standard) of the equivalent sample, as 
described 290. Data from independent experiments were standardised to their respective 
non-transfected control. All data were then collated and presented as mean + sd. 
 
Protein knockdown: Western Blotting 
The stability and basal expression of proteins are variable, and in combination determine a 
protein’s turnover rate. Therefore, as well as measuring the degree of RNA knockdown 48 h 
after siRNA transfection, it was important for us to identify the time at which protein 
expression was also sufficiently attenuated. In light of this, we incubated cells for 48 or 72 h 
following transfection – periods often used to achieve maximum gene silencing. Protein-rich 
cell lysates were then extracted and expression of GST was analysed by western blotting as 
described in 3.5 of Materials & Methods. We also intended to assess the level of GST 
protein expression however as discussed in Chapter 4.5, GST in MLE cells (in contrast to 
that in A549 cells) was not detected with the antibodies purchased.  
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Activity knockdown: GST activity assay 
Global GST activity was also measured, 48 and 72 h after transfection with GST  or  siRNA, 
alone or combined, using the GST activity assay as described in 3.3: Materials & Methods. 
 
8.3.4 Influence of specific GST protein knockdown on cellular response to stress 
Having explored the above factors, we went on to study the impact of specific GST isoform 
attenuation in cells maintained in normal conditions and those exposed to oxidative stress. 
As described above, cells were either non-transfected or transfected with scrambled, GST 
or GST siRNA, alone or in combination. Following 48 h, media was replaced and cells were 
exposed to either: 
 
- H2O2 at increasing concentrations (0.5 and 1mM) for 5 h; or  
- Hypoxia (24 h) followed by reoxygenation (6 h) (Hx/Rx), as described in Chapter 4.3. 
 
In line with studies carried out with GST inhibitor EA, we investigated two major cellular 
responses to stress following siRNA knockdown. These included: (i) cell injury using the MTT 
assay (as described 4.3), and (ii) inflammatory gene expression of chemokine KC and 
adhesion molecules ICAM-1 and VCAM-1, by means of ELISA analysis and flow cytometry, 
respectively (as described 7.3). The results from repeated experiments were standardised to 
the data from non-transfected cells (to account for variation in cell number between 
experiments). Data from all experiments were then collated and are presented as mean + 
sd, relative to cells transfected with scrambled siRNA (which served as the transfection 
control). 
 
 239 
8.4 RESULTS 
 
8.4.1 Efficacy of siRNA-mediated GST knockdown 
 
GST and  RNA expression  
Specific RNA expression was determined by qPCR 48 h post-transfection, where cells were 
either non-transfected (NT) or transfected (using lipofectamine) with scrambled, GST or 
GST siRNA. As illustrated in Figure 8.2, cells transfected with GST siRNA showed 87 ±4.2 % 
knockdown of GST RNA expression, while expression of GST was not significantly 
affected, as compared to that expressed in scrambled controls. Similarly, GST siRNA 
attenuated GST RNA expression by 90 ±2.9 %, but had no effect on GST RNA expression. 
These data demonstrate a high level of specific siRNA-mediated GST inhibition.   
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Figure 8.2 GST and  RNA expression, measured by RT-PCR 48 h after cell transfection. Cells were 
transfected with scrambled (black), GST (grey) or GST (white) siRNA.  N=4; *p<0.05 vs. scrambled 
control.   
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GSTM1 protein expression 
The impact of scrambled and GST siRNA transfection on the protein expression of GST, as 
compared to cells that were non-transfected, was evaluated by western blotting (Figure 
8.3). The estimated molecular weight (MW) of GST is 24kDa - strongly visible in lane 8 
containing mouse lung homogenate as a positive control. Equivalent protein bands are 
clearly seen in lanes 2, 3, 5 and 6 containing lysates from non-transfected (NT) or 
scrambled-siRNA transfected cells. However, such bands are absent in lanes 4 and 7 
containing lysates from cells that had been transfected with GST siRNA for 48 h or 72 h, 
respectively.  
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Figure 8.3 A representative western blot displaying GST (with MW of approx. 24kDa), 48 and 72 
h post-transfection (post-tx). Cells were either non-transfected (NT, in lanes 2 & 5) or transfected 
with scrambled siRNA (in lanes 3 & 6) or GST siRNA (in lanes 4 & 7). Expression of β-actin was also 
assessed (with MW of approx. 42kDa) as an internal loading control. N=3. 
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Quantitative analysis of the bands representing GST (at position 24kDa) in lanes 2 – 7, was 
carried out using GeneTools software. Figure 8.4 shows the level of intracellular GST 
protein (standardised to the level of β-actin) in cells transfected with scrambled or GST 
siRNA, as a percentage of that detected in non-transfected (NT) cells. At 48 h post-
transfection, GST protein was reduced by 86% in cells transfected with GST versus 
scrambled siRNA, compared to a reduction of 76% at 72 h post-transfection. These data 
confirm successful knockdown of GST at a protein level at 48 (and 72 h) post-transfection. 
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Global GST activity 
Preliminary studies investigating the global GST activity at 48 and 72 h post-siRNA 
transfection revealed similar results at the two time points. Since the 48 h time point 
appeared to attenuate both RNA and protein expression significantly, we specifically 
focussed on measuring GST activity at 48 h post-transfection.  
 
Figure 8.4 Quantification of intracellular GST protein at 48 and 72 h post-transfection (post-tx). 
Cells were either non-transfected (NT) or transfected with scrambled or GST siRNA. Densities of 
bands representing GST were standardised with those representing β-actin. Data from 
independent experiments (calculated as a percentage of non-transfected control) were collated. 
N=3; *p<0.05 vs. scrambled control. 
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We found that GSTM1 siRNA alone reduced GST activity from 28.2 ±5.2 to 10.1 ±3.2 
mUnits/mg of protein, achieving a 65% knockdown of global GST activity. By contrast, GSTP1 
siRNA alone had no effect on overall GST activity compared to that of cells transfected with 
scrambled siRNA.  
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Transfection with a combination of GST M1 and P1 siRNA, delivered at the same individual 
concentrations as prior experiments, was found to attenuate overall GST activity by 52%. 
Matched quantities of scrambled siRNA (indicated as ‘scr (x2)’) had very little effect on GST 
activity. 
 
8.4.2 Cellular injury resulting from specific GST isoform knockdown 
To test the hypothesis that GST and/or  inhibition impacts on cell survival, cells were 
transfected with GSTM1 and/or GSTP1 siRNA and their viability (as compared to those 
transfected with scrambled siRNA) was determined by the MTT assay.  
 
Figure 8.5 Global GST activity assessed 48 h after GST  and  siRNA transfection. Cells were 
transfected with either GSTM1 (grey) or P1 (white) siRNA alone or combined (grey+white) and their 
GST activity was compared with cells transfected with scrambled siRNA (black). N=4; *p<0.05 vs. 
scrambled control.    
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Under normal conditions, (in the absence of any further oxidative stress) individual 
knockdown of GST  and  reduced cell viability by 7.4% and 13.7%, respectively compared 
with cells transfected with scrambled siRNA. This is illustrated in Figure 8.6, in the absence 
of H2O2 treatment (0mM). Similarly, transfection of cells with both GST isoform siRNAs 
reduced viability by 7.2% however none of these changes were found to be significant. 
 
The influence of GST attenuation in stressed conditions was then evaluated in transfected 
cells exposed to either increasing concentrations of H2O2 or Hx/Rx. The pattern of cell 
viability following these various siRNA transfections was sustained in the presence of H2O2, 
whereby GST knockdown alone or in combination with GST knockdown led to a small and 
non-significant reduction in cell viability, as compared to cells transfected with scrambled 
siRNA (in single or double dose to serve as comparable controls). Interestingly GST siRNA-
transfected cells appeared to be more susceptible to stress-induced injury and displayed a 
significant reduction in cell viability of 26% and 42% after exposure to 0.5 and 1mM H2O2, 
respectively, compared with that of cells transfected with scrambled siRNA and exposed to 
equivalent concentrations of H2O2 (Figure 8.6).  
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Figure 8.6 Impact of GST  and/or  attenuation on H2O2-induced cell injury. N=4-6; *p<0.05 vs. 
cells transfected with scrambled siRNA and exposed to the same concentration of H2O2. 
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Similarly, a lack of GST in cells maintained in normoxic (Nx) conditions (incubated in media 
lacking FCS for 24 h) led to a small but significant 13% reduction in mitochondrial activity, 
while attenuation of GST had no such effect (Figure 8.7). As discussed in Chapter 4, MLE 
cells displayed tolerance towards Hx/Rx conditions. Interestingly siRNA-mediated 
attenuation of GST isoform resulted in a reduction in mitochondrial activity of 12.4 and 
19.8% in Hx and Hx/Rx conditions, as illustrated in Figure 8.7 A and B respectively, when 
compared to cells transfected with scrambled siRNA. Cells transfected with GST siRNA 
alone or together with GST siRNA also displayed reduced cell viability, yet these changes 
were not found to be statistically significant. 
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Figure 8.7 Influence of specific GST isoform attenuation on cellular response to Hx and Hx/Rx. 
48 h post-transfection, cells were exposed to: (A) 24 h of normoxia (Nx) or hypoxia (Hx) alone; 
and (B) Hx and 6 h reoxygenation (Hx/Rx). N=4; *p<0.05 vs. control cells transfected with 
scrambled siRNA. 
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8.4.3 Impact of GST knockdown on inflammatory gene expression 
The levels of cytokine KC released from transfected cells exposed to 24 h of Nx or Hx and 
those released following a subsequent 6 h of reoxygenation (Rx) are shown in Figure 8.8 A 
and B, respectively. Hx itself induced over 4 times greater KC expression in all siRNA 
knockdown groups when compared to that released in Nx (A). By contrast, there was no 
difference in cytokine levels released during the reoxygenation phase following Nx and Hx 
(B). While Hx treatment significantly upregulated KC, no significant differences were found 
between cells transfected with specific GST siRNAs and those with scrambled control siRNA. 
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Figure 8.8 Influence of GST  and  attenuation on cytokine release after exposure to Hx/Rx.    
(A) 24 h Nx or Hx alone, and (B) Nx or Hx in combination with 6 h reoxygenation (Hx/Rx) N=2. 
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Cell surface expression of ICAM-1 and VCAM-1 after 24 h Nx or Hx with/without 6 h Rx was 
also assessed by FACS. There was a small but significant increase in ICAM-1 expression on 
cells exposed to Hx compared with those incubated in Nx conditions (Figure 8.9A). A very 
similar increase in ICAM-1 was observed following Hx/Rx treatment (data not shown). 
Attenuation of GST isoform in cells exposed to either: Nx, Hx or Hx/Rx tended to increase 
levels of ICAM-1 expression compared to cells transfected with scrambled siRNA control, 
however these differences were small and not significant. VCAM-1 expression appeared to 
be unaltered in cells exposed to Hx compared to Nx (Figure 8.9B). Similarly to ICAM-1 
expression, GST knockdown appeared to increase VCAM-1 expression compared to cells 
transfected with scrambled siRNA, yet results were not significantly different. 
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 Figure 8.9 Influence of GST  and  attenuation on adhesion molecule expression after Hx (24 h). 
We specifically assessed: (A) ICAM-1 and (B) VCAM-1 expression. N=3. 
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8.4.5 Effects of siRNA-mediated GST knockdown vs. pharmacological GST attenuation 
Before moving onto the discussion of this chapter, I have presented the principal findings 
from siRNA experiments in a tabular format (Table 8.3) and made a comparison with those 
revealed following EA and CA-mediated GST attenuation. The latter results were fully 
described in Chapters 4 and 7. 
 
 
 
PHARMACOLOGICAL 
INHIBITORS 
SiRNA KNOCKDOWN 
EA CA GST GST GST  +  
Maximum 
attenuation of 
GST activity 
79%       
[0.1mM] 
35%          
[1mM] 
64.7% 3.7% 52.2% 
Potentiation of 
H2O2-induced 
cytotoxicity 
Yes         
[0.1mM] 
Yes      
[0.5mM] 
No                         Yes No 
Potentiation of 
Hx/Rx-induced 
cytotoxicity 
Yes         
[0.1mM] 
----- No Yes No 
Influence on 
inflammatory 
gene expression 
No effect on 
KC expression 
Induces ICAM 
& VCAM 
[<25uM] 
----- 
No 
significant 
effect 
No 
significant 
effect 
No 
significant 
effect 
 
Table 8.3 Principal in vitro findings following global GST attenuation by pharmacology (EA and 
CA) and specific GST isoform knockdown using siRNA. 
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8.5 DISCUSSION  
 
8.5.1 GST knockdown 
Knockdown of cellular RNA using siRNA has enabled researchers to perform loss-of-function 
experiments in a wide variety of cell types and model systems. However it must be 
appreciated that many factors may influence efficacy of knockdown such as: cell type, 
transfection reagent and siRNA target. There is evidence in the literature that MLE-12 cells 
have been successfully transfected with lipofectamine reagent 388,393. Furthermore, our 
preliminary studies, involving transfection of GFP-DNA plasmid using lipofectamine and 
visualisation of fluorescent cells using a fluorescence microscope, suggested a relatively high 
level of delivery. In terms of our siRNA targets, it is important to note that human and 
mouse GST isoforms (like many enzymes) are not homologous, therefore a direct correlation 
between GST  and  knockdown in humans and mouse is difficult 394. Not only does the 
number of isoenzymes within each isoform class vary between human and mouse, but also 
their specific roles and tissue distribution. Following careful consideration, we decided to 
specifically attenuate GSTM1 and P1, as discussed in 8.3. 
  
During preliminary experiments we found that the transfection procedure caused slight 
cytotoxicity, as is often documented 395. We therefore optimised our siRNA transfection 
protocol for MLE cells by adjusting: cell density/well, volume of media used during 
transfection, concentration of lipofectamine and time period of transfection. We also varied 
the incubation period proceeding siRNA transfection and assessed the RNA and protein 
expression of specific GST isoforms at 48 and 72 h post-transfection. Both GST  and  
mRNA were significantly knocked down, by >85%, at 48 h post-transfection. In addition, the 
levels of non-specific attenuation were very low, suggesting that the siRNAs and the 
TaqMan probes used in RT-qPCR were specific. GST protein expression, measured by 
western blotting, was also successfully attenuated at 48 h and to a lesser extent 72 h post 
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GST siRNA transfection. We also intended to assess GST protein knockdown, however 
were unable to identify GST in non-transfected MLE cell lysates (as illustrated in 4.4). This 
could be due to: poor specificity of primary antibody against mouse GST (in contrast to its 
high specificity towards human A549 cell GST), a relatively low abundance of GST in MLE 
cells; or compartmentalisation of GST for instance in the mitochondria or nucleus 317,396. In 
spite of this, collectively these RNA and protein expression data validated the use of these 
siRNAs in reducing both RNA and protein expression by 48 h post-transfection. 
 
Preliminary experiments found little difference in the extent of GST activity attenuation 
between 48 and 72 h post-transfection (data not shown) and as GST protein knockdown 
appeared to be more pronounced at 48 h post-transfection, we focussed on this time-point 
for all subsequent experiments. We found that GST siRNA knocks down the overall GST 
activity by over 65%. These results suggest that GSTM1 is the predominant cytosolic GST 
isoform in MLE cells. By contrast, GST siRNA appears to have no effect on global 
intracellular GST activity. It would be reasonable to conclude that GST isoform makes up a 
very small proportion of total intracellular cytosolic GST activity in MLE cells, which would 
correlate with the difficulty in detecting GST by western blotting. Another plausible 
explanation could relate to the compartmentalisation of GST as mentioned in the previous 
paragraph.  
 
Overall, I conclude that lipofectamine-mediated siRNA delivery into cells was effective and 
the knockdown of GST isoforms was specific, as observed in the case of RNA expression by 
PCR. Several siRNA studies and independent manufacturer’s guidelines report that protein 
knockdown generally occurs between 48 - 72 h after transfection. Our results suggest that 
GST RNA and protein expression are significantly attenuated by 48 h post-transfection, 
suggesting the rapid turnover of GST production. 
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8.5.2 Cellular injury 
We have demonstrated that attenuation of GST leads to a small but significant decrease in 
cell viability, suggesting that GST may play a key role in survival of cells in non-stressed 
conditions. We also found that these cells were more susceptible to stress-induced injury if 
exposed to H2O2 or Hx/Rx. These data are consistent with recent studies where exposure of 
intestinal adenocarcinoma cells to ROS-generating chemicals such as rotenone and 
antimycin A, decreased cell viability and reduced mitochondrial membrane potential. In 
these studies, the overexpression of GSTπ specifically diminished these changes, while GST 
π-targeting siRNA abolished the protective effect of GSTπ on the mitochondria under 
oxidative stress 396. Collectively, these results draw attention to the potential importance of 
GST in the protection of cells in stress conditions. 
 
Overexpression of GST has also been associated with transformation to malignancy 397 and 
acquired resistance to electrophilic anticancer drugs 398. This could be due to protection of 
cells against cytotoxic chemicals through detoxification with GSH, but also may stem from 
high intrinsic GST-mediated JNK inhibition allowing tumour cells to escape apoptosis 217. In 
our experiments, increased ROS may lead to increased GST–JNK disassociation, as reported 
previously 218, thus releasing JNK and allowing JNK-mediated responses such as cell death.  
Cells with GSTM1 null and GSTP1 polymorphisms are also unable to inhibit their respective 
apoptosis pathways (via ASK1 and JNK) 218,277,399. Therefore it is possible that siRNA-
mediated knockdown of GST could reduce JNK inhibition and render the cells more 
susceptible to H2O2-induced cell death.  
 
In contrast to GST knockdown, that of GST had no significant effect on cell viability. This is 
consistent with the finding that  knockdown does not alter breast cancer susceptibility 400. 
There may be multiple reasons why GST knockdown had no effect. There could be 
redundancy in the system, whereby other cytosolic GSTs provide sufficient antioxidant 
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capacity to protect cells. Alternatively the lack of GSTM1 may actively induce compensatory 
antioxidant mechanisms, through upregulation of other intracellular GSTs or other 
antioxidant proteins. However, the former is less likely, as siRNA-mediated knockdown of 
GST led to a significant attenuation of GST activity  by 48 h post-transfection. 
 
In both physiological and stressed conditions, a combination of GST and  knockdown 
resulted in less cytotoxicity than GST knockdown alone. This is difficult to explain as the 
concentration of each siRNA used in single or double transfections was equal. Moreover, in 
cells exposed to H2O2, comparable controls with double (x2) the scrambled siRNA had no 
influence on cell viabiliy (data not shown). The dampened effect of combined  and  
knockdown as compared to  knockdown alone, in terms of cytotoxicity, may be due to a 
finite quantity of siRNA being transported into the cell. As such, there may be a threshold 
level of siRNA that is capable of entering lipofectamine, thus cellular uptake of these siRNAs 
could be reduced, with combined as opposed to single siRNA exposure. Similarly, 
intracellular siRNA may compete to interact with the RNA-induced silencing complex (RISC). 
These could also explain how GST  and  transfection combined results in a reduced level 
of GST activity attenuation as compared with that achieved by GST  knockdown alone. 
 
8.5.3 Inflammatory gene expression (cytokine and adhesion molecules) 
Several studies have reported an upregulation of inflammatory cytokines upon exposure of 
cells to Hx. This is thought to be mediated by an increase in ROS that can activate NFB or 
HIF-1 which in turn can induce cytokine transcription as part of the inflammatory response 
401,402. Thus, we expected cytokine production to increase in cells exposed to Hx or Hx/Rx. In 
accordance to this, KC release increased after 24 h Hx. We also expected further KC release 
during reoxygenation, however this was not the case. GST knockdown had no further effect 
on cytokine release, suggesting that neither GST nor GST attenuation, in cells exposed to 
physiological or stressed conditions, modulate expression or release of cytokine KC. 
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Analysis of cell surface adhesion molecules following Hx revealed a small increase in ICAM-1 
but no change in VCAM-1 expression as compared to Nx controls. As discussed in Chapter 7, 
these data do not support the widely held view of redox regulation of adhesion molecule 
expression by redox-sensitive transcription factors 77,403,404. However, oxidative stress plays 
a dual role in NFB regulation, as oxidation of sulphydryl groups on the p65 and p50 
subunits reduces DNA binding ability 405. Alternatively, we may have underestimated 
adhesion molecule expression, as these may be shed during stressed conditions 406,407. It is 
also likely that complete inflammatory gene upregulation may require epithelial-leukocyte 
interaction and cross-talk between soluble molecules and pulmonary cells. For instance, 
alveolar macrophages producing TNFα have been shown to augment the baseline 
inflammatory response of MLE cells 280. The impact of specific GST isoform attenuation on 
adhesion molcule surface expression was small. Cells with GST knockdown tended to 
express increased levels of ICAM-1 in both physiological and stressed conditions, although 
this was more pronounced in those exposed to Hx. This suggests that GST substrates, 
which may accumulate in stressed conditions and in the event of GST attenuation, may be 
involved in the activation of transcription factor-mediated ICAM-1 upregulation, however 
these results are very preliminary. 
 
In summary, we have successfully achieved RNA and protein knockdown in both GST  and 
 isoforms by 48 h post-transfection. While global GST activity attenuation appeared to be 
relatively high following GST as compared to GST siRNA transfection, this may be due to 
lower levels of intracellular GST and/or its intra-organelle compartmentalisation. SiRNA-
mediated knockdown experiments revealed that GST specifically may play an important 
role in cell survival and protection in stressed conditions. Further studies would be required 
to fully understand the role of GST isoforms in inflammatory gene expression. 
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Chapter 9:  
INFLUENCE OF EA ON AN  
ISOLATED PERFUSED LUNG (IPL) 
MODEL 
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SUMMARY 
We have successfully investigated the role of GST in in vitro models of oxidative stress 
through the use of EA and CA and siRNA transfection. These studies have revealed that 
intracellular GST activity (perhaps specifically that of GST) is important in cell survival in 
both optimal and stressed conditions. To complement these cellular studies we initiated 
pilot ‘proof of concept’ studies to begin exploring the physiological role of endogenous GST 
using a mouse ex vivo model known as the isolated perfused lung (IPL), which has been 
optimised in our laboratory over the past three years. This set of experiments was carried 
out in collaboration with Kenji Wakabayashi, a member of the critical care research group. 
The major advantage of using this ex vivo lung model is that it involves the lung as a 
complete organ with its many cellular and humoral interactions between the resident cells 
and is therefore more realistic than in vitro cell culture. Furthermore, recent improvements 
to the method have allowed the duration of IPL experiments to be increased.  
 
Similarly to the in vitro experiments, the perfusate of this ex vivo model was supplemented 
with EA for up to 2 h to elucidate the impact of GST attenuation on lung mechanics and gas 
exchange parameters of the IPL model. Alterations of pro-inflammatory cytokine levels in 
the perfusate and BALF were also assessed. The presence of GST inhibitor EA caused major 
changes in lung mechanics and significantly increased epithelial barrier permeability. 
Collectively, the data suggest that the presence of EA may lead to lung injury, which was 
represented by the increased pulmonary permeability, oedema formation and subsequent 
rise in pulmonary elastance and resistance. However, in contrast to our hypothesis, EA was 
found to significantly reduce cytokine (KC and MIP-2) release compared to that observed in 
the untreated control IPL. Although our preliminary findings are compatible with the 
hypothesis that attenuation of overall GST by EA is associated with epithelial cell stress such 
as cell injury and barrier dysfunction, these would need further confirmation and 
mechanistic insights in larger definite studies. 
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9.1 BACKGROUND 
As discussed in the General Introduction (Chapter 1) ALI and ARDS are severe pulmonary 
diseases that can develop as a result of intense pulmonary inflammation leading to 
respiratory failure. Oxidative stress in particular has been implicated in its pathophysiology. 
Several candidate susceptibility genes (such as those encoding antioxidants) have been 
evaluated in animal models due to their involvement in ALI/ARDS pathogenesis. For 
instance, experiments with SOD3 knockout mice have shown that deletion of SOD3 
enhanced susceptibility to lipopolysaccharide (LPS)-induced lung injury and inflammation, 
whereas overexpression of SOD3 reduced inflammation induced by LPS thus confirming an 
important role for this gene in protection against lung injury 408. Functional polymorphisms 
displayed in patient case-control investigations (identified using genetic and genomic 
approaches) have also highlighted genes that may potentially contribute to the 
pathogenesis of and/or susceptibility to ALI. GST and  isoforms specifically, appear to be 
important in the survival response to such oxidative stress, and a recent clinical study, 
revealing the beneficial effect of NAC in ALI/ARDS patients, reported the need for GST 
genotyping in predicting patient’s clinical response to NAC treatment 275. Despite these 
clinical associations between GST polymorphisms and susceptibility to and outcome of ALI 
syndromes, to my knowledge, there are no in vivo studies investigating the mechanisms 
which link these two factors. 
 
We have so far reported the cytotoxic effects of GST attenuation in in vitro models of ALI. 
While these studies have suggested the importance of GST in cell survival, specifically in 
stressed conditions, cell culture studies are unable to accurately mimic cellular responses in 
a whole organism. The signalling, feedback loops and crosstalk between different cell types 
and systems in individual tissues, organ systems and organisms is highly complex. Although 
more clinically relevant, animal models also have their limitations. For example, in vivo 
phenotypes resulting from ALI-related challenges may not share the same pathogenic 
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mechanisms as those observed clinically. In addition, it is difficult to study the role of a 
protein (such as GST) in one specific organ such as the lung. While in vivo pharmacological 
or siRNA -mediated inhibition are strong tools for investigating the role of a specific protein, 
the resulting systemic effects can make the mechanistic interpretation difficult. For instance 
EA is a strong diuretic that modulates the reabsorption of sodium and water in the 
ascending limb of the loop of Henle. As a result, plasma volume falls and aldosterone 
production rises, both of which can cause systemic effects. In addition, like any 
pharmacological agent, EA administration can cause a number of side-effects which could 
interfere with its specific GST-inhibitory effect in the lung.  
 
To overcome such difficulties, we employed an ex vivo IPL model, where the lung is 
ventilated in the same way as an in vivo mouse model, but perfused as an independent 
organ. This enabled us to exclude the diuretic effect of EA, while still maintaining the 
physiological relevance. As such, this IPL model provided a useful tool for investigation into 
the impact of GST inhibitor EA on pulmonary physiology and function. In addition to the 
pathophysiological effects of EA on respiratory mechanics and pulmonary permeability, we 
considered the possibility that GST inhibition may also modulate expression of inflammatory 
mediators. These often serve as a sensitive index of pulmonary stress during mechanical 
ventilation as supported by findings from an ARDS study in which mortality correlated with 
cytokine levels 409. 
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9.2 AIMS 
The underlying hypothesis of this work was that inhibition of endogenous GST would 
increase oxidative damage of pulmonary tissue, which could in turn disrupt pulmonary 
physiology and initiate an inflammatory response in the IPL setting. As a first step towards 
testing this hypothesis, we have investigated the influence of GST inhibitor EA on the 
physiology of and inflammatory gene expression in a mouse IPL model. We specifically 
assessed the effects on: 
 
a. respiratory mechanics; 
b. pulmonary permeability; and  
c. inflammatory gene response of the lung. 
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9.3 PROTOCOLS 
The IPL system is described in detail in Chapter 3. In brief, mice were anaesthetised, 
ventilated, and after thoracotomy/laparotomy, heparinised and exsanguinated. Lungs were 
then ventilated with VT of 8 ml/kg and perfused in a non-recirculating manner via the 
perfusion circuit illustrated in Figure 3.3 (page 122). Photographs of the ex vivo mouse IPL 
model and the cannulated lung and heart, taken by Dr Kenji Wakabayashi, are shown below. 
A B
 
 
 
 
The pulmonary arterial pressure (PAP) was monitored continuously via the side port of the 
PA cannula. The system was equilibrated for 15 min and baseline measurements were 
recorded. Mice were perfused for a further 1 h 45 min with RPMI in the absence/presence 
of GST inhibitor EA. Preliminary perfusions were carried out with the routine clinical dose of 
the diuretic drug EA, 30mg/L (0.1mM), however this caused no significant change in the 
respiratory mechanics, perfusion pressure or pulmonary permeability, therefore an 
increased dose of 1mM EA was used for all subsequent experiments.  
 
The ventilator setting is a critical determinant of pulmonary injury, thus it was carefully 
considered and adjusted in the optimisation of the IPL model in order to reduce the basal 
Figure 9.1 Photographs of the ex vivo IPL model. (A) Mechanical ventilation is underway and the 
ribcage has been pinned down, allowing cannulas to be inserted into the pulmonary artery and the 
left atrium of the heart. The lungs are then perfused in a non-recirculating manner. (B) During the 
equilibration period, perfusion washes blood out of the lungs, which subsequently appear white. 
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level of injury and extend the length of perfusion. The ventilation strategy included a low VT, 
a positive end-stage expiratory pressure (PEEP) of 2.5-3cmH2O and sustained inflations (20 
cmH2O for 5 seconds) every 5 min to re-inflate any collapsed part of the lung and thus avoid 
atelectrauma. The airway pressures (PEEP, peak inspiratory pressure PIP, and plateau 
pressure Pplat) and gas flow were monitored by a transducer and pneumotachograph 
respectively, and respiratory system elastance (Ers) and resistance (Rrs) determined by end-
inflation occlusion 303 at 5-minute intervals (just prior to the sustained inflations). Data were 
acquired using a PowerLab data acquisition system (as detailed in 3.10). In addition, 
perfusate was collected from the reservoir at 30-min intervals for immediate gas analysis. 
 
Ventilation was carried out for 2 h but was stopped prematurely if the PIP increased by 
>30% of its initial value. Upon termination of experiments, BALF was collected and lungs 
were harvested (as detailed in 3.10) and used immediately, along with perfusate samples to 
assess pulmonary permeability. We used a fluorescence-labelled (Alexa Fluor 594-
conjugated) albumin to identify the extent of vascular leak into the alveolar space 305,306. The 
protocol is described fully in Chapter 3.10. Evaluation of the fluorescence levels of 
perfusate, BALF and lung homogenate supernatants (using fluorescence plate reader at 
590nm) gave us an index of endothelial and epithelial permeability by the ratio of 
lung:perfusate and BALF:perfusate fluorescent signal, respectively. The impact of EA on 
pulmonary permeability was also assessed independently through determination of BALF 
protein concentration.  
 
In line with the investigation into the impact of GST inhibition on inflammatory gene 
expression in vitro (described in Chapter 7), we evaluated the release of pro-inflammatory 
cytokines KC and MIP-2 in the IPL model perfused with/without EA. Both perfusate and BALF 
samples (collected at 30-min intervals and upon termination, respectively) were aliquoted, 
stored (at -80°C) and later used for cytokine analysis by ELISA (as described in 3.5). 
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9.4 RESULTS 
 
9.4.1 Impact of EA on pulmonary physiology 
 
Respiratory mechanics 
Supplementation of perfusate with EA resulted in a 30% rise in PIP and significantly 
increased Pplat from 8.7 1.3 to 11.6 2.4 cmH2O after 120 min as shown in Figure 9.2 A + B, 
respectively. 
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Figure 9.2 Influence of EA (   ) on airway pressures of the mouse IPL model: (A) Peak inspiratory 
pressure (PIP) and (B) plateau pressure (Pplat). Control is represented by ▲. These were monitored 
every 5 min and data is displayed at 15 min intervals. N=3; *p<0.05 vs. untreated control at matched 
time point. 
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It is well acknowledged that an increase in PIP is indicative of oedema formation however 
this can arise from an elevation in Ers or Rrs, individually or combined. In the control IPL, 
there was a non-significant tendency for both Ers and Rrs to decrease over time (Figure 9.3 A 
+ B, respectively). In contrast, the presence of EA resulted in significant changes in both Ers 
and Rrs, which displayed 32.3 27 and 29.1 21 % increase, respectively, compared with 
baseline values at the 2 h time point. 
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Figure 9.3 Influence of GST inhibitor EA (   ) on respiratory mechanics of mouse IPL over 120 min. 
(A) Respiratory elastance (Ers) and (B) respiratory resistance (Rrs) were monitored every 5 min and 
results are displayed at 15 minute-intervals. Control IPL (in the absence of EA) is represented by ▲. 
N=3; *p<0.05 vs. untreated control at matched time point. 
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Perfusion parameters 
The PAP remained <8mmHg throughout the control IPL experiments (Figure 9.4). In addition, 
EA-supplemented perfusate had no significant effect on PAP, even after 120 min perfusion.  
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Gas analysis of perfusate was performed at 30-minute intervals to monitor pulmonary gas 
exchange. The partial pressure of O2 (pO2) was approximately 150mmHg, while that of CO2 
was found to be between 35 – 37mmHg. Neither pO2 nor pCO2 significantly changed during 
the 120-minute perfusion and both are within the physiological range. 
 
Pulmonary permeability 
The permeability index (PI) was assessed after 2 h perfusion, using a fluorescence-labelled 
albumin marker. The endothelial PI increased by over 35% in the presence of EA, however 
this was not found to be significant. In contrast, a significant 3-fold increase in the 
BALF:perfusate ratio of fluorescent signal (an index of the epithelial barrier permeability) 
was observed in the presence of EA, as compared to control (Figure 9.5). 
  
Figure 9.4 Impact of EA (  ) on pulmonary arterial pressure (PAP) over 120 min of perfusion. 
Control IPL is represented by ▲. No significant changes were observed during the course of 
perfusion in either group. N=3. 
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To obtain an independent measure of lung permeability, the protein content of BALF from 
control and treated IPLs was also assessed. EA-supplemented perfusate led to a significant 
change in BALF protein, resulting in an increase from 0.69 0.45 to 4.27 2.42 mg/ml as 
shown in Figure 9.6.  
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Figure 9.5 Influence of EA-supplemented perfusate on endothelial and epithelial barrier 
permeability in IPL model. This was determined by the degree of translocation of a fluorescence-
labelled albumin marker from the perfusate to lung tissue and intra-alveolar space. N=3; *p<0.05 vs. 
control IPL. 
Figure 9.6 Influence of EA-supplemented perfusate on BALF protein content following 2 h 
perfusion in IPL model. This was assessed by the protein assay. N=3; *p<0.05 vs. control IPL. 
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9.4.2 Impact of EA on inflammatory response 
 
Perfusate cytokine content 
Assessment of pro-inflammatory cytokines revealed a significant increase in both KC and 
MIP-2 released into the perfusate of control IPL experiments. In contrast to our hypothesis, 
we found that cytokine levels were significantly lower in the presence of EA (Figure 9.7). For 
instance, following 90 min of EA-supplemented perfusion, the levels of KC and MIP-2 fell by 
80 and 65%, respectively. 
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 Figure 9.7 Influence of EA on inflammatory cytokine release into the perfusate. (A) KC and           
(B) MIP-2 release during the course of perfusion. N=3; *p<0.05 vs. untreated control at matched 
time-point. 
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BALF cytokine content 
We also investigated the level of KC and MIP-2 in BALF collected upon termination of the 
experiments. Similarly to the data reported above, significant quantities of pro-
inflammatory cytokines were found in the BALF of control IPL experiments and the presence 
of EA in the perfusate led to a significant drop in the level of both KC and MIP-2 released 
into the BALF. More specifically, BALF KC content fell from 1234.6 449 to 360.7 96 pg/ml, 
while that of MIP-2 fell from 3217.1 1578 to 861.8 280 pg/ml, as shown in Figure 9.8 
below.  
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Figure 9.8 Influence of EA on BALF cytokine levels in mouse IPL model. (A) KC and (B) MIP-2 levels 
detected in the BALF, collected after 120 min perfusion. N=3; *p<0.05 vs. untreated control. 
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9.5 DISCUSSION  
In our experiments, we found that routine clinical and experimental doses had no effect on 
pulmonary physiology of our IPL model or the inflammatory response, as compared to the 
control IPL. In contrast, higher doses of EA produced dramatic alterations in lung mechanics, 
permeability and cytokine release, as I shall discuss below. This could indicate that higher 
doses of EA attenuate GST more effectively which over time renders the lung more 
susceptible to injury. It is also possible that EA, at this higher concentration, has a number of 
non-specific, deleterious effects.  
 
9.5.1 EA-induced changes in lung mechanics 
We found that both the PIP and Pplat remained stable throughout the perfusion of the 
control IPL experiments, but increased progressively in the presence of GST inhibitor EA, 
peaking at termination of the experiments (after 120 min perfusion). An increase in PIP (and 
Pplat) could be a direct result of either increased pulmonary Ers or Rrs, individually or 
combined.  
 
In contrast to control IPL experiments, our data shows that EA treatment leads to a rapid 
rise in Ers after 105 min perfusion. This increased tendency for the lungs to recoil is 
indicative of alveolar fluid accumulation. Importantly, elastance could be influenced by 
factors other than lung fluid including pulmonary fibrosis, atelectasis and increased 
pulmonary venous pressure 410. Of these, atelectasis is the only variable likely to be present 
in this model, but with the use of lung recruitment manoeuvres involving sustained 
inflations (specifically applied to re-inflate any collapsed lung units), the risk of atelectasis 
was minimised. Similarly, the presence of EA in the perfusate resulted in a significant 
increase (of >30%) in Rrs compared to baseline values, in contrast to the very small changes 
seen in the control IPL model over the same time period. This increased resistance most 
commonly occurs due to: secretions, filling of the conductive airways with oedema or 
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interstitial oedema surrounding the airways. Clinically, this has been seen to increase PIP 
but not affect plateau pressure 411. Collectively, these respiratory mechanics data suggest 
that the presence of EA increases oedema formation in the intra-alveolar spaces and the 
conductive airways. This is likely to be the main contributor towards increased PIP and Pplat 
and can result from epithelial or endothelial barrier injury and increased permeability.  
 
9.5.2 Impact of EA on pulmonary permeability 
Pulmonary oedema generally accumulates when microvascular and alveolar permeability 
increase, facilitating passage of fluids, plasma proteins and activated inflammatory cells into 
the interstitial tissues and ultimately into the alveoli themselves. Interstitial oedema and 
inflammatory parenchymal damage can cause severe hypoxaemia, a characteristic feature of 
ALI/ARDS. While pO2 levels remained constant throughout perfusion, probably due to the 
low oxygen consumption of the lung, we found that EA exposure led to an increase in the 
pulmonary permeability and BALF protein content. The increase in lung:perfusate ratio of 
fluorescent signal is indicative of microvascular injury, while the significant increment in 
BALF:perfusate ratio of fluorescent signal suggests that the alveolar epithelial barrier is more 
severely injured. However, it is difficult to make solid conclusions from the endothelial 
permeability data, as a large proportion of tracer (fluorescent dye) may have translocated 
into the intra-alveolar space due to the significant breakdown of the epithelial barrier. 
Nevertheless, collectively these data indicate that GST inhibitor EA causes endothelial and 
epithelial injury. This may have led to an infiltration (or leakage) of proteins from the 
vascular and interstitial space into the alveolar compartments, demonstrated by the rise in 
BALF protein upon termination of perfusion.  
 
Mounting evidence suggests that a major cause of increased permeability and intra-alveolar 
oedema formation is oxidant injury to the endothelial and alveolar epithelial cells. For 
instance, ROS (and RNS) can modify or damage ion channels (such as epithelial sodium 
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channels) that play a key role in maintaining fluid balance in the lung, via a number of redox-
regulated mechanisms 412. This situation can be further exacerbated as increased oxidant 
formation results in the depletion of key pulmonary antioxidant defences, that would 
normally prevent much of the ‘first-pass’ damage in the lung. While the antioxidant defence 
system of the lung is complex, one of the key cellular defences is glutathione (GSH) and 
glutathione-metabolising enzymes such as GSTs, which are particularly important in 
removing toxic secondary oxidation products, specifically lipid hydroperoxides (LOOHs, 
formed from oxidation of PUFAs) and lipid-derived aldehydes. Members of the GST 
superfamily appear to be essential in catalyzing the addition of GSH to electrophilic carbon 
centres on these various secondary oxidation products. This process usually detoxifies the 
compound (via biotransformation) and may also mark it for export from the cell. Our 
findings support the importance of GSTs as protective antioxidants against pulmonary injury, 
through demonstration that GST inhibitor EA leads to an increase in lung permeability and 
BALF protein and an alteration in pulmonary mechanics associated with oedema formation. 
 
Pulmonary oedema can also arise from increased capillary hydrostatic pressure. Notably, 
despite significant changes in respiratory mechanics and permeability, EA had no significant 
effect on PAP. As left atrial pressure was kept constant, PAP is also indicative of pulmonary 
vascular resistance (PVR), therefore our results suggest that in a constant flow preparation, 
the major determinants of PVR (such as microvascular tone and reactivity) remained 
unaffected by EA.  
 
9.5.3 Influence of GST inhibitor EA on inflammatory response of IPL 
Lung-borne cytokines are commonly involved in the development of organ failure 413. 
Furthermore, it has been documented that increased ROS, such as LOOH and their 
downstream oxidative products (i.e. substrates of GST enzymes) can cause constitutive 
activation of cell signalling pathways 414, which could in turn result in an upregulation of 
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inflammatory players. We therefore evaluated the influence of GST inhibitor EA on the 
levels of pro-inflammatory cytokines released into both the perfusate and BALF. However, 
our cytokine data were quite unexpected. 
 
In the control IPL experiments we found a relatively high level of and time-dependent 
increase in both KC and MIP-2 in the perfusate, starting from 30 min of control perfusion. 
ELISA analysis of BALF samples revealed similarly high levels of KC and particularly MIP-2. 
This may indicate that despite preserved lung physiology in our control IPL method, we still 
trigger an inflammatory response capable of inducing pro-inflammatory cytokine release. It 
is interesting to note, the discrepancy between high cytokine content and preserved lung 
mechanics and permeability, indicating that these cytokines alone are not sufficient to 
produce large pathophysiological responses. The mechanisms triggering such an 
inflammatory response in our IPL remain unknown. Experiments carried out after the series 
described here, suggest that the system may have been contaminated with bacterial 
lipopolysaccharide. Changing the source of bovine albumin and ensuring solutions are free 
of endotoxin, has subsequently attenuated the pro-inflammatory events during normal IPL.  
 
Our working hypothesis was that EA may induce pulmonary physiological changes through 
increased oxidative stress and perhaps redox related inflammatory signalling and cytokine 
release. In contrast to this, we found that EA-supplemented perfusate significantly 
attenuated cytokine release, despite a significant pathological response reflected by 
changes in lung mechanics and permeability indices. These data again demonstrate that the 
latter physiological changes are independent of KC and MIP-2. We may postulate therefore 
that GST inhibition by EA enhances oxidative stress which directly affects endothelial and 
epithelial barrier function leading to increased permeability and altered lung mechanics. 
Such oxidative stress may actually inhibit redox signalling, attenuate NFB activation and 
interfere with inflammatory gene expression. These in vivo data would correlate with our in 
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vitro observations whereby higher concentrations of EA reduced adhesion molecule 
expression. Secondly, GST inhibition may impact on various metabolic pathways which may 
directly impact on permeability and/or have a negative influence on gene expression and 
subsequent protein synthesis.  
 
While this interpretation is plausible, EA exposure may induce various deleterious off-target 
effects such as ion channel modification. Alternatively, the dose of EA employed in our IPL 
experiments may have been relatively toxic, causing rapid injury and potentially resulting in 
the upregulation of apoptotic gene expression as opposed to that related to inflammation. 
As such, it is possible that EA, although a clinically-used drug, may be injurious in some 
situations. Therefore we cannot rule out that the effects of EA may be unrelated to GST 
inhibition. Nevertheless, these preliminary experiments have allowed us to successfully 
evaluate the impact of GST inhibitor EA in the ex vivo IPL model. Furthermore, our findings 
are compatible with our overall notion regarding the potentially important physiological 
roles of GST in regulating endothelial and epithelial permeability and aspects of pulmonary 
inflammation. Further studies and genetic approaches such as in vivo siRNA or GST knockout 
mice may highlight specific roles of endogenous GSTs in pulmonary physiology, function and 
inflammatory response in optimal and stress conditions. Unfortunately these are outside 
the scope of my PhD program.  
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SUMMARY 
Since the first description of ARDS in 1967, many studies have been performed in an 
attempt to develop new therapies and ventilation strategies that could improve outcomes 
for ALI/ARDS patients. The reported mortality rates vary hugely; some studies show a 
significant decrease in mortality rate and relate this to improved treatment of the 
underlying disease and the use of "lung-protective" mechanical ventilation strategies. By 
contrast, a number of studies still report >50% mortality rates, highlighting the lack of 
specific therapies available, and thus warranting the need for more basic research. 
 
Regardless of the underlying illness, the clinical and pathological manifestations of ALI/ARDS 
are very similar. Oxidative stress has emerged as one of the central and common features in 
the disease’s pathophysiology, perpetuating tissue injury and inflammation. However, the 
outcomes of several antioxidant-mediated studies have been largely unsuccessful. Although 
the major components of antioxidant defence and thus potential therapeutic targets have 
been known for some time, new information has recently sparked considerable interest in 
the GST enzyme family in the clinical setting.  
 
Within this PhD project, we investigated the role of total and specific intracellular GST 
activity in in vitro models of stress. One of our major findings was that GST attenuation 
induced death in various cell types and rendered cells more susceptible to stress-induced 
injury. We concluded that this response was mediated by ROS accumulation which may in 
turn cause cell injury directly or via modulation of (i) metabolic balance and/or (ii) redox-
signalling mechanisms. It appeared that GST activity attenuation in the ex vivo IPL model 
affected pulmonary mechanics and permeability, but did not induce inflammatory gene 
response. The discussions in Chapters 4 – 9 were largely limited to the specific hypotheses 
tested and the results generated. Thus in this final chapter I shall draw together the 
conclusions that we reached and discuss them in the context of relevant literature. 
 273 
10.1 TREATMENT OF ALI WITH ANTIOXIDANTS 
It is well acknowledged that ALI/ARDS may be produced or worsened by the accumulation 
of toxic oxygen free radicals and non-radical oxidant species. One of the earliest 
manifestations is the activation of pulmonary endothelium and macrophages, which 
upregulate adhesion molecules and cytokines that induce a massive sequestration of 
neutrophils from the pulmonary microvasculature into the alveolar space. Here the 
activated leukocytes, and as a result, the resident pulmonary cells, release a variety of 
cytotoxic and pro-inflammatory compounds; primarily ROS/RNS and inflammatory 
cytokines. While there are many antioxidant defence mechanisms in place, extensive 
overproduction of ROS can overwhelm endogenous antioxidants systems and ultimately 
permit oxidative cell-damage. This phenomenon has been demonstrated in ARDS patients 
by a decrease in total GSH and a relative increase in GSSG in alveolar fluid 415. 
 
As a result the administration of antioxidants such as SOD and Vitamin E and C has been 
frequently evaluated in the prevention and/or management of patients with ALI/ARDS. In 
addition, it was also considered that repletion of GSH may safely be accomplished with NAC, 
due to its SH-donating properties, which may restore cellular redox state and shorten the 
duration of lung injury 416. Recent studies have shown that intravenous treatment with NAC 
can effectively increase extracellular antioxidant power and total thiol molecules, and 
improve systemic oxygenation 417. Subsequent studies demonstrated that the need for 
ventilatory support in patients presenting with mild to moderate ARDS, was reduced by NAC 
treatment and the outcomes of patients improved. However, as with many therapeutic 
studies, there are discrepancies in the results, with several studies reporting no survival 
benefit of NAC administration, despite promising results in the early onset of ALI 418. 
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One possible explanation for discrepancies in clinical studies is genetic heterogeneity within 
the studied population. This was explored by Moradi et al., who recently revealed that 
treatment with NAC has a beneficial effect in ALI/ARDS patients by improving oxygenation 
and decreasing mortality rate, especially in patients with GST M1 null or GST M1 and T1 
double null genotypes 275. This is an important study, as it highlights a different concept in 
the nature of oxidative stress. It suggests that the principal limitations in oxidative stress 
defence, in sensitive individuals, may be related to the GST-mediated detoxification of lipid 
hydroperoxides and secondary oxidants in a GSH dependent manner. Although this study 
has provided principle proof for such a concept and highlighted the novel benefit of NAC 
treatment in ALI/ARDS in a personalised way depending  GST genotypes, further multicentre 
and randomised studies with larger patient sample size is required to provide further poof 
and perhaps better treatment protocols. 
 
Another major ‘proof of principle’ line of investigation, supporting the potential beneficial 
role of GST system in ALI, comes from studies aiming to increase GST activity in stress 
conditions, through upregulation of specific GST isoforms (in particular GST) 419 or delivery 
of recombinant GST enzymes into cells and in vivo mouse models 313. In various 
experimental models these have lead to reduced oxidative stress, suppression of the 
inflammatory response and reduced cellular and organ injury.  
 
These studies indicate the beneficial aspects of GST activity in stress conditions, specifically 
in the protection against cell death and attenuation of inflammation. However, the 
pertinent question of how reduced GST activity in individuals with GST polymorphisms 
impacts on the patient’s response to oxidative stress and their susceptibility to injury in the 
clinical setting, remains unknown. We have attempted to explore this issue in detail through 
relevant experimental models, in this project. 
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10.2 PRECISE ROLE OF GST IN MECHANISMS UNDERLYING ALI PATHOGENESIS 
Investigation into the biological role of GST in lung epithelial cells was, on the whole, 
successful. We revealed that GST inhibitors EA and CA compromised MLE (as well as mouse 
endothelial and human epithelial) cell viability in a concentration- and time-dependent 
manner and rendered MLE cells more susceptible to oxidative and metabolic stress. These 
data suggest that endogenous GST activity is essential for normal homeostasis and viability 
of cells exposed to IR-related stress. The involvement of specific GST isoforms in cellular 
response to stress was evaluated following RNAi-mediated GST  and  attenuation. 
Interestingly, cells transfected with GST siRNA were more susceptible to injury under 
normal and H2O2 or Hx/Rx conditions, perhaps highlighting the specific importance of GST 
in the survival of lung epithelial cells exposed to physiological and stress conditions.  
 
Our data strongly suggest that cell death is mediated by an accumulation of ROS, with 
redox-sensitive fluorescent probes DCF and DHR123 demonstrating a significant increase in 
fluorescence after exposure to EA, alongside a concentration-dependent decrease in 
intracellular NAD⁺/NADH ratios confirming a change in global intracellular redox state. 
Furthermore, NAC blocked EA-induced ROS increase completely, and abolished EA and CA-
induced cytotoxicity suggesting that oxidative stress is the primary mediator of GST 
inhibitor-induced cell death. EA was also found to significantly potentiate H2O2-induced 
increase in protein carbonyls, highlighting their potential involvement. 
 
While EA and the associated oxidative stress had no effect on the mitochondrial function, as 
far as ATP synthesis is concerned, our metabonomics data revealed that oxidative stress and 
GST inhibitor significantly altered the global metabolic profiles of cells, with nearly 60% of 
identified metabolites changing considerably. It would be important to consider information 
generated from metabolic profiling, genetics, transcriptomics and proteomics research 
paradigms to fully understand the mechanisms underlying GST inhibition. 
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Many reported aspects of GST polymorphisms could be explained by activation of redox 
signalling pathways and inflammatory gene expression. Contrary to expectation, we found 
that neither p38 nor p65 are likely mediators of cell injury. Our initial data suggested that EA 
activates p38 which may trigger transcription factors, other than NFB, which may in turn 
stimulate inflammatory gene expression. However GST attenuation, using either 
pharmacology or genetic strategies, failed to modify the expression of a select number of 
inflammatory genes, suggesting that and individual’s inflammatory profile (namely 
chemokine and adhesion molecule expression) is not affected by reduced GST activity. 
 
Pilot studies, using a mouse ex vivo IPL model and the GST inhibitor EA, were carried out to 
explore the physiological role of GST. EA caused major changes in lung physiology, 
increasing respiratory elastance and resistance, and pulmonary permeability. Unexpectedly, 
EA significantly reduced rather than increased pro-inflammatory cytokine (KC and MIP-2) 
release. However, these data consolidate those revealed in in vitro experiments of 
inflammatory gene expression and imply that GST inhibition has very little effect on these 
particular inflammatory cytokines.  
 
In summary, the changes in a number of cellular responses and intracellular mechanisms 
induced by the presence of GST inhibitors have highlighted and partly defined the biological 
and physiological role of GST. Many of our findings have been robust, supporting our 
original hypothesis that GST is an essential player in the intracellular defence against 
oxidative stress. 
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10.3 FUTURE DIRECTIONS 
Given the reported association between GST polymorphisms and development of PGD 
following lung transplantation, and ARDS in critical care, our data may shed light on the 
mechanistic concepts underlying such clinical observations. However, we must consider the 
major limitations of this PhD, such as the use of pharmacology, the small number of 
independent experiments carried out and the high concentrations of EA used in IPL 
experiments, and the translationability of our data from mouse to human. Therefore, 
further studies could be carried out to strengthen some of our data.  
 
For instance, we have clearly demonstrated, by several different means, that EA-induced 
cell death is mediated by intracellular oxidative stress. In an attempt to identify the nature 
of oxidant species we found that H2O2-induced increase in protein carbonyl levels was 
significantly enhanced. To expand on these findings, it would be interesting to assess the 
EA-induced variability in upstream lipid hydroperoxides or lipid-derived aldehydes, 
specifically those known to be GST substrates. Such data could draw attention towards 
deleterious effects of specific compounds, which accumulate in the event of reduced GST 
activity, and may highlight potential therapeutic strategies.  
 
Secondly, the metabonomics approach was able to define the global and specific metabolic 
profile of MLE cells in response to oxidative stress and GST inhibition, however due to time-
constraints; in-depth studies into the impact of the most variable metabolites could not be 
carried out. Further investigation into these modified metabolites and their potential role in 
GST-inhibitor induced cytotoxicity may provide links between oxidative stress and resulting 
cell injury. Since such global metabolic profiling is sensitive enough to identify small 
metabolic alterations under varying conditions, it would also be useful to explore the 
metabolic profile of IPL tissues and perfusate following attenuation of GST activity. This 
exploratory investigation could be extended to evaluating ‘exhaled breath’ or ‘tissue 
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samples’ from clinical patients in ICU, who could also be genetically screened for GST 
polymorphisms. This may help elucidate the source of metabolite biomarkers and highlight 
further roles of important enzymes such as GST. 
 
While we demonstrated that GST inhibition induced p38 activation, the increase in our 
chosen inflammatory molecules was limited. Therefore further studies focussing on 
different inflammatory pathways, including alternative signal transduction events and 
expression of other inflammatory gene products, are needed to clarify the precise role of 
GSTs in a stress-induced inflammatory response. 
  
For the most part of my PhD, I focussed on in vitro attenuation of GST in single cell lines. 
While the presented data strongly indicates the importance of total intracellular and 
specifically GST isoform in the protection of cells exposed to oxidative stress, it is difficult 
to extrapolate these data to explain the clinical observations regarding the roles of GST  
and  polymorphisms in ALI. Successful epithelial-leukocyte co-culture stress models (which 
is not represented by the ex vivo IPL model), with attenuated GST  or  expression, would 
highlight the importance of leukocyte-epithelial signalling and perhaps reveal a more 
significant role in the setting of leukocyte-mediated lung injury.  
 
In addition, we had hoped to further our studies with the ex vivo IPL by establishing an IR 
model and investigating the impact of attenuated GST, through the use of GST inhibitor EA. 
However, the IPL system principally is devoted to the PhD project of another student in the 
Critical Care Group and priorities had to be given to his own studies. During my write-up 
period the group had the opportunity to develop the mouse IR model, thus the influence of 
EA on IRI may be feasible in the future using the mouse IPL system. 
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Beyond the pharmacological model and its associated limitations, we have considered the 
application of genetic models for the IPL preparation. Currently there are knockout mice 
available for at least four different GST isoforms including  and . While both of these 
knockout animals should be tested, our siRNA studies in cultured cells would predict specific 
importance of the GST. Thus my strategy would be to focus on  knockout animals. In 
these experiments, physiological and biochemical responses of the IPL taken from wild type 
mice and knockout mice and subsequently exposed to IR, could be assessed and compared. 
This combination of in vitro and ex vivo pharmacological and genetic experiments should 
provide robust opportunities to conclude the potential roles of GST in the setting of IR and 
oxidative stress conditions and on the intracellular mechanisms contributing to its 
cytoprotective properties. 
 
Beyond IRI it would be interesting to explore the role of the GST enzymes in other models of 
lung injury. Our laboratory has established mouse models of ventilation induced lung injury 
in healthy animals, and various models of airway and lung microvascular inflammation in 
single and double hit models. The studies could be easily expanded into these areas 
broadening the scope to ALI of mechanical or infective (pneumonia and sepsis) origin.  
 
Alternative experiments could consider human studies in patients with GST polymorphism 
both in the lung transplant or critical care setting. Epithelial cells or alveolar macrophages 
could be isolated from lung tissue, obtained during the clinical evaluation, and oxidative 
stress, metabolic profile, redox signalling and gene expression could be assessed. However, 
obviously such studies would be very complex and GST polymorphism would only be one 
factor in the observed changes. Thus, experimental studies would still be much needed in 
the fundamental understanding of this fascinating paradigm. 
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10.4 CONCLUDING REMARKS 
This project has addressed many aspects of the role of GST in ALI-related pathologies, in 
experimental models. I have identified that global (non-specific) GST attenuation can result 
in epithelial and endothelial cell death which is likely a result of increased intracellular 
oxidative stress. We also showed that the presence of EA enhanced cellular injury induced 
by various stresses possibly via oxidative stress-mediated potentiation of protein 
carbonylation and metabolic derangements. To expand on these findings, I developed an 
siRNA transfection model, whereby GST  and  expression and activity were significantly 
attenuated and I was able to demonstrate that a lack in functional GST isoform specifically 
can have deleterious effects on cell viability in both physiological and stressed conditions 
(such as H2O2 and Hx/Rx). While further ex vivo and in vivo studies are required to 
strengthen this data, these findings support our original hypothesis and emphasize that GST 
activity is paramount in the survival of cultured lung epithelial cells, especially in stress 
conditions. These interesting findings could be extrapolated to the clinical situation, helping 
us interpret how GST polymorphisms may impact on the survival of patients with pulmonary 
disorders. For instance, in line with suggestions by Moradi et al., it may, in the future, be 
beneficial to screen ICU patients for specific target genes such as GST, as this could enable 
patient-specific diagnosis and treatment, which may ultimately improve the prognosis of 
acute (and perhaps chronic) lung diseases. 
 
Limited progress was made with respect to identifying the signalling pathways involved in 
EA-induced cell death, as both p38 and NFB appeared to play protective as opposed to 
cytotoxic roles. In addition, GST inhibitor EA was found to have little effect on inflammatory 
gene expression, which could possibly be explained by the lack of intercellular 
communications and crosstalk between the cellular and humoral arms of an organ’s 
response to stress and which is essential in the expression of inflammatory mediators. 
Metabonomic profiling, a technique which has been used clinically to determine biomarkers 
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in the assessment of a patient’s pathophysiological state, but which has had little 
application in the quantification of experimental lung injury, revealed some interesting 
results. As discussed in ‘10.3 Future Directions’, such investigations could be carried out in 
animal models, as there is now a growing and unfulfilled need for predictive in vitro and in 
vivo models that can improve our understanding of disease pathogenesis. Metabonomic 
profiling of human samples, alongside GST genotype screening of ICU patients, may also 
provide further information of underlying mechanisms involved in pathophysiological 
response of individuals expressing GST polymorphisms. 
 
Finally, the use of the ex vivo mouse IPL model allowed us to begin investigating the impact 
of GST inhibitor EA in a physiological setting. We observed altered pulmonary mechanics, 
increased pulmonary permeability and an unexpected reduction in inflammatory cytokine 
release following perfusion with EA. In-depth investigation of the mechanisms underlying 
EA-induced physiological disturbance of the IPL was beyond the remit of this study, but in 
light of our data it appears that GST attenuation is also deleterious in the ex vivo setting. 
 
Some of our data is potentially very clinically applicable and, with further investigation, 
could have far-reaching applications in future research. One direct application could involve 
assessment of the impact of GST polymorphism on extent of donor lung injury and recovery, 
using ex vivo lung perfusion and reconditioning. In these settings, genetic analysis could be 
combined with tissue injury assessment, degree of oxidative stress and global metabolic 
derangements. I hope that my studies provide an excellent experimental framework and 
methodological know-how to pursue such exciting and directly clinically relevant research. 
The combination of such clinical translational studies together with progress in mouse 
models of donor injury and IRI, and mouse ex vivo lung perfusion in my supervisors’ 
laboratory, will provide a unique lung transplant study environment at Imperial College.  
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In summary, these comprehensive investigations have significantly improved our 
understanding of the relevance of endogenous GST in epithelial cell physiology and may 
have extensive future implications for studying the roles of specific GST isoforms and the 
cellular and molecular interactions involved in the pathogenesis of ALI in patients expressing 
GST polymorphisms.  
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